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Thesis Abstract 
Objective: Recent improvements in the treatment of Human-
Immunodeficiency Virus-1 (HIV) (Highly Active Anti-Retroviral Therapy 
[HAART]) have dramatically reduced mortality rates. However, improved 
survival has led to more people with HIV experiencing mild-moderate 
cognitive impairment. Impairments in executive functions (EF), for example 
planning and impulsivity, are often identified in people with HIV, with wide-
ranging and complex implications, including employment and medication 
adherence. Previous research has predominantly used ‗traditional tests‘ 
such as the Stroop, which do not have good ecological validity (Bennett et 
al., 2005). The main aim of this study was to assess EF in people with HIV 
using a battery approach with good ecological validity, the Behavioural 
Assessment of the Dysexecutive Syndrome (BADS) (Wilson et al., 1996). 
Secondary aims were: i. to compare BADS performance to functional 
outcomes associated with EF as measured by self- and other-report on the 
Dysexecutive Questionnaire (DEX) (Wilson et al., 1996), and ii. to assess 
potential mediating factors for EF impairment.  
 
Design: The study used a cross-sectional comparison pilot design to 
compare performance on the BADS of a sample of participants with HIV 
relative to the published normative data.  
 
Method: A total of 20 participants (13 men; 7 women) with HIV were 
assessed on the BADS and completed the DEX self-report. An identified 
proxy for each participant also completed the DEX. Demographic, medical 
and cognitive, emotional and behavioural information was also collected. 
 
Results: On average, participants scored significantly lower on the BADS 
relative to normative data. However, performance on the BADS did not 
relate to self- or other-report of everyday functioning as measured by the 
DEX. EF impairment on the BADS was present despite the majority of 
participants taking HAART and having maximally suppressed plasma viral 
loads. BADS performance was significantly associated with demographic 
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factors: gender and ethnicity, where female and Black African/Caribbean 
participants were more impaired.  
 
Conclusions: EF impairment, particularly impulsivity, planning and self-
monitoring, is evident in this sample of people with HIV relative to 
normative data published in the BADS manual. This suggests the value of 
using a battery approach with good ecological validity and converges with 
previous research suggesting EF impairment in people with HIV. The lack of 
significant association between the BADS and DEX-S and DEX-O might 
suggest potential limitations in insight, where participants are less able to 
accurately predict performance on the BADS or other people‘s perceptions. 
Further research should develop the use of neuropsychological batteries 
with good ecological validity to consider EF impairment in people with HIV in 
larger representative samples to improve external validity of the results. 
Clinical implications include the potential of EF screening for people with HIV 
and raised awareness in health service staff. 
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Abstract 
Impairments in executive functions (EF), for example planning and 
impulsivity, are often identified in people with Human-Immunodeficiency 
Virus-1 (HIV). Previous research has predominantly used ‗traditional tests‘ 
such as the Stroop, which do not have good ecological validity (Bennett et 
al., 2005). The main aim of this study was to assess EF in people with HIV 
using a battery approach with good ecological validity, the Behavioural 
Assessment of the Dysexecutive Syndrome (BADS) (Wilson et al., 1996). 
The study used a comparison pilot design to compare performance on the 
BADS within a sample of participants with HIV to the published normative 
data. A total of 20 participants with HIV were assessed (13 men; 7 women). 
On average, participants scored significantly lower on the BADS relative to 
normative data. Further research should develop the use of 
neuropsychological batteries with good ecological validity to consider EF 
impairment in people with HIV. Clinical implications include the potential of 
EF screening for people with HIV.  
 
Keywords: HIV/AIDS; Neuropsychological impairment; BADS; Dysexecutive 
syndrome; Ecological validity; Everyday functioning 
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Assessment of Executive Functions in Human-Immunodeficiency 
Virus-1 (HIV) Infection using the Behavioural Assessment of the 
Dysexecutive Syndrome: A pilot study 
 
Introduction 
Since the 1980s HIV has affected more than 40 million people worldwide 
(Manji & Miller, 2004) with 77,400 people living with HIV infection in the UK 
at the end of 2007 (Health Protection Agency [HPA], 2008). The 
introduction in the mid-1990s of Highly Active Anti-Retroviral Therapy 
(HAART) revolutionised the treatment of HIV by blocking viral replication 
and restoring immune function. This has dramatically improved survival 
rates, physical health, resistance to opportunistic infections and reduced the 
prevalence of HIV-Associated Dementia (HAD) (Lawrence & Major, 2002). 
Despite these improvements, up to 60% of people with HIV still present 
with mild-moderate HIV-related cognitive impairments, which significantly 
impact daily functioning (Ghafouri et al., 2006). In fact, the actual overall 
prevalence of cognitive impairment in HIV has increased, possibly due to 
increased survival rates and limited ability of some anti-retrovirals to cross 
the blood-brain-barrier, leaving the brain to act as a sanctuary for the HIV 
virus (Starace et al., 2002).  
  
HAART may have a non-uniform effect on neuropsychological functioning 
(Cysique et al., 2004) where participants on HAART regimes continue to 
experience deficits in cognitive abilities such as working memory and 
mental flexibility (Gibbie et al., 2006). Further still Starace et al. (2002) 
demonstrated individuals on HAART regimes were more likely to show 
cognitive impairment than those not taking HAART (Starace et al., 2002) 
(see extended paper). Cognitive impairments are most often observed in 
the symptomatic stages of HIV, but are often still detectable in 
asymptomatic stages when compared to the non-clinical population (Reger 
et al., 2002). As well as stage of HIV, the expression of cognitive 
impairment is thought to be predicted by other factors, such as low CD4 
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count, high plasma viral load, older age, intravenous drug use and female 
gender (DeRonchi et al., 2002) (see extended paper). 
 
Executive functions (EF) are associated with the frontal brain regions and 
describe abilities such as planning, mental flexibility, impulsivity, insight, 
decision-making and inhibition (Verdejo-Garcia & Perez-Garcia, 2007). 
These skills have been theoretically ‗fractionated‘ into a heterogeneous 
group of dissociable but interdependent skills necessary for socially 
appropriate behaviour (Jurado & Rosselli, 2007) (see extended paper). Even 
subtle deficits in EF can impact on quality of life (Heaton et al., 2004), 
medication adherence (Hinkin et al., 2002) and employment (Hoffman, 
1997). Consequently, research into EF may have wide-ranging implications 
for people with HIV, particularly for social and interpersonal relationships.  
 
Response inhibition (Hinkin et al., 1999), impulsivity (Hardy et al., 2006) 
and decision-making (Sahakian et al., 1995) have been shown to be 
impaired in people with HIV. However, EF has been predominantly assessed 
using ‗traditional measures‘, for example, Trail Making Test (Reitan & 
Wolfson, 1985) or the Stroop (Stroop, 1935) which are brief, abstract and 
laboratory-based. These traditional measures are often insensitive to EF 
problems and not representative or predictive of real-world problems 
(Alvarez & Emory, 2006). In other words, they have poor ecological validity 
(Chaytor & Schmitter-Edgecombe, 2003) (see extended paper). Hardy et al. 
(2006) used the Iowa Gambling Task (IGT), a measure with suggested good 
ecological validity which examines decision-making to assess people with 
HIV and found increased levels of impulsive behaviour compared to HIV-
negative controls. However, the relationship between the IGT and real-
world behaviour remains largely unexplored (Tranel et al., 2007). Moreover, 
no single test is sensitive to all aspects of the fractionated EF, so a battery 
approach has been indicated to better examine EF (Woods et al., 2009). 
Sahakian et al. (1995) used the Cambridge Neuropsychological Test 
Automated Battery (CANTAB) (Sahakian & Owen, 1992) and found EF to be 
particularly affected in people with HIV, especially planning. However, this 
study took place before the widespread introduction of HAART. 
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Comprehensive reviews of neuropsychological effects of HIV (Grant, 2008; 
Woods et al., 2009) have pointed to the remarkable lack of further research 
robustly exploring executive function in-depth, with participant selection 
heavily biased towards white homosexual men allowing for little 
generalisation to further populations (Pereda et al., 2000). 
 
The Behavioural Assessment of the Dysexecutive Syndrome (BADS) (Wilson 
et al., 1996) is a battery approach to EF assessment which has good 
ecological validity, simulating aspects of everyday living. The BADS is 
supplemented by the Dysexecutive Questionnaire (DEX), with versions for 
self- and other-report, providing evidence of functional outcomes associated 
with EF. There is a significant evidence base supporting the validity, 
reliability and superiority of the BADS over traditional tests of executive 
function (Norris & Tate, 2000) (see extended paper). The BADS has been 
used with many neurological populations such as Parkinson‘s Disease 
(Kamei et al., 2008), and people with risk factors for HIV, such as injecting 
drug-users (Verdejo-Garcia & Perez-Garcia, 2007).  
 
Therefore, the research problem is that previous empirical studies have 
identified EF impairment in people who are HIV-positive compared to the 
non-clinical sample using traditional measures. However, these traditional 
measures are limited as they do not easily reflect everyday experiences and 
are rarely comprehensive. This study therefore questions to what extent, 
and in what way, does EF impairment still exist when using a battery 
measure with good ecological validity which more accurately reflects real-
world experience.  On this basis EF in with people with HIV was assessed 
using the BADS in a cross-sectional descriptive pilot study to explore broad 
aims within a small sample and determine trends and patterns, before 
investing resources into larger studies (Van Gorp et al., 1993). This group 
difference comparison design (Coolican, 2004; Cook & Campbell, 1979; 
Fraker & Maynard, 1987) used independent samples to compare existing 
groups (see Extended Paper). This primary aim of the study was to: 
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 Explore executive function in people with HIV-infection using the 
BADS relative to published norms (Wilson et al., 1996).  
 
This reflects the real-life experience of clinical neuropsychologists who do 
not have the benefit of a control group and rely on normative data to 
interpret scores (Muir-Broaddus et al., 2002). This aimed to make the study 
findings more clinically relevant.   
 
The study had two secondary aims:  
i. To triangulate quantitative measurement of executive deficits on the 
BADS to self- and proxy-report questionnaires on day-to-day 
experience of executive functioning   
ii. To explore risk factors that might contribute to expression of 
executive deficits in people with HIV.  
 
Method 
 
Research Participants 
A sample of 20 participants with HIV participated in the study. Sample 
characteristics are presented in Table 1. This sample size is similar to 
previous pilot studies employing comparable methodologies (Jovanovski et 
al., 2007; Moriyama et al., 2002). Participants were recruited from local 
Genito-Urinary (GU) clinics and Infectious Diseases (ID) departments. Staff 
from these departments identified and approached potential participants 
according to the inclusion/exclusion criteria. If participants were interested 
in taking part staff took consent for participant details to be passed to the 
researcher using the referral form (Appendix B) and gave potential 
participants a copy of the study information sheet (Appendix C). The 
principal investigator also liaised with local charitable organisations to 
advertise (Appendix D) and enable self-referral to the study through the 
distribution of information sheets and referral forms via these agencies. 
Participants were not recruited on the basis of known/suspected 
neurological deficits. 
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Characteristic Frequency            Mean (SD) Range 
Demographic Factors 
Age (years)  43.47 (8.26)  28-59 
Gender  
        Male 
        Female 
 
13 
7 
 
 
 
Ethnicity  
       White British 
Black African/ Caribbean 
 
15 
5 
 
 
 
Sexual Orientation 
        Heterosexual 
        Homosexual 
        Bisexual 
 
11 
8 
1 
 
 
 
 
Employment 
       Employed 
       Unemployed 
 
6 
14 
 
 
 
 
Living Arrangements 
       Alone 
       With Others 
 
12 
8 
 
 
 
 
HIV Medical Factors    
Time since Diagnosis (years)          9.78    (5.76)     3-24 
CD4 count (cells per mm
3)       493.26 
(151.83)  
259-715 
Medication Regime 
        None 
        Duo-therapy 
        HAART 
        Unknown 
 
4 
1 
14 
1 
 
 
 
 
Months on Current Medication   39.73   (33.59)  1-104 
HIV Stage 
        Asymptomatic 
        Symptomatic/ 
        AIDS 
        Unknown 
 
10 
9 
 
1 
 
 
 
 
Cognitive, Behavioural and Emotional Factors 
Education 
       5-11 years 
       12-13 years 
       14-16 years 
       17+ years 
 
8 
6 
5 
1 
  
 
Table 1.  
Characteristics of the Study Sample 
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Monthly alcohol use (units)  4.60  (8.68) 0-30 
Pre-morbid IQ (WTAR)  96.50 (20.98) 50-120  
Mood (HADS) 
      Anxiety 
      Depression 
  
7.95 (3.41) 
             
5.35(2.41) 
 
3-18 
1-11 
 
 
 
 
Once referral details were received by the principle investigator, participants 
were contacted to arrange the assessment. Participants meeting the 
following inclusion criteria were selected for participation: a positive HIV-1 
diagnosis and aged between 18 and 60 years old.  
 
Exclusion criteria were: having received a HIV-positive diagnosis in the last 
three months; fluctuating medical status (more than one night stay in 
hospital for any illness or infection in the last two weeks/change in HIV 
medication regime in the last two weeks); major psychiatric disorders 
(current episode of psychosis, mania or severe depression); significant 
substance misuse (self-reported intravenous drug use in the last week); 
severe neurological deficits (history of head injury/cerebral incident 
requiring hospital admission for more than 24 hours/degenerative 
neurological disease, e.g. Multiple Sclerosis/brain tumours). Also excluded 
were people who were unable to complete the assessment due to: visual 
impairments (unable to read font size 28 with corrected vision), hearing 
impairments (unable to hear the researcher in a quiet room with corrected 
hearing), unable to understand and consent to the research process based 
on the principles set out in the Mental Capacity Act (2005), insufficient 
language ability (score of less than 15 on the Sheffield Screening Test for 
Acquired Language [SST]) (Syder et al., 1993). The SST is a brief screening 
measure to identify communication problems (Blake et al., 2002). It 
assesses receptive and expressive language and has been widely used in 
other neurological samples such as dementia (Potkins et al., 2003). 
 
 
Note. WTAR=Wechsler Test of Adult Reading; HADS=Hospital Anxiety and Depression Scale; 
HAART= Highly Active AntiRetroviral Therapy 
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Procedure and Measures 
The assessment duration was 1-1½ hours. This took place either at local 
clinics, drop-in centres, participants‘ homes or university, depending on the 
participant‘s preference and which environment was most conducive to 
assessment (quiet, distraction-free and confidential). After sight, hearing 
and language ability were checked, other exclusion criteria were assessed 
using participant self-report. Participants who did not meet the criteria to be 
included in the study were excluded at this point with an opportunity to 
discuss reasons for exclusion with the researcher. Participants who were 
eligible to participate had the opportunity to discuss the benefits and 
possible inconveniences of participation. Sufficient understanding of the 
implications and requirements of participation in the study was checked 
verbally and all participants who were included signed an informed consent 
form confirming their voluntary participation (Appendix E).  
 
Socio-demographic and behavioural information (age, ethnicity, sexual 
orientation employment status, living arrangements, years of education and 
monthly drug and alcohol use) were collected via an interview with multiple-
choice options (Appendix F). To control for confounding variables brief 
questionnaires were used to assess: mood (Hospital Anxiety and Depression 
Scale [HADS]; Snaith & Zigmond, 1994) and pre-morbid IQ (Wechsler Test 
of Adult Reading [WTAR]; Wechsler, 2001). The HADS is a 14-item self-
report screening measure for anxiety and depression specifically developed 
for use with people with physical illnesses. The HADS has been favourably 
compared to structured clinical interviews for mental health problems 
(Whelan-Goodison et al., 2009). The WTAR is a commonly used measure to 
estimate pre-morbid IQ by relying on previous knowledge (word 
pronunciation) rather than current cognitive functioning (Franzen et al., 
1997). The WTAR displays high correlation with comprehensive measures of 
IQ which suggests the WTAR has good construct validity (Wechsler, 2001) 
(see extended paper).  
 
To assess EF, participants completed the self-report version of the DEX and 
the BADS neuropsychological battery. The DEX (Wilson et al., 1996) is a 20-
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item questionnaire which provides information around activities of daily 
living associated with executive functions, particularly interpersonal 
interactions (Shinagawa et al., 2007). Each item is measured on a 5-point 
Likert scale ranging from ‗never‘ to ‗very often‘. Scores are summed to an 
overall score with high scores indicating more problems with executive 
functions in everyday life (see extended paper). The BADS take 
approximately 40 minutes to administer by a trained professional and 
consists of six sub-tests: 
1 – Card Sort  
Participants are required to respond to a series of playing cards with 
‗yes‘ or ‗no‘ according to certain rules. It is scored on number of errors 
made and completion time. This particularly examines inhibition and 
mental flexibility.  
2 – Action Program Test 
Participants are required to solve a novel problem practically: how to 
get a small cork out of a long thin tube using a beaker of water, a wire 
hook, a bottomless tube and a screw top. Structured prompts are given 
if the participant gets stuck although for each prompt given a point is 
deducted (from a starting point of 4). This considers problem-solving 
and sequencing. 
3 – Key Search Test 
Participants are asked to imagine they have lost their keys in a field 
(represented by a square on a piece of paper). They are directed to 
search the field drawing a line to show where they would walk. 
Participants are scored on completion time and efficiency of search 
strategies. This especially focuses on planning and impulsivity. 
4 – Temporal Judgement 
Participants estimate time to do four common activities. One point is 
awarded for each answer within a specified range. This measures ability 
to self-monitor and select an appropriate cognitive plan. 
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5 – Zoo Map Test 
Participants plan a route around a zoo visiting pre-identified locations 
following certain rules. In the ‗high-demand‘ trial, participants are 
responsible for planning the route and ensuring they do not break rules. 
In the ‗low-demand‘ trial with the route specified so participants are 
only responsible for ensuring they do not break the rules. Participants 
are scored on route taken, planning and completion times with points 
deducted for rules broken. This assesses planning and inhibition.  
6 – Modified Six Elements Test 
Participants have 10 minutes to attempt three tasks, each with two 
parts, (dictation, picture naming and arithmetic). The instructions make 
it clear the participant cannot complete all tasks within the time and 
should plan their time to attempt some of each subtask, whilst following 
the rule that two parts of the same task cannot be attempted 
immediately after one another. The test is scored on number of 
subtasks attempted, time spent on each subtask, with points deducted 
for rule breaks. This explores strategy application, planning, 
perseveration and self-monitoring. 
 
Each subtest raw score is converted to a standard score between 0 and 4. 
Subtest standard scores are summed and converted to a Total Profile 
standard score (mean 100, SD 15). Higher scores on the BADS represent 
better performance and less impairment. The BADS has normative data 
derived from 216 participants from a non-clinical sample (Wilson et al., 
1996) (see extended paper). 
 
The participant designated someone who knew them well (a proxy/other) 
(family/friend/healthcare professional) to complete the DEX. Proxies were 
unaware of how participants rated themselves. As the same questionnaire is 
used with participants (DEX-S) and proxies (DEX-O) it has been suggested 
that a comparison between the two scores may give an idea of participants‘ 
insight (Bogod et al., 2003).  
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In addition to this information, with participant consent, staff from GU or ID 
departments collected medical information pertaining to HIV from 
participants‘ medical notes (time since diagnosis, most recent CD4 count 
and viral load, medication regime, length of current medication regime, HIV 
Stage as measured by the Center for Disease Classification [CDC],1993) 
(Appendix G). Participants were offered a £10 gift voucher as a goodwill 
gesture for participating in the research. Feedback on test performance in 
the form of a brief neuropsychological report or face-to-face feedback was 
optional. The study was approved by a NHS Research Ethics Committee 
(Appendix H-I).  
 
Statistical Analysis 
Statistical procedures were conducted using Statistical Package for the 
Social Sciences (SPSS) v16.0. An independent samples t-test was used to 
compare the sample mean BADS Total score with the normative average, as 
provided in the BADS manual. Bivariate correlations (one-tailed) were used 
to calculate Spearman‘s rank coefficients to explore the association between 
the BADS Total score, DEX-O and DEX-S. Spearman‘s correlations (one-
tailed) were conducted to explore associations between executive measures 
(BADS Total score, DEX-S and DEX-O) and demographic, medical and 
cognitive, behavioural and emotional variables which have been previously 
identified to influence performance. Black African and Black Caribbean 
participants were grouped together for ethnicity analyses as subgroup 
numbers were small. A Bonferroni correction could have been used to 
correct for multiple comparisons and reduce the resultant Type I error. 
However, this reduces statistical power and increases the risk of a Type II 
error (Perneger, 1998) and was therefore omitted. An alpha level of .05 was 
used for all statistical tests. 
 
Results 
Of the 30 potential participants identified through recruitment (24 self-
referrals, 6 staff-referrals) 20 participants went on to complete the 
assessment (see Figure 1).  
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Relationship between the BADS and Normative data 
Table 2 describes participants‘ means and SDs of BADS performance and 
scores on the DEX-O and DEX-S. Overall BADS performance classification 
categorisation is presented in Figure 2 and demonstrates that 20% of 
participants fell into the ‗impaired‘ range on the BADS Total score but no 
participants were classified as ‗superior‘.  
 
Table 2. 
BADS and DEX scores for the sample 
Characteristic Number (%) Mean (SD) Range 
BADS Total Profile Score  85.30 (23.67) 33-113 
DEX-S  22.80 (10.07) 4-46 
DEX-O  29.76 (13.31) 9-60 
DEX-O Rater 
        Family/Friend 
        Healthcare Professional 
        Not Completed  
 
11 (65) 
6  (35) 
3 
  
 
 
         
30 participants referred 
or self-referred 
7 potential participants non-
contactable 
23 participants 
contacted and met for 
assessment 
20 participants 
assessed 
3 participants excluded: 
Current severe depression (1) 
Insufficient language ability to 
complete assessment (2) 
 
 
Figure 1. Flow of participants through the study 
Note. BADS=Behavioural Assessment of the Dysexecutive Syndrome; DEX-S=Dysexecutive 
Questionnaire-Self Report; DEX-O=Dysexecutive Questionnaire-Other Report 
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Figure 2. Percentage of participants by BADS performance category 
 
 
The average score for the BADS Total score was lower for the study sample 
(M = 85.30, SE = 5.29) than the BADS normative sample (M = 100.00, SD 
= 15.00). This difference was statistically significant t(234) = 3.96, p<.001, 
with a small-moderate effect size r = .25 (Cohen, 1988). A one-sample t-
test showed that the BADS total score mean for this sample was 
significantly different to the population mean t(19) = 2.78, p=.01, r = .54.   
 
The means and standard errors of participants‘ subtest scores on the BADS 
are displayed in Figure 3. From Figure 3 it is possible to see that, on 
average participants performed less well on the Zoo Map test, with 
relatively preserved performance on the Action Program test (see extended 
paper).  
BADS Classification Category 
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Note. BADS=Behavioural Assessment of the Dysexecutive Syndrome 
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Figure 3. Mean BADS subtest score 
 
Relationship between the BADS, DEX-S and DEX-O 
The BADS Total Profile Score was not statistically significantly correlated 
with the DEX-S (rs = .11, p=.33, one-tailed) or the DEX-O (rs = -.33, p=.10, 
one-tailed). However, the negative association between the DEX-O and the 
BADS approaches significance and suggests that ‗others‘ report more 
everyday problems when more impairment was found on the BADS. On the 
other hand, the lack of association between self-report (DEX-S) and BADS 
suggests participants are not accurately reporting their performance as 
demonstrated by the BAD. The DEX-S and DEX-O were not statistically 
significantly associated with any of the BADS subtests, nor were they 
significantly correlated with one another (rs = .26, p=.15, one-tailed). It is 
not possible to statistically consider whether the DEX scores are comparable 
to the non-clinical population due to lack of normative data reported in the 
manual (see extended paper).  
 
 Note. BADS=Behavioural Assessment of Dysexecutive Syndrome 
 
BADS Subtests 
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Relationship between measures of EF and mediating variables 
Table 3 displays the coefficients of the correlational analyses between the 
medical, demographic and cognitive, emotional and behavioural variables 
and the BADS, DEX-S and DEX-O. 
 
 
 
 
 BADS Total Score DEX-S DEX-O 
Medical Factors  Correlation coefficient rs  (p-value) 
Time since 
diagnosis 
           .21 (.20)          -.07 (.40)  -.32 (.13) 
HIV stage (CDC)            .31 (.10) .47 (.02)* .07 (.40) 
CD4 count            .09 (.36) .01 (.49) -.14 (.30) 
Medication 
Regime 
           .14 (.29) .41 (.04)* -.01 (.49) 
Months on 
medication 
regime 
          -.24 (.20) .27 (.17) -.09 (.38) 
Demographic Factors                  
Gender           -.48 (.02)*        -.23 (.16) .17 (.26) 
Ethnicity           -.52 (.01)**        -.42 (.03)* -.22 (.20) 
Age            .34 (.07)        -.09 (.35) -.04 (.44) 
Referral Source            .20 (.20)          .54 (.01)** -.22 (.20) 
Cognitive, Emotional and Behavioural Factors 
Average alcohol 
use 
        .26 (.13)  .27 (.12)  -.07 (.39) 
Years of 
education 
           -.07 (.39)  -.22 (.18) .34 (.09) 
WTAR        .23 (.16)  -.01 (.48) .08 (.39) 
HADS-A      -.15 (.26)     .39 (.04)* -.06 (.41) 
HADS-D      -.11 (.33)    .16 (.25) .02 (.47) 
 
 
 
Note. HIV=Human Immunodeficiency Virus; WTAR=Wechsler Test of Adult Reading; HADS-
A=Hospital Anxiety and Depression Scale-Anxiety Subscale; HADS-D=Hospital Anxiety and 
Depression Scale-Depression Subscale *=p<.05, **=p<.01 
 
Table 3. 
Correlation coefficients for comparison between variables and the BADS, 
DEX-S and DEX-O (one-tailed) 
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Medical Factors 
It was not possible to determine the association between the measures of 
EF and plasma viral load as 85% participants had undetectable viral loads. 
The BADS Total Score and DEX-O were not associated with any HIV medical 
factors. The DEX-S was statistically significantly positively correlated with 
CDC HIV stage (rpb = .47, p=.02, one-tailed) in the expected direction. The 
DEX-S was also positively correlated with medication regime (rpb = .41, 
p=.04, one-tailed) although this was not in the anticipated direction. 
Overall, those in later stages of HIV and on more medications were more 
likely to report more problems with executive function (see extended 
paper). 
 
Demographic Factors 
The BADS Total Score was significantly correlated in the predicted directions 
with gender (rpb = -.48, p=.01, one-tailed) and ethnicity (rpb = -.52, p=.01, 
one-tailed) on point biserial correlations (Male=0, Female=1; White 
British=0, Black African/Caribbean=1). Women and Black African/Caribbean 
participants performed less well on the BADS than the male or White British 
participants. The DEX-S was also significantly correlated with ethnicity (rpb = 
-.42, p=.03, one-tailed) where Black African/Caribbean participants 
reported fewer problems than White British which was not in the expected 
direction. The DEX-S was also associated with referral source in the 
anticipated direction (rpb = .54, p=.01, one-tailed) (Self-referral=0, Staff-
referral=1) so staff-referred participants reported more problems than self-
referred participants. The DEX-O was not associated with demographic 
variables (see extended paper).  
 
Cognitive and Emotional Factors 
The BADS and DEX-O were not significantly associated with cognitive, 
behavioural or emotional measures. There was significant positive 
correlation in the expected direction between the DEX-S and anxiety as 
measured by the HADS (rs = .39, p=.04, one-tailed) so more anxious 
participants reported more EF problems in their day-to-day life (see 
extended paper).  
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Discussion 
 
The main aim of the study was to assess executive function in people with 
HIV-infection using a measure with good ecological validity (BADS) 
compared to normative data. Despite 75% of the sample being on HAART 
regimes and 85% having undetectable viral load levels which are thought to 
protect against neuropsychological impairment (Ferrando et al., 1998), this 
study still found difficulties with EF in this sample. The results showed the 
EF ability in this sample was below that which was predicted by normative 
data for the BADS. This is consistent with previous research demonstrating 
EF impairment in people with HIV (e.g. Sahakian et al., 1995). The present 
study adds to these findings by using a battery, measuring more than one 
aspect of EF, which is reported to have superior ecological validity to 
traditional laboratory tests such as the Trail Making Test or the Stroop 
(Norris & Tate, 2000) (see extended paper). 
 
Participants performed on average most poorly on the Zoo Map, with 
relatively preserved performance on the Action Program. This suggests 
decreases in ability to plan and self-monitor and increases in impulsivity are 
evident in participants with HIV in this sample. This is consistent with Hardy 
et al. (2006) who found increased impulsivity in people with HIV. 
Sequencing and approaches to novel tasks are less affected aspects of EF in 
participants in this sample as shown by normal performance on the Action 
Program. However, these conclusions are only tentative because although 
subtest may be weighted more on particular skills, all the subtests are 
multi-faceted in nature to reflect the complexity of everyday tasks.  
 
Seventy percent of the sample was unemployed and 45% cited disability 
related to HIV as the reason for their unemployment. This may be, in part, 
due to executive function difficulties and would support previous findings, 
which reported that those with cognitive impairment were more likely to be 
unemployed than those without (Heaton et al., 1995). Further research is 
needed to explore this relationship. 
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The study had two additional aims:  
 
i. To triangulate quantitative measurement of executive deficits on the 
BADS to self- and proxy-report questionnaires on day-to-day experience of 
executive functioning (DEX).  
 
The results showed the BADS, DEX-S and DEX-O were not significantly 
related to each other. Although this finding does not support previous 
research (e.g. Wilson et al., 1998), which found strong relationships 
between the BADS and DEX (especially DEX-O), it is consistent with Norris 
and Tate (2000) and Woods and Liossi (2006), who also found limited or no 
association between the DEX and BADS. This lack of significant association 
may be due to differing levels of demand in each individual‘s environment, 
leading to different relative importance of EF skills. 
 
Proxies more closely reported problems similar to BADS performance than 
participants themselves, although the association between the BADS and 
DEX-O only approached significance. Participants self-report (DEX-S) was 
not statistically significantly associated with the BADS or the DEX-O which 
suggests they could not accurately predict their performance or how others 
saw them. , This converges with previous research which suggests a lack of 
insight is associated with EF difficulties (Jovanoski et al., 2006) (see 
extended paper). 
 
ii. To examine factors that might contribute to expression of executive 
deficits in people with HIV. 
 
Medical Factors (see extended paper) 
Factors relating to HIV and disease progression were not significantly 
associated with the BADS or DEX-O. This presence of EF problems in this 
study, even whilst on HAART regimes, adds weight to previous studies 
which found minimal benefit of HAART for mild-moderate cognitive 
problems (Cysique et al., 2004). This may initially seem contrary to 
research which has pointed to the benefit of HAART for memory and 
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psychomotor speed (e.g. Ferrando et al., 1998) but these studies did not 
demonstrate benefits for EF. Although medication adherence was not 
directly measured in the current study, these findings cannot be attributed 
to insufficient adherence or ineffective HAART regimes as higher CD4 counts 
were associated with longer length of medication regimes. Maximum viral 
suppression was evident in most participants which is noted as the gold 
standard outcome for HAART. 
 
Participants in symptomatic stages of HIV reported more EF problems on 
the DEX-S than asymptomatic participants. Likewise, participants taking 
HAART reported more problems than those taking fewer or no medications. 
This indicates that disease progression is associated with increased 
reporting of EF difficulties in everyday life, although disease progression is 
not associated with BADS performance. Therefore, it may be that the BADS 
is not picking up subtle difficulties, although a floor effect was not evident in 
the data. Alternatively, progression of the disease may lead to increase 
environmental demand, for example medications for physical health 
problems and increased anxiety, which affect the importance of EF in their 
day-to-day life. However, as HAART is not a homogenous regime but 
involves various antiretroviral combinations, different regimes may vary in 
ability to cross the blood-brain-barrier. This might lead to different regimes 
affecting cognitive abilities differently. 
 
Demographic Factors (see extended paper) 
Women performed less well on the BADS than men, although this difference 
was not found on self- or other-report of everyday functioning. This poorer 
BADS performance suggests HIV may affect the frontal regions of women 
more than men. This corresponds to Failde-Garrido and colleagues (2008) 
who also found women were likely to experience more cognitive impairment 
in HIV than men. There may be differences in history of drug use/abuse 
(Failde-Garrido et al., 2008), or education level (Stern et al., 1996) 
between men and women which may influence EF ability. However, no 
significant differences between men and women were found on these 
variables in this study. Alternatively, there may be differences in brain 
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structure (Cahill, 2006) and hormone receptors in the brain (Hafner et al., 
1994; Kimura, 1992) between men and women. Whichever mechanism, this 
has implications for the tendency for women to be under-represented in HIV 
research. 
 
Black African/Caribbean participants tended to perform less well on the 
BADS than White British participants. This is consistent with previous 
research where people from non-Western backgrounds performed less well 
on neuropsychological tests (Rivera Mindt et al., 2008). As participants from 
Black African/Caribbean backgrounds did not speak English as a first 
language they may have been at a disadvantage when completing the 
BADS. However, all participants scored above the cut-off on a basic 
language ability test. There were also no differences between groups on 
pre-morbid IQ levels. However, there may be other risk factors in people 
from BME backgrounds which either affects their EF ability or their ability to 
perform on the BADS (Rivera Mindt et al., 2008). For example, there may 
be differences in access to education (Kaufman, Cooper & McGee, 1997), 
acculturation (Lucas, 1998) or literacy (Manly, Touradji, Tang & Stern, 
2003). Socio-economic status may also restrict access to services such as 
healthcare, and influence brain development (Brickman Cabo & Manly, 
2006). Additionally EF might be more ‗culturally mediated‘ than other 
cognitive skills (Rivera Mindt et al., 2008). Tests such as the BADS 
developed and normed within Western countries, may be ‗euro-centric‘ and 
have less validity for black and minority ethnic (BME) groups living with 
HIV, in keeping with previous research (Proctor & Zhang, 2002). It is not 
possible to further speculate as no data is recorded in the BADS manual on 
the ethnicity of the non-clinical normative sample. Moreover, 85% of the 
Black African/Caribbean participants were women so there may be 
combined effects of gender on poorer EF outcome for this group.  
 
Black African/Caribbean participants reported fewer everyday EF problems 
despite more difficulties being found on the BADS score for these 
participants. This might provide some support for reduced insight into EF 
impairment (Hart et al., 2005) but in contrast several authors have not 
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found the connection between executive functions and insight (Sanz et al., 
1998). Instead self-report may offer a realistic representation of everyday 
experience where Black African/Caribbean participants experienced fewer 
problems pertaining to EF. This may be due to low level of environmental 
demands which influences the importance placed on EF skills but needs 
further exploration.  
 
Cognitive, Emotional & Behavioural Factors (see extended paper) 
Participants with higher levels of anxiety reported more problems on the 
DEX-S. However, problems with EF may cause more anxiety and increased 
hypervigilance to difficulties. This would support previous research on the 
detrimental effects of anxiety on cognitive performance (Kizilbash et al., 
2002).  
 
Strengths and Limitations 
The study did not include a matched control group with which to directly 
compare participants‘ performance on the BADS. A matched control group 
might have provided a more accurate estimation of expected performance 
by controlling for a number of participant variables, such as fatigue 
(Coolican, 2004). However, comparison of the sample to the normative data 
was felt to be important as this reflects real-world experience of 
neuropsychologists. Neuropsychologists rarely have the ability to compare 
patient data to a matched control and rely on the normative data available 
(Muir-Broaddus et al., 2002) so this method should enhance the clinical 
utility of the findings. The study sample and BADS normative sample were 
not significantly different in age or IQ, so the two groups were matched to 
some extent making comparisons appropriate (see extended paper).  
 
The large number of statistical analyses on a small heterogeneous sample in 
the current study may statistically increase the likelihood of false positive 
findings over multiple comparisons. The small sample may also have led the 
study to be under-powered and the effect sizes were within the small-
moderate range. However, the intention of this study was to be explorative 
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and promote effective allocation of resources in future research to further 
explore the trends found in this study.  
 
Despite the small sample size, one of the strengths of the study is the 
larger proportions of females, heterosexuals and BME groups than previous 
research and the minimal exclusion criteria to allow for greater 
representativeness in the sample than in previous research and thus 
achieve more clinically useful findings. However, it is important to bear in 
mind the limitations of using a measure developed and normed in a 
Western country and English language when considering the performance of 
participants who have a different cultural heritage (see extended paper). 
 
Future Research 
This pilot study has suggested the value of using a battery approach with 
good ecological validity to explore the fractionated EF construct. A 
longitudinal study of EF in people with HIV within a larger cohort of 
participants might allow for identification of patterns of impairment or 
compensation and factors that facilitate or inhibit this process. Other 
measures with good ecological validity that gather additional qualitative 
information such as the Multiple Errands Test (Shallice & Burgess, 1991), 
might allow for detailed analysis of strategies used by participants and 
analysis of common errors made. Future research should also incorporate 
functional and meaningful outcomes related to EF and look to explore 
individual environmental demands, for example, the burden of medication 
adherence, as a potential predictor of the impact of EF in everyday life (see 
extended paper).  
 
Clinical Implications 
Screening for EF difficulties in people with HIV, even early in the course of 
the infection, or when there is maximum viral suppression, may be 
particularly useful, especially in women and people from BME 
communities. The BADS might be a useful tool for this purpose due to its 
focus on ecological validity. In comparison with traditional tests the BADS 
clearly resembles everyday activities more accurately and the close 
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approaching significance of the association between the BADS and DEX-O 
might suggest this is a useful approach. However, it would be important to 
supplement this with both self- and other-report, to determine the 
functional impact and environmental demands, being mindful of potential 
difficulties with insight.   
 
The support of future research, considering compensation strategies might 
lead to the improvement of rehabilitation strategies and/or rehabilitation 
programs for people with HIV who might benefit (see extended paper). As 
EF difficulties often present most evidently in social interactions, it might 
be useful to have information on executive function difficulties available to 
patients and their families to develop awareness of potential difficulties. A 
comprehensive understanding of EF might also benefit staff working with 
people with HIV, with implications for staff training in providing effective 
support strategies.  
 
Conclusions 
Previous research with people with HIV has used traditional measures such 
as the Trail Making Test, which might be insensitive to real-world 
implications of EF difficulties. Using a neuropsychological battery with 
renowned ecological validity, EF difficulties were found in people with HIV, 
especially women and people from BME communities. These difficulties are 
evident even in maximal viral suppression, which suggests HAART may not 
have universal protective side-effects. Further research needs to consider 
these provisional findings in larger samples, incorporating not only 
functional outcome assessment but exploration of individual environmental 
demands. 
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Extended Background 
This extended background provides a comprehensive critical review of the 
literature relating to Human-Immunodeficiency Virus (HIV) and executive 
function. First, HIV and the general cognitive impact for individuals, 
including the influence Highly Active Anti-Retroviral Therapy (HAART), is 
discussed before a brief exploration of the implications of cognitive 
difficulties and some of the factors which might influence expression of 
cognitive impairment. Executive functions are theoretically discussed and 
literature on HIV and executive functions specifically is explored. The review 
considers measurement issues in executive function, in particular ecological 
validity. A particular measurement tool, with good ecological validity, the 
Behavioural Assessment of the Dysexecutive Syndrome (BADS) is 
discussed. Finally the review finishes with an extension of the aims and 
research question of the study. 
 
Search Strategy 
Research studies and theoretical articles were identified using electronic 
databases such as PsycINFO, Web of Science and Ovid, using key words 
such as ‗HIV‘, ‗AIDS‘, ‗dementia‘, ‗executive function‘, ‗neuropsychology‘, 
‗cognitive impairment‘, ‗BADS‘ and ‗ecological validity‘. The reference list 
and citing articles for these articles were also searched and relevant articles 
obtained. All studies were considered for inclusion and critically appraised 
for methodological quality using guidelines, such as the Strengthening the 
Reporting of Observational Studies in Epidemiology (STROBE) 
(Vandenbroucke et al., 2007). Most research has examined the aetiology of 
neuropsychological impairment in HIV, rather than treatment, often 
therefore using observational cross-sectional case-control methodologies. 
This methodology is not high in the hierarchy of rigorous evidence and can 
only offer speculations on associations, not causality (Greenhalgh, 2001). 
Although attempts have been made to be comprehensive, this review does 
not aim to be a systematic review. Therefore, only the most important 
previous research articles have been presented to highlight and identify 
strengths and gaps in the evidence base. 
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Epidemiology & Overview 
It is valuable to have a basic understanding of the HIV infection, the course 
of the disease and psychopharmaceutical effects of commonly used 
treatment as these may interact in complex ways with cognitive functioning. 
 
HIV is a systemic viral infection identified by testing for antibodies to HIV 
(seroconversion) (Enzyme Linked Immuno-Sorbent Assay [ELISA]). As a 
retrovirus, HIV contains an enzyme which replicates HIV cells using the DNA 
of the cell it has infected. High levels of infection in the blood (plasma viral 
load) weaken the immune system by destroying CD4 cells. This lowers CD4 
count and the immune system cannot function effectively, increasing 
susceptibility to infections (for details on structure and mechanism of HIV 
see National Institute of Allergy and Infection Diseases [NIAID]).  
 
Lowered CD4 and consequent infections affect all organs, including the 
brain, causing progressive changes (Kopinsky, Bao & Lin, 2007). HIV affects 
nearly 33 million people worldwide (Woods, Moore, Weber & Grant, 2009). 
Unlinked anonymous methods calculate the number of individuals unaware 
of their HIV-positive status through analysis of blood samples collected from 
the general population gathered for reasons other than HIV testing. It is 
currently estimated that 27% of those with HIV in the UK are unaware of 
their serostatus (McGarrigle et al., 2006). There have been dramatic 
changes in prevalence from predominantly homosexual men to 40% of all 
new infections being in young adults (aged 15-24) (Knoll, Lassmann & 
Temesgen, 2007) and 30-35% of those infected with HIV in Europe being 
women (Maki & Martin-Thormeyer, 2009). HIV is transmitted through 
contact with the blood or bodily fluids (such as plasma/semen) of an 
individual infected with HIV. The main exposure to these fluids is through: 
 Unprotected sexual contact 
 Sharing needles (intravenous drug use) 
 Mother-baby transmission 
 Recipient of blood products  
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Types 
There are two recognised types of HIV infection: HIV-1 and HIV-2. HIV-1 
accounts for the vast majority of cases, whereas HIV-2 is predominantly 
found in West Africa (Oster, 2000). Both infections lead to Auto-Immune 
Deficiency Syndrome (AIDS) with little differences in CD4 counts (Grand et 
al., 1997) and are nearly indistinguishable in autopsy (Ndour et al., 2000). 
The main difference is that HIV-2 is less easily transmissible and, with lower 
viral load levels, is thought to have a longer duration between infection and 
illness (Ndour et al., 2000). However, due to environmental differences 
comparisons between HIV-1 and HIV-2 are limited (Ndour et al., 2000). 
Due to the location of the current study in the United Kingdom and its 
predominance in Western countries, HIV-1 is the focus of this research 
study. In HIV-1 there are genetically distinct subtypes thought to affect 
transmissibility and medication response, however, research in this area is 
inconclusive (Oster, 2000). 
 
Stages and Course of Infection 
Both the World Health Organisation (WHO) (2007) and the Center for 
Disease Classification (CDC) (1993) have suggested staging models for HIV 
which classify severity and progression of the infection. The CDC model, 
outlined in Table 4, has been used in the present study as it integrates both 
disease indicator factors and infections, compared to the WHO which 
focuses on solely clinical manifestations. The CDC model describes three 
main stages in HIV infection: asymptomatic, symptomatic and AIDS (Table 
4). Although this model is a helpful guide to severity of HIV, it has been 
criticised by clinicians as in this model patient cannot return to previous 
stages irrespective of whether the AIDS-defining illnesses resolve or CD4 
count improves.  
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Table 4  
Simplified Version of CDC Classification of Stage of HIV infection 
CDC Classification 
Stage 
Corresponding 
Infection Level  
Details 
1 Asymptomatic 
No serious illness 
CD4 above 200mm
3 
2 Symptomatic 
Non-AIDS defining illnesses 
CD4 above 200mm
3 
3 AIDS 
AIDS-defining opportunistic 
infection 
Current or previous CD4 
below 200mm3 
 
 
Treatment  
Pre-1996 HIV was treated with single anti-retroviral drugs (mono-therapy). 
Since 1996, HIV has been treated with Highly Active Anti-Retroviral Therapy 
(HAART). HAART is a combination of at least three anti-retroviral drugs 
from the finite number of anti-retrovirals available. HAART combinations 
usually include two nucleoside reverse-transcriptase inhibitors and one 
protease inhibitor (Ellis, Langford & Masliah, 2007). As HAART aims to 
suppress viral replication it cannot cure HIV, so once individuals start on 
these medications most may remain on them for the rest of their lives, 
although they may change the specific regimes (Panel on Clinical Practices 
for Treatment of HIV Infection, 2001). The maximum success of HAART is a 
viral load which is undetectable using conventional assays, associated with 
restoration of the immune system (Burgoyne, 2005). As a result, HAART 
has reduced the incidence of AIDS-defining illnesses from 30% to 10% 
(Lawrence & Major, 2002) and increased survival rates from 64% to 85% of 
people surviving for more than 2 years post positive diagnosis (Knoll et al., 
2007). As a result of its success in prolonging life, HAART is recommended 
for all patients with HIV (Knoll et al., 2007).  
 
Despite its successes, maintaining viral suppression requires high levels of 
adherence to medication regime, which involve managing complex and 
Note. CDC=Center for Disease Classification 
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frequent dosing and unpleasant side-effects (Burgoyne, 2005). For HAART 
to be effective 90% adherence to the regime is required and poor 
adherence can lead to medication resistance (Bangsberg et al., 2000). 
Resistance is problematic because there are only a finite number of anti-
retrovirals available. Indeed, increasing numbers of individuals are 
developing medication resistance (Robertson et al., 2007). Furthermore, 
although some anti-retroviral medication, such as zidovudine, may have 
neuro-protective effects (Baldeweg et al., 1995), there is a question over 
the ability of other anti-retroviral to blood-brain-barrier (BBB) and act 
directly on the brain (neuroactive). Research is currently inconclusive as 
some authors have found the BBB becomes compromised as HIV 
progresses, making it easier for HAART to cross (Robertson et al., 2007).  
 
As a result of the change in HIV from a fatal disease to a chronic infection 
(Robertson et al., 2007), clinical management issues have shifted towards 
issues of daily functioning and the potential neurotoxic side-effects of 
HAART (Melrose, Tinaz, Castelo, Courtney & Stern, 2008). Accordingly the 
prevalence of other difficulties such as mild-moderate cognitive impairment 
has increased and become a key quality of life issue (Ghafouri, Amini, 
Khalili & Sawaya, 2006).  
 
Neurobiology 
HIV is known to affect the brain even early in the course of the infection 
(Ghafouri et al., 2006), and, after the lungs, the brain is the most affected 
organ (Masliah, DeTeresa, Mallory & Hansen, 2000). HIV viral agents, 
proteins and free radicals as well as by-products of HIV replication may 
directly damage neurones (Antony & Bell, 2008; Hult, Chana, Masliah & 
Everall, 2008). However, the presence of HIV in the brain may also cause 
chronic inflammation of the macrophages and microgilia (immune cells in 
the brain tissue) or set off disturbances in astrogilia (which maintain 
neurone viability) that ultimately leads to neuronal cell death (Grant, 
Marcotte & Heaton, 1999). There may also be additive/multiplicative effects 
of polypharmacy, high levels of stress hormones, opportunistic infections 
and normal ageing (Kopinsky et al., 2007). For further discussion on the 
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mechanisms of HIV in the brain see Brew, Crowe, Landay, Cysique and 
Guillemin (2009). An understanding of the underlying neural systems 
affected by HIV may help understand the neuropsychological consequences. 
 
The main structural brain changes are shrinkage enlarged ventricles and 
sulci (Sahakian et al., 1995) and thinning of the prefrontal cortex 
(Thompson et al., 2005). The fronto-striatal circuits, linking the prefrontal 
cortex to the striatum and basal ganglia, have been identified as the most 
affected areas of the brain (Castelo, Sherman, Courtney, Melrose, & Stern, 
2006; Ellis et al., 2007). This is particularly relevant to the present study as 
the prefrontal cortex is closely associated with executive functions. 
Functional magnetic resonance imaging (fMRI) of 11 people with HIV 
showed that, compared to HIV-negative controls, functional changes in the 
prefrontal cortex may occur before the structural changes and there is some 
suggestion of a re-organisation of function and compensatory brain 
mechanisms such as activation of the parietal region (Melrose et al., 2008). 
 
Cognitive Impact of HIV Infection 
The neurobiology described and resultant cognitive impairment 
encompasses a range of cognitive domains for people with HIV including 
memory, attention, and executive functioning (planning and problem-
solving). Global cognitive disturbances are described as HIV-Associated 
Neurocognitive Disturbances (HAND). Cognitive deficits within HAND can 
range from subtle minor motor/cognitive disorder (MCMD) to severe and 
disabling HIV-Associated Dementia (HAD) (Woods et al., 2009). Figure 4 
outlines terminology used to describe HIV-associated cognitive impairment. 
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Figure 4. Definitions and classification of HAND  
 
Despite limited research, most researchers consider the milder forms 
(MCMD) as distinct from dementia (HAD) and not necessarily linked to one 
another (Heaton et al., 1995). Unlike other neurodegenerative disorders 
such as Alzheimer‘s, HAND is not invariably progressive and individuals may 
recover, worsen or experience static (Cole et al., 2007) or fluctuating 
courses (Robertson et al., 2007).The inconsistent use of terminology used 
in HIV research however, hinders the research in cognitive impairments in 
HIV as it makes different study findings difficult to compare (Grant, 2008). 
For further definition of the terms see Woods et al. (2009).  
HIV-Associated 
Neurocognitive 
Disorder (HAND) 
Subsyndromic 
neurocognitive 
impairment (SNI) 
Mild 
Motor/Cognitive 
Disorder (MCMD) 
HIV-Associated 
Dementia (HAD) 
Asymptomatic 
neurocognitive 
impairment (ANI) 
 
HIV-Associated 
Mild Neurocognitive 
Deficits (MND) 
 
HIV-Associated 
Dementia (HAD) 
Mild 
neurocognitive 
impairment 
 
Does not interfere 
with activities of 
daily living (ADL) 
Marked 
impairment in at 
least two 
cognitive domains 
 
Decline in ADLs 
 
Severe impairment 
in at least two 
cognitive domains 
 
Considerable 
impairment in ADLs 
Previous 
Terminology 
Newest 
Terminology 
Details 
Note. Adapted from Grant & Atkinson, 1995; Woods et al., 2009; Antinori et al., 2007) 
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History of cognitive impairment in people with HIV 
Although it is no longer the case, before the introduction of HAART, 
cognitive impairment was often a sign of imminent mortality in people with 
HIV (Woods et al., 2009). An integrated global cognitive assessment battery 
was suggested (Butters et al., 1990), which included tests such as the Trail 
Making Test (TMT) (Reitan, 1958) and the Grooved Pegboard test (Trites, 
1977). This recommendation has been highly influential and this battery is 
still commonly used today, despite being nearly 20 years old. This approach 
is also used to categorically determine whether individuals with HIV have a 
cognitive impairment or not. Cognitive impairment is ‗diagnosed‘ when an 
individual scores below two standard deviations on two or more tests. This 
black/white categorisation is a significant weakness of previous studies as it 
does not consider everyday function or specific cognitive domains. Although 
some authors have moved away from this model of assessment, most of 
the research outlined below is based on the Butters et al. (1990) battery, 
with focus on biomedical rather than psychosocial aspects of cognitive 
impairment (Rivera Mindt et al., 2008). For this reason this study will also 
use the term ‗cognitive difficulties‘ to denote the idea that cognitive abilities 
lie on a spectrum. The research body has also been greatly affected by the 
use of HAART, with studies divided into ‗pre-HAART‘ and ‗post-HAART‘ 
depending on whether they were conducted with people prior to (pre-) the 
introduction of HAART or since then (post-). This review focuses on the 
post-HAART era, as most useful to place the current study within a context. 
 
Prevalence of cognitive impairment in HIV 
Most research suggests between 30-60% of people with HIV show at least 
mild cognitive impairments (Grant, 2008) with the prevalence of cognitive 
difficulties increasing as CDC disease stage progresses (Reger, Welsh, 
Razani, Martin & Boone, 2002). Goodkin et al. (2001) reported that 5-14% 
of asymptomatic individuals showed signs of MCMD/MND compared to 25% 
of people with AIDS. However, even asymptomatic individuals show nearly 
double the rate of cognitive impairment (35.3%) compared to matched HIV-
negative controls (17.0%) (Grant et al., 1999). Reger et al. (2002) used 
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rigorous methodological inclusion criteria (interval/ratio level data, matched 
control group and use of well-known standardised tests) to identify 41 
primary studies of cognitive impairment in people with HIV to be included in 
a meta-analysis. The analysis found effect sizes for global cognitive 
impairment increased with disease progression, from .05 to .21 in 
asymptomatic individuals to .42 to .82 in individuals with AIDS, with 
significant impairments in motor and executive functions. However, there 
was considerable overlap between the CDC stages, especially between 
symptomatic and AIDS categories, and the system used to classify effect 
size is arbitrary and may not be clinically meaningful (McGrath & Meyer, 
2006). There is a considerable lack of consistency between the studies in 
terms of populations sampled, definition of impairment, methodology and 
outcome measures which limits the ability to compare findings across 
studies, potentially undermining conclusions made by Reger et al. (2002). 
Moreover, little research has included the impact on activities of daily living 
when determining cognitive impairment, despite this being a defining 
feature of MND or HAD. 
 
Impact of HAART 
In an 18-month longitudinal prospective study including 130 homosexual or 
bisexual men Ferrando et al. (1998) demonstrated the superior effects of 
HAART on reversing cognitive deficits in attention, learning, memory and 
psychomotor speed. This benefit was less evident in measures of executive 
function (as measured by the TMT and Stroop). Unfortunately, the authors 
do not comment on this discrepancy in their interpretation and conclude 
that HAART may traverse a compromised BBB or that low concentrations 
are sufficient to help neuropsychological function. Tozzi et al. (1999) and 
Letendre et al. (2004) also found that individuals who achieve viral 
suppression through HAART showed a significant improvement in 
neuropsychological test performance, although the samples used were small 
so results have limited power. However, this finding does agree with large 
cohort studies where HAART has been found to reduce the relative risk of 
HAD (Bhaskaran et al., 2008), although these authors did not distinguish 
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between cognitive domains or randomise participants to treatment groups 
due to the complex nature of HAART regimens.  
 
Although there are reduced rates or even reversal of severe forms of 
cognitive impairment, the prevalence of individuals experiencing milder 
forms of cognitive problems is still substantial (Baldewicz et al., 2004). It 
has been suggested that people on HAART may reach a sub-optimal plateau 
(Ellis et al., 2007). Research also reveals that not all individuals or cognitive 
domains benefit uniformly as a result of HAART. Cysique, Maruff and Brew 
(2004a) compared two cohort studies and found individuals on 
monotherapy showed deficits in attention, verbal fluency and visuospatial 
skills, whereas individuals on HAART showed deficits in learning and 
complex attention. Overall the authors found no statistically significant 
difference between prevalence rates of cognitive impairment in participants 
on mono-therapy compared with HAART, 41.1% and 28.8% respectively, 
although this does seem like a large difference. Moreover, this study 
compared two different cross-sectional studies which used different 
outcome measures so results are not directly comparable. Nonetheless, the 
results do agree with other research studies, such as Tozzi et al. (2007) 
who found that 62.8% of 26 patients persistently showed abnormal 
neuropsychological performance over 65 months despite HAART, using a 
prospective observational cohort. However, medication adherence was not 
accounted for, so participants may not have been taking HAART as 
instructed, which may reduce viral suppression and influence 
neuropsychological impairment (Tozzi et al., 2007).  
 
Cysique, Maruff and Brew (2004b) investigated the impact of neuroactive 
HAART on neuropsychological function in 97 individuals with advanced HIV 
(exclusions: previous psychiatric disorders, neurologic disease or drug use). 
Individuals were assessed on the measures recommended by Butters et al. 
(1990) and found individuals on neuroactive drugs did not perform better 
on neuropsychological tests than those on less neuroactive combinations. 
However, the post-hoc quasi-experimental design may mean individuals 
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were specifically prescribed a neuroactive HAART regimen due to pre-
identified cognitive problems. 
 
Overall, research continues to point to neuropsychological impairment in 
HIV, despite HAART. Indeed, 8-34% of individuals with HIV continue to 
show cognitive decline despite undetectable viral load (Cysique, Maruff, & 
Brew, 2006; Hammer et al., 1997). Bias has been introduced in the wider 
research by reporting several cross-sectional analyses from participants 
enrolled in longitudinal studies. Therefore, the same sample are reported 
several different times leading to over-representation in the research (e.g. 
Ferrando et al. 1998). Most studies also do not control for length of time 
individuals have been taking HAART thought to influence the magnitude of 
relationship with neuropsychological functioning (Lovejoy & Suhr, 2009).  
 
Patterns of cognitive deficit 
Recent studies (Dawes et al., 2008) have identified the prototypical profiles 
of cognitive difficulties in HIV, predominantly: 
 Poor attention and working memory 
 Slower speed of information processing  
 Impaired executive functions and motor skills 
 Relatively intact language, visuo-spatial perception and long term 
memory.  
This pattern of difficulties is indicative of a subcortical dementing process of 
the frontal-striatal system (Heaton et al., 1995). Executive function deficits 
seem to be a central feature to most HIV-associated neurocognitive 
impairment patterns, especially important as executive functions are 
strongly associated with impairment in everyday activities (Heaton et al., 
2004). While these are typical features, there seems to be considerable 
heterogeneity in this presentation.  
 
Implications of Cognitive Deficits 
Even minor cognitive deficits may have significant implications for 
employment (Albert et al., 1995; Heaton et al., 1994), financial 
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management, social support (Honn & Bornstein, 2002), adhering to 
medication regimes and mortality (Ellis et al., 1997; Mayeux et al., 1993). 
Many of these activities are cognitively demanding and require forward 
planning, strategising and ability to make decisions (Lovejoy & Suhr, 2009). 
Individuals with asymptomatic HIV and cognitive impairments are twice as 
likely to be unemployed (Heaton et al., 1995), or have difficulties at work 
(Grant et al., 1999), than those with asymptomatic HIV without 
neuropsychological impairment. Van Gorp, Baelwald, Ferrando, McElhiney 
and Rabkin (1999) found that people with HIV who were unemployed were 
more likely to exhibit deficits in memory, set-shifting and flexibility. Poor 
health, including cognitive impairments, may also cause social network size 
to diminish (Kaplan, Patterson, Kerner & Grant, 1997), which is consistently 
acknowledged as an important quality of life factor (Emlet, 2006).   
 
Hinkin et al. (2002) examined the interactive effects of neuropsychological 
impairment and medication adherence in 137 people with HIV (aged 25 to 
69 years, 18% women, 69% African American). Participants were assessed 
on a variety of neuropsychological measures including the Trail Making Test 
(TMT), Controlled Oral Word Association Test (COWAT) (Benton & Hamsher, 
1976), Stroop (Stroop, 1935) (for a description of these measures see 
Appendix J) and medication adherence was monitored using electronic 
bottle caps (monitoring frequency and quantity of medication taken). The 
study found significantly lower medication adherence in individuals with 
cognitive impairments, particularly executive function impairment. The large 
culturally heterogeneous sample and stringent recording of medication 
adherence confer good external validity of the results (the validity of 
generalising the results to the wider population). However, longitudinal 
exploration might assist in determining causality, whether medication 
adherence affects cognitive abilities or cognitive abilities affect medication 
adherence. The link between medication adherence and executive functions 
(e.g. Wagner, 2002) has been supported by recent reviews of the literature 
(Lovejoy & Suhr, 2009).  
  
 
Page 49 of 255 
    
Mediating Factors in Cognitive Impairment 
Regardless of disease stage, not all infected individuals show cognitive 
difficulties (Basso & Bornstein, 2000). Wilkins et al. (1990) found the 
number of confounding factors had an additive effect on cognitive 
impairment. Neuropsychological performance is influenced by a number of 
medical, demographic and cognitive, behavioural and emotional factors 
which may act directly on cognition or affect general level of arousal and 
fatigue (Grant, 2008). Most research has used stringent exclusion criteria to 
control for these factors, leading to samples not being representative of the 
population (DeRonchi et al., 2002). This section considers the most 
important of these factors in more depth. For details of how these factors 
were accounted for in the current study see extended methodology. 
Medical factors: 
CD4 Count 
Although CD4 count is a strong predictor for AIDS-defining illnesses, the 
research on the association between CD4 count and neuropsychological 
impairment is less clear (Marcotte et al., 2003). In a ten-year longitudinal 
study Childs et al. (1999) found CD4 counts of less than 200 cells per mm
3 
was associated with a moderate risk for HAD. More recent longitudinal 
studies (Marcotte et al., 2003; Bhaskaran et al., 2008) also found an 
inverse relationship between neuropsychological impairment and CD4 count. 
However, these studies only included a small number of participants with 
neuropsychological impairment and other authors have found CD4 count 
could not predict neuropsychological impairment or had a weak relationship 
at best (Bornstein et al., 1993; Miller et al., 1990; Stern et al., 2001).  
 
Plasma Viral Load 
Childs et al. (1999) found high plasma viral load levels resulted in a greater 
risk of dementia. However, similar studies (e.g. Ellis et al., 1997) found no 
significant relationship between plasma viral load and neuropsychological 
impairment. More recently Reger, Martin, Cole and Strauss (2005) in 140 
individuals with HIV, also failed to find a relationship between plasma viral 
load and risk of neuropsychological impairment. However, this study sample 
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was highly educated (mean 13.4 years of education) which may influence 
interpretation of the results, as higher levels of education could mean better 
‗meta-cognitive‘ coping skills and strategies. Although most authors agree 
cognitive impairment is more common in HIV positive individuals who are 
immune-suppressed, the evidence for those who have HIV without 
significant immune-suppression is inconclusive (Pereda et al., 2000). Since 
HAART, the utility of plasma viral load levels to predict cognitive impairment 
has reduced (Sevigny et al., 2004). 
 
Time Since Diagnosis 
Increased survival in people with HIV lengthens the exposure of viral agents 
to the brain and neurotoxic consequences (Robertson et al., 2007). Several 
authors have reported longer duration of seroconversion increases risk of 
cognitive difficulties (Bornstein, Nasrallah, Para, Whitacre & Fass, 1994). 
Bhaskaran et al. (2008) empirically validated this in a large multi-national 
observational cohort finding both older age and length of infection increased 
the risk of cognitive problems in HIV.  However, this is confounded by the 
increased risk of neurological problems as individuals get older (Bhaskaran 
et al., 2008).  
 
Co-morbidities 
Out of the numerous co-morbidities often found in HIV, Hepatitis C (HCV) is 
often cited as the most difficult to manage. As many as 1/3 of all people 
with HIV also have HCV (Anderson, Guest & Rimland, 2004) and HCV may 
accelerate the course of the HIV, introducing further neuropsychological 
complications (Livry et al., 2003). However, Parsons et al. (2006) found 
individuals co-infected with HIV and HCV improved more (from baseline 
cognitive impairment) after starting HAART medications than individuals 
with HIV alone. Although this study used alternate test versions to improve 
test-re-test reliability there was a 35% drop-out rate and some 
discrepancies between group characteristics, which reduces internal validity 
of results. 
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Demographic Factors: 
Age 
Risk of cognitive impairment increases with age in the non-clinical 
population, for example, the prevalence increases from 1.5% in people 
aged 65-69 to nearly 25% in adults aged over 85 years (National Institute 
for Health and Clinical Excellence [NICE], 2006), whereas prevalence of 
dementia in adults younger than 65 is thought to be around 150 people per 
250,000 of the population (Harvey, 1998). Risk of cognitive impairment in 
HIV also appears to increase with age (Janssen, Nwanyanwu, Selik, & 
Stehr-Green, 1992). Valcour et al. (2004) found individuals with HIV aged 
over 50 years had a prevalence of dementia at 25% compared to 13% of 
individuals aged 20-39. Older age especially affects novel tasks that require 
faster speed of processing (Grant, 2008). Research in this area is relatively 
sparse due to the recent introduction of HAART as the preferred treatment 
and the resulting increased life expectancy in people with HIV.  
 
Ethnicity 
Rivera Mindt et al. (2008) found HIV-positive Hispanic American participants 
performed worse on a neuropsychological battery (similar to Butters et al., 
1990) compared to European Americans with HIV.  A significant association 
was found between literacy and global neuropsychological functioning, but 
literacy did not predict executive function abilities. This may be because 
executive functions are more ‗culturally mediated‘ than other cognitive 
abilities (Rivera Mindt et al., 2008). Rivera Mindt and colleagues (2008) 
used a large well described sample but did not include a HIV-negative 
control group which might have improved the validity of the results and 
helped to build a causative model of how these factors affect one another. 
Further empirical work is also needed to clarify the role of family history, 
environmental influences (such as education or literacy), and the 
neuropsychological tests and measures used (i.e. cultural validity) in 
mediating this difference in performance. Low socio-economic status can 
have multiple effects such as reduced access to healthcare services, which 
could influence treatment and thus directly impact on cognitive impairment 
(Shapiro, 1999), although research has not conclusively proven the 
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association between socioeconomic status and neuropsychological 
functioning (Rivera Mindt et al., 2008).  
Gender 
Most research with people with HIV has under-represented women, with 
only 31% of studies included women with approximate representational 
equality (Maki & Martin-Thormeyer, 2009), despite the rapidly increasing 
number of women being diagnosed as HIV positive (Durvasula, Miller, Myers 
& Wyatt, 2001). Women may be more likely to experience cognitive 
impairment in HIV than men (McArthur et al., 1997). A recent study (Failde-
Garrdio, Alvarez & Simon-Lopez, 2008) found women showed slightly higher 
rates of neuropsychological impairment than men, though differences were 
not statistically significant. The matched HIV-negative control groups confer 
good internal validity for the results. However, there is little information on 
recruitment so it is not possible to determine any if the sample was subject 
to selection bias.  
 
There may be many reasons for cognitive differences between men and 
women including sex hormones (Hafner et al., 1994; Kimura, 1992) and 
brain structure (Hamilton, 1986), with some researchers finding increased 
numbers of sex hormone receptors on the prefrontal cortex of females 
(Bixo, Backstrom, Winblad & Andersson, 1995). Females who are HIV-
positive are also more likely to have a variety of other risk factors such as a 
history of drug abuse (Failde-Garrido et al., 2008), lower socio-economic 
status (Ickovics & Rodin, 1992) or lower education level (Stern, Silva, 
Chaisson & Evans, 1996). There is also some evidence to suggest females 
have less access to HAART compared to males (Lopez, Wess, Sanchez, Dew 
& Becker, 1999). 
 
Cognitive, Behavioural and Emotional Factors: 
Intravenous Drug Use 
Much research has pointed to drug use having an effect on 
neuropsychological impairment, irrespective of HIV infection (e.g. Vasquez-
Justo, Alvarez & Ferraces Otero, 2003; Carlin & O‘Malley, 1996). 
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Approximately one third of people with HIV use illicit drugs (Waldrop-
Valverde, Ownby & Kumar, 2005) and individuals with HIV who abuse drugs 
have higher rates of impairment than those who do not (Egan, Crawford, 
Brettle & Goodwin, 1990). Intravenous drug use in particular increases the 
risk of cognitive impairment in people with HIV with additive or interactive 
effects (Pereda et al., 2000), by further compromising the immune system 
or increasing susceptibility to depression (Waldrop-Valverde et al., 2005). 
On the other hand, research in this field is seriously limited by recruitment 
methods, for example, recruiting homeless participants directly from the 
streets. However, people may become homeless because they have 
cognitive impairment and are less able to manage their finances (Spence, 
Stevens & Parks, 2004). This recruitment method also does not account for 
intravenous drug users who are HIV-positive but retain their 
accommodation. There are also limitations in the accurate recording of drug 
use and subsequent ability to determine true relationships. Moreover, like 
women, injecting drug users are less likely to be prescribed HAART 
(Himelhoch et al., 2007). 
 
Problem Alcohol Use  
Prevalence rates of problem drinking in people with HIV range from 29% to 
60% (Meyerhoff, 2001) compared with approximately 15% of people 
reporting hazardous drinking in the non-HIV population (Webb, Ashton, 
Kelly & Kamali, 1996). The frontal circuits of the brain seem to be affected 
both by alcoholism and HIV (Sullivan et al., 2003; Winsauer et al., 2002). 
Schulte, Mueller-Oehring, Rosenbloom, Pfefferbaum and Sullivan (2005) 
compared four groups of participants (HIV-negative controls, patients with 
alcoholism, patients with HIV, patients with HIV & alcoholism) on a 
computerised version of the Stroop test. They found participants in the HIV 
& alcoholism group had slower reaction times than controls, indicating 
compromised executive function. However, as the first research study of its 
kind, further research needs to develop these findings.  
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Psychiatric Disorders 
Bing et al. (2001) found nearly half of people with HIV could be diagnosed 
with a psychiatric disorder, especially depression. This is twice as high as 
rates of depression in the healthy community (Chandra, Desai, & Ranjan, 
2005). This may be due to the psychological impact of receiving a positive 
HIV diagnosis (Chandra et al., 2005), direct effects of HIV on the brain 
(Gibbie et al., 2006), side effects of medications (Rourke, Halman & Bassel, 
1999), or exacerbation of pre-morbid conditions (Ellen, Judd, Mijch & 
Cockram, 1999). These prevalence estimates may be an under-estimate, as 
healthcare professionals see depression as a normal response to receiving a 
HIV diagnosis and therefore may not be diagnosed or reported (Chandra et 
al., 2005). 
 
Large quantities of research point towards cognitive impairment in 
psychosis and mania (e.g. Kravariti, Morris, Rabe-Hesketh, Murray & 
Frangou, 2007). Although causality is a key issue in interpreting results as 
individuals with ‗serious mental illness‘ are at high risk of HIV infection 
(Cournos & McKinnon, 1997) and those with HIV are more susceptible to 
psychiatric difficulties (Chandra et al., 2005). There is also some evidence 
that anxiety may affect performance with participants feeling threatened by 
instant feedback causing distraction and interfering with optimum 
performance (Satz et al., 1993). 
 
Depression 
Vasquez-Justo et al. (2003) found HIV-positive individuals experiencing 
depression performed significantly worse on neuropsychological tests than 
those in HIV alone or non-clinical control groups with a particularly 
detrimental effect on memory and executive functions (Ottowitz, Dougherty 
& Savage, 2002). Although it is useful to bear in mind, that depression is 
likely to be under-diagnosed in people with HIV. Likewise Gibbie et al. 
(2006) in a two-year cohort of 80 participants with HIV found depressed 
participants showed more neuropsychological impairment than those who 
were not depressed, independent of medical factors. However, this does not 
imply causality – depression may influence cognitive performance, cognitive 
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performance may influence depression or the relationships could be 
mediated through other factors.  The minimal exclusion criteria of Gibbie et 
al. (2006) study (aged over 18 and English-speaking) allow for good 
statistical power and comprehensive statistical analyses infer good internal 
validity. However, the sample included very few women and all participants 
were in good physical health so results may not be widely generalisable. 
Additionally, the authors do not report on the test-retest reliability of the 
measures used (the Cambridge Neuropsychological Test Automated Battery 
(CANTAB) (Sahakian & Owen, 1992) and the HIV-Dementia Scale (HDS) 
(Power, Selnes, Grim & McArthur, 1995). Moreover, affective disturbances 
may increase complaints of cognitive problems irrespective or whether 
these cognitive problems are found in neuropsychological performance 
(Mapou et al., 1993). 
 
As the mechanism for how depression affects cognitive functioning is 
unclear, it is also uncertain whether the effects of depression are long 
lasting (e.g. Reischies & Neu, 2000) or are reversed on remission of 
depression (e.g. Neu, Kiesslinger, Schlattmann & Reischies, 2001). Biringer 
et al. (2005) found after 26 months in a sample of 30 HIV-positive 
individuals who had experienced a major depressive episode, those who had 
improved in terms of their depressive symptomology also improved on 
measures of neuropsychological performance. However, there were high 
drop-out rates, who may have been the people who remained cognitively 
impaired. Despite these limitations these results were replicated by 
Westheide and colleagues (2007) using more sensitive measures (the Iowa 
Gambling Task). HAART may also have a role in reducing the prevalence of 
major depressive disorder from 31% to 14% of people with HIV (Gibbie et 
al., 2006). However, it is not possible to determine whether this is due to 
brain changes, a psychological response to cognitive deterioration, or 
indeed a placebo effect.  Furthermore, rather than focusing on severity or 
dimensional models research in this area is limited by the dichotomisation 
of both depression and cognitive impairment, which loses the rich 
information in the raw data. 
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Level of Education and Pre-morbid IQ 
People who have had more education tend to perform better on 
neuropsychological tests due to ‗cognitive reserve‘. The cognitive reserve 
hypothesis suggests individuals who have more cognitive resources, from 
longer time spent in education for example, will have a higher threshold 
before the effects of cognitive deterioration are shown (Satz et al., 1993). 
In essence cognitive resources act as a buffer against neurological insults 
(Pereda et al., 2000). Individuals with higher cognitive reserve have also 
had increased opportunities to learn facts and strategies implicit in many 
neuropsychological tests (Grant, 2008). Supporting this hypothesis, 
prevalence of HAD in people with HIV was higher in those who had less than 
six years of education (DeRonchi et al., 2002), despite the limited measures 
used and more than half of the sample were younger than 28 years old.  
Overall lower premorbid IQ does seem to lead to both risk of 
neuropsychological impairment and more rapid decline (LeCarret et al., 
2005).  
 
Executive Function 
Executive functions are the skills required to organise domestic, community 
and professionals activities, social interactions and adaptation to a 
constantly changing environment (Chevingard et al., 2008). Executive 
function skills are used to create models of self-directed action through 
‗formation, planning and carrying out of goal-directed plans and effective 
performance‘ (Jurado & Rosselli, 2007, p214). These skills are also 
associated with insight and play a central organisational role, integrating 
and monitoring other cognitive and emotional functions (Hart, Whyte, Kim & 
Vaccaro, 2005). Executive function problems are therefore most evident in 
interpersonal interactions in the social world (Channon & Crawford, 1999). 
Impairment in these skills can be termed the ‗dysexecutive syndrome‘ 
(DES) and, like HAND, are inextricably linked to frontal subcortical circuits 
(Verdejo-Garcia & Perez-Garcia, 2007).  
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Executive function poses a particular problem for clinical identification 
because of the association with lack of insight. This tends to mean self-
report needs to be supplemented by neuropsychological testing. There are 
two main aims of neuropsychological testing – one is to determine level of 
impairment and the other to determine whether the difficulties will interfere 
with everyday life (Silverberg & Millis, 2009). Neuropsychological testing is 
based on the assumption that damaged brain processes give rise to poor 
test performance which represent poor processing outside of the testing 
environment (Chaytor, Schmitter-Edgecombe & Burr, 2006). 
 
Models of executive function 
Unitary Models  
Several models of executive functions have been developed (e.g. Stuss & 
Benson, 1986; Duncan, 1995) to try and encapsulate the executive 
functions within a single unifying theory. The predominant model 
conceptualises executive function and skills as part of a unitary supervisory 
system (Norman & Shallice, 1980). This model suggests that a contentional 
scheduling system manages over-learned and routine behaviours whereas a 
supervisory attention system (SAS) regulates responses to novel and 
complex tasks, and the SAS is where the executive functions are required. 
However, there has been much speculation over the active role of the SAS 
in routine action (Schwartz, 1995) as there may not be clear categorical 
demarcation between novel and routine tasks (Chan, 2001). 
 
Other unitary models have been proposed including: 
 
 Attentional control (Stuss & Benson,1986)  
 Goal-directed behaviour (Duncan et al., 2000)  
 Working memory (Goldman-Rakic, 1992)  
 Somatic marker hypothesis (Damasio, 1995) 
 
For a review of these models refer to Chan (2008). 
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Fractionated Models 
Stuss and Alexander (2007) have been instrumental in claiming there is no 
undifferentiated ‗frontal lobe syndrome‘ or ‗supervisory attention system‘ 
but three related systems: energisation (initiating and sustaining 
responses), task setting (setting a stimulus-response relationship and 
suppressing salient responses) and monitoring (checking the task over 
time). Nevertheless, other research models have categorised these systems 
differently, into different organisations and arrangements (e.g. Godefroy, 
2003). For example, Fisk and Sharp (2004) also suggest three systems but 
term them: updating (monitoring and manipulation of information), 
inhibition (inhibit automatic or impulsive response when necessary) and 
shifting (flexible adaptations). Other authors have considered specific 
models of what the ‗fractions‘ may look like, such as Levine et al. (1998) 
who identified that one of these fractions may be ‗strategy application 
disorder‘ – ‗a pattern of problems which manifest themselves most in real-
life complex situations which require organisation and structuring of goal-
related behaviour‘ (Burgess, 2000, p.279). Bechara, Damasio, Damasio and 
Lee (1999) have split executive functions into mechanistic and ‗cold‘, such 
as multi-tasking and cognitive flexibility, and ‗hot‘ tasks compared to those 
that involve emotional reasoning, such as decision-making and social 
behaviour. However, few of these system arrangements include the concept 
of decision-making (Bechara et al., 2001) or account for lack of insight or 
lethargy commonly associated with impaired executive function.   
 
Taken together this makes for a complex, contradictory and hotly debated 
field of research. There is much debate about the definition of executive 
functions as the concept encompasses a wide range of skills, with different 
authors placing different emphasis on different skills (Jurado & Rosselli, 
2007). Moreover, this vast range of theories are not detailed models but 
frameworks which are less able to predict and explain specific fractionations 
of executive functions (Burgess, 2000). This has strong implications for 
interpreting the research, where articles which claim to be researching 
‗executive functions‘ tend to be exploring one fraction of this system. Based 
on the empirical evidence so far it seems that ‗executive functions‘ is a 
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useful macroconstruct label to describe abilities that allow us to ‗engage in 
independent and purposive behaviour‘ (Jurado & Rosselli, 2007 p. 231).  
 
Neurobiology of Executive Functions 
It is useful to briefly consider the neurobiology of executive functions to 
make the links with the neurobiology of HIV. Executive functions are 
inextricably linked to the prefrontal cortex (PFC). In evolutionary terms this 
is the ‗latest addition‘ to the brain and developmentally the slowest brain 
function to develop, showing much more individual variation (Fan, 
McCandliss, Sommer, Raz & Posner, 2002). Particular areas of the PFC have 
been identified as having a specific role in fractionated executive function 
(Table 5). However, these skills are not exclusively associated with frontal 
lobe functioning and research is often focused on individuals with discrete 
lesions after brain injury rather than neuro-degenerative changes as seen in 
people with HIV. 
 
Table 5. 
Executive function skills associated with areas of the prefrontal cortex 
Lesion Site Associated  Skills 
Orbito-frontal  
Projects to Caudate Nucleus 
 
 
 impulsivity 
 distractibility 
 disinhibition 
 social behaviour  
Dorso-lateral  
Head of Caudate Nucleus 
 working memory/attention 
 set shifting and perseveration 
 planning and organisation 
 disinhibition 
 problem solving 
 abstract thinking and reasoning 
 ability to integrate information 
 self-monitoring 
Ventro-medial  
Anterior Cingulate projects 
to Nucleus Accumbens 
 motivation and apathy  
 initiation  
 attention 
 self-awareness 
 social behaviour  
 humour 
Note. Adapted from information in Malloy, Bihrle, Duffy & Cimino, 1993; Alvarez & Emory, 
2006; Bamdad, Ryan & Warden, 2003; D‘Esposito, Postle & Rypma, 2000; Stuss & Levine, 
2002; Ross & Stewart, 1981)  
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Executive Function and HIV 
As outlined in previous sections, executive functions are affected early in 
the course of infection and tend to be the most severely impaired cognitive 
domain in people with HIV (Basso & Bornstein, 2000). Research has 
identified that people with HIV have impairments in inhibition (Hinkin, 
Castellon, Hardy, Granholm & Siegle, 1999; Llorente et al., 1998), working 
memory (Martin et al., 2001) planning and sequencing (Sahakian et al., 
1995). Bearing in mind the variability in the frameworks used to describe 
executive functions and that most research with people with HIV has 
included broad global measures of cognitive assessment, this section 
focuses on the studies so far that have directly considered executive 
function in HIV.  
 
In the pre-HAART era a case-control study (Sahakian et al., 1995) recruited 
40 people with HIV, 19 participants were medication free, and 21 were on 
mono-therapy. Over two sessions participants were assessed on the 
CANTAB and the COWAT (Benton & Hamsher, 1976). The analysis showed a 
specific pattern of deficits, where participants with HIV solved significantly 
fewer problems correctly on more complex tasks, with no evident memory 
impairment, compared to 18 matched controls. These results point to 
inefficiency in executive functions, specifically planning, attention and 
flexibility. The COWAT, a frequently used test of executive function, failed to 
pick up these subtle deficits. These results may reflect that the CANTAB is 
more complex than the COWAT, however, Alzheimer‘s patients have shown 
a dissociable pattern, performing well on tests of executive function, and 
poorly on the COWAT. Sahakian et al. (1995) increased the validity of their 
results by using a matched seronegative control group, recruited after 
having taken a HIV-antibody test. However, by including only homosexual 
men, the external validity of results is severely limited and analysis of drug 
and alcohol use to consider alternative interpretations of the results would 
have been useful. One further crucial limitation is that this research was 
conducted prior to the wide-spread use of HAART. 
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The finding of executive function difficulties in people with HIV has been 
replicated in other pre-HAART research using the Stroop (Hinkin, et al., 
1999; Martin, Robertson, Edelstein, Jagust & Sorensen, 1992). Hinkin, et al. 
(1999) used a traditional and a computerised version of the Stroop task to 
assess 51 individuals with HIV and 21 HIV-negative controls. They found 
that individuals with HIV had slower reactions times than seronegative 
controls. Castellon, Hinkin and Myers (2000) also used the Stroop and self-
report measures (NeuroPsychiatric Inventory [NPI] (Cummings et al., 1994) 
to assess irritability and apathy in 86 participants with HIV (28 
asymptomatic, 37 symptomatic, 2 AIDS; 71% were taking HAART) and 21 
seronegative controls. After excluding individuals with previous neurological 
incidents, substance use disorder or a psychiatric history, the authors found 
apathy or irritability in people with HIV were associated with poor automatic 
thinking. However, participants had higher average IQ (110.7) than the 
non-clinical population (100) which may compromise generalisabilty of the 
results.  
 
Most recently Hardy, Hinkin, Levine, Castellon and Lam (2006) explored one 
of the executive function skills, decision-making, in 67 individuals with HIV 
(58% AIDS; all receiving HAART) and 19 HIV-negative controls using the 
Iowa Gambling task (IGT) (Bechara, Damasio, Damasio & Anderson, 1994). 
Paralleling previous studies, Hardy et al. (2006) found individuals with HIV 
showed more impulsivity and were, more likely to choose immediate 
rewards over gradually accumulated smaller rewards compared to HIV 
negative controls. The study‘s strengths and originality lie in its use of a 
sensitive and newly developed measure (IGT), broader inclusion criteria to 
include drug dependence, and 34% female participants, which increase 
external validity. However, the HIV-negative control group had spent 
significantly longer in education (13.9 compared to 12.7 years) than the 
HIV-positive group, and the HIV-positive group were significantly more 
depressed, which might account for the differences over and above HIV 
infection.  
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This research is predominantly cross-sectional, with restricted evaluation of 
progression of executive function difficulties (Bornstein et al., 1993). In an 
eight-year longitudinal study  with 114 participants (55 HIV-positive and 59 
HIV-negative), Baldewicz et al. (2004) found deficits in motor and 
processing speed but no differences over time in executive function (as 
measured by the TMT and Stroop). This methodology increases the 
statistical power as each individual acts as their own control. However, 
although they controlled for depression and IQ, generalisability is limited by 
only including young homosexual men, especially as younger people show 
greater practice effects which lead to a regression towards the mean 
(Heaton et al., 2001). 
 
Summary  
Despite the evidence that executive function difficulties are a dominant part 
of the cognitive profile in HIV and the wealth of conceptual models, few 
studies have considered the underlying components of executive function or 
important functional outcomes (Woods et al., 2009). Sample sizes are small 
so the results cannot reliably inform public policy (Van Gorp, Lamb & 
Schmitt, 1993). The recommended large assessment batteries, assessing 
various cognitive domains, (Butters et al., 1990) increase the possibility of 
detecting a difference when no such difference exists (Type I error). It may 
also be that traditional tests are insensitive because of ceiling effects and 
reliance on psychomotor abilities to measure executive function (Basso & 
Bornstein, 2000). Moreover, there have been variable definitions of 
impairment, which more-or-less arbitrarily range between 1 and 2 SD‘s 
below the mean or on some occasions clinical judgement (e.g. Saykin et al., 
1998). Some studies have used matched control groups, which provide 
internally valid results; although due to subset differences individual levels 
of change may be difficult to determine (Heaton et al., 2001). There are 
also queries as to group matching methodology which is rarely reported 
(e.g. Wacholder, Silverman, McLaughlin & Mandel, 1992).  
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Traditional measurement of executive functions 
Due to the wide ranging consequences of deficits in executive function, 
correct identification is critical to provision of appropriate support 
(Manchester, Priestley & Jackson, 2004). However, the ongoing debate 
surrounding the construct of executive functions necessarily entails 
difficulties around assessment (Jurado & Rosselli, 2007). This section 
outlines how executive functions have been traditionally measured in nearly 
all HIV research. Traditional measures of executive functions include (for 
brief descriptions see Appendix J):  
 Wisconsin Card Sort Test (WCST) (Heaton, Chelune, Talley, Kay & 
Curtis, 1993)  
 Trail Making Test (TMT)  
 Stroop Test 
 Verbal Fluency/Controlled Oral Word Association Test (COWAT) 
 Cognitive Estimates Test (CET) (Shallice & Evans, 1978) 
 Tower of London (Shallice, 1982) 
 
These traditional tests have been developed from construct-driven 
psychology rather than a function-driven perspective (Burgess et al., 2006). 
This has led several authors to question the use of traditional tests in 
assessing executive function. Further, the development in understanding 
executive functions theoretically as fractionated sub-systems suggests that 
no single measure can capture the whole range of executive functions. 
Instead, each individual measure provides information on one aspect of the 
concept (Boone, Ponton, Gorsuch, Gonzales & Miller, 1998). 
 
Alvarez and Emory (2006) employed a comprehensive search strategy 
(inclusion criteria: adult brain injury, not solely focal frontal damage, a 
healthy control group, brain imaging data, appropriate analysis) to identify 
27 studies to review the validity of three traditional measures (WCST, 
COWAT, Stroop). They found that although these tests are regularly used in 
research and clinical work, they were insensitive or, in the case of the 
WCST, sensitive but not specific, to frontal lobe damage. Indeed, the 
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validity of the commonly used Stroop, was based on one study, and had 
only been considered in five further studies (Alvarez & Emory, 2006). 
Furthermore, none of the measures examined the whole of the executive 
construct. Although it was a small study, Gouveia, Brucki, Malheiros and 
Bueno (2007) also found the WCST was remarkably insensitive in 35 adults 
with focal frontal lesions and comment that its place as a measure of 
executive function should be reviewed.  
 
Although traditional tests may demonstrate statistical significance in 
discriminating between clinical and non-clinical groups there is little 
information about the size of the difference, and high specificity may mask 
poor sensitivity (Manchester et al., 2004). For example the discriminant 
validity of the Stroop test is reported as 61.2% but this is derived from 
95.7% specificity and only 30.8% sensitivity (69.2% of the clinical group 
were misidentified) (Wildgruber, Kischka, Fassbender & Ettlin, 2000). 
Several further studies have reported that individuals with frontal brain 
damage perform within the normal range on other traditional tests such as 
the TMT or COWAT (e.g. Ahola, Vilki & Servo, 1996). However, much 
validity research uses individuals with brain injury which does not 
necessarily entail executive function problems so it may be more useful to 
establish validity in groups with pre-identified dysexecutive qualities.  
 
Salthouse, Nesselroade and Berish (2006) found within-person variability 
could account for 50% of the change in test scores over time so a single 
assessment may not be sufficient to draw adequate conclusions on cognitive 
tests (Salthouse, 2007). Rather than conceptualising cognitive abilities at a 
single discrete level, they are arranged over a distribution with many 
potential levels of performance per individual (Salthouse, 2007). However, 
tests of executive function rely on problem solving novel situations and 
cross-sectional research methods without considering these within-person 
fluctuations (Heaton et al., 2001). Additionally, traditional tests are 
‗impure‘, triggering several executive process and non-executive processes 
(Burgess, Alderman, Evans, Emslie & Wilson, 1998). The recently devised 
Delis-Kaplan Executive Function System (D–KEFS) (Delis, Kaplan & Kramer, 
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2001) brings together modified versions of well-known measures (e.g. TMT, 
Stroop, COWAT); consequently this battery is vulnerable to some of the 
same limitations as these traditional tests. 
 
Traditional testing environments may not be representative of real-life: a 
quiet distraction-free space where the examiner takes the lead and initiates 
rules, goals and prompts where the examiner ‗acts as the participant‘s 
frontal lobes‘ (Manchester et al., 2004). The structured nature of traditional 
tests entails that participants do not have to select a task from competing 
possibilities (Stuss & Alexander, 2000) or may attempt to use strategies 
because they are aware they are being observed (Bennett, Ong & Ponsford, 
2005). The use of overall scores might mask this increased effort and lead 
neuropsychologists to conclude the individual has no executive function 
difficulties in everyday life when this is not the case (Bennett et al., 2005). 
Alternatively, office tests may provide an over-estimate of everyday 
difficulties because participants find it hard to imagine the situation in 
reality and the concepts are too abstract (Channon & Crawford, 2008). 
Therefore, traditional tests should be interpreted with caution due to the 
rich contextual cues for expected behaviour provided by the testing 
environment (Manchester et al., 2004).  
 
Ecological validity 
There is increasing support for the idea that cognitive tests should not be 
looking to provide categorical diagnoses but outline the ‗behavioural 
consequences of brain damage‘ (Ready, Steirman & Paulsen, 2001, p.314). 
Ecological validity describes the ability of a test to represent and predict 
real-world behaviour (Burgess et al., 2006). Ecological validity can be 
broken down into verisimilitude (the ability of tests to resemble real-life 
demands) and veridicality (the ability of tests to relate to measures of 
everyday function) (Chaytor & Schmitter-Edgecombe, 2003). Unlike other 
forms of validity, there has been no formal level set to define the strength 
of the relationship needed between test performance and everyday 
behaviour to claim good ecological validity (Chaytor & Schmitter-
Edgecombe, 2003). By virtue of the concept, measures with good ecological 
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validity are more discriminative than traditional tests and have good 
predictive validity for behaviour outside of the ‗lab‘ (Verdejo-Garcia & Perez-
Garcia, 2007). For tests to be predictive of behaviour in the real world 
requires assessment of the individual within their day-to-day environment. 
Individuals may express no real world problems if their usual environment 
places little demand on executive functions or minor impairment may 
produce large disabilities in a highly demanding environment (Chaytor, 
Schmitter-Edgecombe & Burr, 2006). For people with HIV it is possible to 
hypothesise their environment would be high demand, especially when 
considering the complex nature of HAART medication adherence. 
 
Inferences made from traditional tests have poor ecological validity, with  
weak-moderate relationships (correlations ranging from .2 to .5) with 
everyday behaviour (Burgess et al., 2006). Overall support has been found 
for superiority of tests that are based on verisimilitude where capturing the 
essence of everyday skills (Chaytor & Schmitter-Edgecombe, 2003). 
However, as verisimilitude is based on face validity which cannot be 
confirmed empirically (Chaytor & Schmitter-Edgecombe, 2003). 
Furthermore, there is also no gold standard way to measure veridicality or 
quantify performance outside of the testing environment as all assessments 
contain some degree of error (Chaytor et al., 2006). 
 
A test with good ecological validity does not aim to assess what the client 
can do in an ideal environment (i.e. impairment) but what the client does 
(i.e. activity/participation) (Odhuba, van den Broek & Johns, 2005) 
including compensatory strategies, which are discouraged during 
assessment with traditional tests (Chaytor et al., 2006). This can be 
conceptualised using the WHO International Classification of Functioning 
(ICF) (2002) which translates HIV infection not only into changes in brain 
function and structure but how that affects the individual in their 
environment to create a more meaningful picture of the experience (Table 6 
Description of levels of functioning). This moves away from a purely medical 
model (illness as a feature of the individual) to synthesise information from 
the social model (disability as socially created). This is especially important 
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because, as discussed, executive function difficulties lead to key quality of 
life issues (Semkovska, Bedard, Godbout, Limoge & Stip, 2004). 
 
Table 6. 
WHO-ICF Category Functioning Descriptions 
Health 
condition  
Impairment 
 
Activity 
Limitation  
Participation 
Restriction  
 Problem with body 
function, 
structure, 
deviation or loss 
Difficulties an 
individual has 
executing an 
activity 
Problems 
experienced in 
involvement in life 
situations 
Note. WHO-ICF=World Health Organisation-International Classification of Functioning 
 
Chaytor et al. (2006) found the WCST, TMT, Stroop and COWAT varied in 
their degrees of ecological validity in different populations. Some research 
has compared these measures to functional outcomes: Pontius and 
Yudowitz (1980) found lower performance on the TMT was predictive of 
more criminal behaviour and Lysaker, Bell and Beam-Goulet (1995) found 
slower performance on the WCST was associated with reduced ability to 
understand work assignments or socialise with colleagues. However, these 
generic outcomes might not accurately reflect the unique complexity of 
people‘s lives (Kibby, Schmitter-Edgecombe & Long, 1998).  
 
In light of the limitations of traditional tests, recent research has seen a 
surge in development of assessment measures of executive functions. 
These tests focus on participants completing multiple tasks over a period of 
time without external feedback, deciding for themselves how to proceed 
(Knight, Alderman & Burgess, 2002). These novel measures include (for a 
brief description of these measures see Appendix J): 
 
 Multiple Errands Test (MET) (Shallice & Burgess, 1991) 
 Six Elements Test (SET) (Shallice & Burgess, 1991) 
 Virtual Reality Tests (O‘Niel-Pirozzi & Goldstein, 2005) 
 Hayling & Brixton (Burgess & Shallice, 1997)  
 Iowa Gambling Task 
 Behavioural Assessment of the Dysexecutive Syndrome (BADS) 
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Modest relationships have been found between tests with good ecological 
validity and traditional tests. Tranel, Hathaway-Nepple and Anderson, 
(2007) compared participants with focal damage to the ventromedial 
prefrontal cortex to participants with prefrontal damage, non-prefrontal 
damage and controls. They found that although the SET and MET were 
moderately associated with the WCST and TMT, traditional tests did not 
show any differences in performance of clinical sample compared to the 
controls, whereas the tests with good ecological validity did discriminate 
between clinical and non-clinical groups and were superior to traditional 
tests at outlining the behavioural sequelae of brain damage (Tranel et al., 
2007). However, there were only small numbers of participants in each 
group (n=8/9) and participants were only included if they had stable focal 
lesions so the results may not be applicable for neurocognitive disturbances 
of HIV. Despite this, the superiority of tests with good ecological validity has 
been supported by previous research (Dimitrov, Grafman & Hollnagel, 
1996; Evans, Chua, McKenna & Wilson, 1997; Norris & Tate, 2000).  
 
Although comparing tests to each other provides useful information it is not 
possible to determine which tests reflect the ‗true‘ score. To provide an 
alternative it is useful to compare cognitive tests to self- and proxy-report 
on measures such as the Dysexecutive Questionnaire (DEX). Burgess et al. 
(1998) compared 11 measures of executive function in a heterogeneous 
population (n=92) to proxy-report on the DEX. Like previous studies, they 
found most traditional measures (e.g. COWAT and CET) were insensitive to 
neurological disorders as measured by the DEX. A strength of the study lies 
in consideration of executive functions as a fractionated system and relation 
of measures to the underlying constructs. Nearly all measures were related 
to the sub-system inhibition, although this construct overlapped significantly 
with ‗general intelligence‘. Intentionality and goal-related behaviour was 
only related to the Six Elements Test (SET), with no overlap with IQ. 
Executive memory (confabulation, perseveration) was related to scores on 
the WCST. However, they also suggested there were two other factors: 
motivation and personality changes, which were not accounted for by 
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neuropsychological tests. Although this was a large multi-centre study, the 
population was very heterogeneous and the assessment was administered 
over a number of sessions which may not take into account within-subject 
differences (Salthouse, 2007). Research in this area uses different 
populations and types of neuropsychological tests which make findings hard 
to compare (Poole, Ober, Shenard & Vinogradov, 1999). Moreover, even 
significant correlations were only of moderate size, meaning that a large 
proportion of everyday skills are not unaccounted for (Chaytor et al., 2006). 
Ecological validity might not be categorically achieved but tests have better-
or-worse ecological validity under defined circumstances (Chaytor & 
Schmitter-Edgecombe, 2003). 
 
Therefore, when research in executive functions in HIV are re-appraised it is 
possible to see the Hardy et al. (2006) is the only study to have used a 
measure of executive function with good ecological validity to consider the 
difficulties people with HIV have in everyday life. However, the IGT only 
considers a single factor of executive function. A battery approach to 
assessment of executive functions with good ecological validity would be 
more appropriate. The Behavioural Assessment of the Dysexecutive 
Syndrome (BADS) (Wilson et al., 1996) assesses several aspects of the 
executive functions and can examine most aspects of executive functions 
using one battery (Kamei et al., 2008) but is not too time-consuming.  
 
Behavioural Assessment of the Dysexecutive Syndrome (BADS)  
The BADS has not been used in clinical research with people with HIV 
previously so this section briefly considers the potential contributions that 
using this measure could make to the research in executive functions in 
people with HIV. The BADS authors have developed normative data from a 
large stratified sample of non-neurologically impaired individuals (n=216). 
The authors report there were approximate equal numbers of men and 
women and adopted a rigorous recruitment strategy to avoid volunteer bias 
(Wilson et al., 1996). The age of the sample ranged from 16 to 87 years, 
with equivalent numbers of participants in below average, average and 
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above average IQ scores. The sample was recruited from participants who 
had previously been involved in collecting population norms, staff from 
healthcare centres and an organisation providing work experience for 
people who have been unemployed. Profile scores are converted to standard 
scores (mean 100, SD 15) which can classify BADS performance in the 
same way as full-scale IQ on the Wechsler Adult Intelligence Scale-Revised 
(Wechsler, 1981). The authors also report data for 78 brain injured 
individuals and 31 individuals diagnosed with schizophrenia. This large 
normative data study allows a baseline for individuals to be compared 
against. However, there is very limited data on describing the normative 
sample on gender or ethnicity.  
 
Although the BADS is an office based test, it moves away from the 
traditional tests and has been designed to reduce load on working memory. 
Much research has shown that the scores on the BADS battery are 
dissociable from scores on tests of memory or language (e.g. Evans et al., 
1997). The BADS has been used in several populations including people 
with problem alcohol use (Moriyama et al., 2002), substance dependence 
(Verdejo-Garcia & Perez-Garcia, 2007), schizophrenia (Jovanovski, 
Zakzanis, Young & Campbell, 2007; Katz, Tadmor, Felzen, Hartman-Maier, 
2007) and Parkinson‘s Disease (Kamei et al., 2008). For example, Verdejo-
Garcia and Perez-Garcia (2007) examined executive function deficits using 
the BADS, WCST and a questionnaire (Frontal Systems Behavioural Scale, 
similar to the DEX, Grace & Malloy 2001) in a heterogeneous group of 37 
substance-dependent individuals and 37 controls (matched for age, 
education and pre-morbid IQ. The results of a MANOVA showed ‗normal‘ 
performance on the WCST in the clinical group, whereas 5 out of the 6 
subtests of the BADS were classified as ‗impaired‘. The benefit of having a 
matched control group gives the study strength but the cross-sectional 
nature does not control for within-person variability. Additionally there were 
only five women in the clinical group and two in the control group so the 
lack of representation in the sample reduces the external validity of the 
results. Moreover, the exclusion criteria (psychiatric disorder, HIV, 
neurological alteration) may also limit the generalisability of the results. 
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However, diagnoses such as schizophrenia and alcoholism are controversial 
and not sufficient to make predictions about behaviour (Bentall, 2003).  
 
Reliability  
Inter-rater reliability of the BADS is high, reported as .99 so clinicians can 
be confident in the scoring strategies suggested in the manual (Kamei et 
al., 2008). However, internal consistency data is not reported for the BADS 
and over six to twelve months most subtests fail to reach the critical level 
(.80) for good test-retest reliability (Jelicic, Henquet, Derix & Jolles, 2001). 
On the other hand, executive function assessments rely on presentation of 
novel tasks so test-retest reliability is often low (Jelicic et al., 2001).  
 
Validity 
Compared to other tests and self- or proxy-report 
Even though the BADS is office-based, many authors report good face 
validity (Wood & Liossi, 2006). The BADS manual (Wilson et al., 1996) 
reports good discriminant validity between clinical (brain injury) and non-
clinical groups. However, there is considerable overlap between the groups 
with 65% of the clinical group not classified as impaired. However, both of 
these results may reflect the heterogeneous sample and the level of 
disability experienced as opposed to poor sensitivity. 
 
The manual reports a significant correlation between functional measures 
(DEX) and the BADS which suggests good ecological validity of the BADS 
(veridicality) in 78 individuals with a brain injury (Wilson, Evans, Emslie, 
Alderman & Burgess, 1998). The BADS profile score was the best predictor 
of proxy-report on the DEX with correlations coefficients on subtests of the 
BADS with the DEX-other ranging from -.31 to -.46 (poorer performance on 
the BADS subtests was associated with higher scores on the DEX). Stokes 
and Bajo (2003) found an association between two of the BADS subtests 
and the DEX, however, this effect disappeared once IQ had been partialled 
out of the regression. Wood and Liossi (2006) compared the same two 
subtests from the BADS to the DEX-other in 165 participants (mean age 
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33.86, range 17-64). Unlike Stokes and Bajo, they found the BADS was not 
correlated with the DEX and there were significant effects of IQ. However, 
as they only used selected subtests the results cannot be generalised to the 
entire BADS battery. Evans et al. (1997) found there were significant 
relationships to the DEX-clinician in people with acquired brain injury 
(n=35) but not in people diagnoses of schizophrenia (n=31), despite 
impairment on the BADS compared to controls (n=26). However, this study 
includes limited demographics sample information and considerable 
variability between the sample groups means it is hard to identify the 
internal causality of this study. Furthermore, the clinical significance of this 
association is questionable and has not always been replicated (Norris & 
Tate, 2000).  
 
Norris and Tate (2000) examined construct and concurrent validity of the 
BADS in 73 participants from three samples (19 brain injury, 17 Multiple 
Sclerosis, 37 matched controls) using the WCST, TMT, Rey Figure, COWAT, 
a role functioning questionnaire and the DEX. They found the BADS had 
adequate concurrent validity with other tests of executive function, although 
this was small (correlations ranging from .23 to .34). This is to be expected 
as the BADS was developed in response to criticisms of these tests. 
However, only one subtest of the BADS correlated with the DEX-other, and 
this was not in the expected direction. Norris and Tate (2000) found 
specificity of the BADS was good (83.8%) although the BADS had a 
tendency for failing to detect effects when such effects really exist (Type II 
error) with only 63.9% of the clinical group were correctly classified. This 
may be because the overall score obscures subtest information and 
disguises sensitivity (Bennett, Ong & Ponsford, 2005). Alternatively this 
may be due to aspects of the executive function construct which are not 
represented in the BADS. As with all tests, the BADS is a compromise 
between the probabilities of committing Type I and Type II errors. The 
BADS accounted for 16.2% of the variance in role functioning. These 
statistics were still better than the traditional tests. However, the clinical 
groups were not screened for dysexecutive problems, which might have 
improved sensitivity of the results. 
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Bennett et al. (2005) assessed 64 brain injury participants (47 male, 17 
female, 17 to 73 years old). Few exclusion criteria were used to maximise 
sample size and thus the statistical power of the study. Participants were 
assessed on the DEX, BADS, WCST, TMT, COWAT and several other, less 
commonly used measures of executive function. The authors concluded the 
BADS contained some useful subtests, in particular the Action Program and 
the SET. They conclude the BADS is more sensitive to executive dysfunction 
than traditional measures. However, this study would have benefitted from 
the inclusion of a control group. Moreover, although the study maximises its 
external validity by having flexible exclusion criteria, the internal validity is 
limited due to the multitude of confounding variables.  
 
Despite the BADS being commonly used cross-culturally (e.g. Kamei et al., 
2008), there is little information on the culturally validity of the BADS. Few 
ethnic minorities are part of normative samples and tests of executive 
function may be limited in considering the social context of the difficulties 
(Proctor & Zhang, 2008). Proctor and Zhang (2008) found in a large sample 
of college students from ethnic groups (African American, Latin American 
and European American), the BADS showed statistically significant 
differences between groups. However, effect sizes were small-moderate and 
no differences were found between groups on 5/6 subtests, but participants 
from an African American background had a larger range of profile scores.  
 
Compared to other functional outcomes 
Little research has compared the BADS to other functional outcomes such 
as employment status. Katz et al. (2007) found the predictive validity of the 
BADS for employment was good in people with schizophrenia. They 
reported a stronger relationship with the BADS and social communication 
than with more basic activities of daily living (ADLs), such as washing and 
dressing, emphasising the involvement of executive functions in complex 
tasks. Moriyama et al. (2002) found the BADS had greater discriminative 
power than the TMT in predicting occupational status in 22 males with 
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chronic alcoholism. However, unlike previous studies, this study found that 
the most useful subtest were Temporal Judgement and Zoo Map. The Zoo 
Map may be one of the most robust subtests, measuring a broadly similar 
process to the MET (Knight et al., 2002). Despite the small sample size, the 
strength of Moriyama and colleagues (2002) study is the longitudinal 
prospective methodology (18-month follow-up). However, employment 
outcomes were classified dichotomously and may have been better 
described on a continuum. 
 
Justification for the use of the BADS 
The BADS has been shown to have the best ecological validity of ‗office-
based‘ tests, over other batteries such as the D-KEFS (Norris & Tate, 2000). 
As well as ecological validity, the BADS employs a battery rather than a 
single executive measure, like the IGT, and includes only minimal load on 
working memory functions. Although the MET is one of the most naturalistic 
assessment methods involving real-world observation of participants 
necessitating good ecological validity, it is time-consuming and reliant on 
several other cognitive functions, such as memory (Sohlberg & Mateer, 
2001).  Moreover, some authors have questioned whether the MET still 
provides too much structure to relate to everyday life (Chevingard et al., 
2008).  The BADS might offer a useful practical alternative to the MET. 
Furthermore there is significant evidence for the validity and reliability of 
the BADS in clinical populations. The BADS also has evidence of superior 
predictive ability over traditional assessments in everyday functioning. This 
also begins to update the research in HIV, moving away from Butters et al. 
(1990) global measurement battery. This also is consistent with the future 
research directions suggested by a recent literature review (Woods et al., 
2009). 
 
Summary 
Previous research has reported the specific, often subtle, deficits in 
executive functions dependent on the fronto-striatal circuits early in HIV 
infection, even since the widespread use of HAART medication. However, 
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most research has used measures not capable of predicting real world 
behaviour or considering more than one of the executive function fractions. 
Previous reviews have recommended the usefulness of a battery approach, 
especially one with good ecological validity, such as the BADS, to further 
develop research with people with HIV (Woods et al., 2009). Overall, the 
BADS is a useful measure that has been used in many populations with 
good validity, with an overall trend, albeit not conclusive, towards good 
ecological validity.  
 
Research Question and Aims of Study  
As a result of consideration of the above literature the research aims were 
derived. The research sample average BADS performance was compared to 
the normative data as suggested by the manual. This is in keeping with 
previous research which has suggested that ideally neuropsychological 
assessment needs to be a performance-based battery and interpreted using 
demographically appropriate normative data (Woods et al., 2009). This 
reflects the experience of neuropsychologists in the real world. It was 
hypothesised people with HIV would perform below what would be expected 
on the BADS relative to age-matched normative scores. The scores were 
kept on a continuum scale rather than dichotomised into impaired or not, 
which might hide variability (Lovejoy & Suhr, 2009). This avoids the 
confounds of unnecessary cut-offs for classification (Carey et al., 2004). The 
inclusion of the DEX encompasses a functional assessment as there are no 
widely agreed clinical measures of everyday functioning for executive 
functioning (Morgan & Heaton, 2009). This functional assessment improves 
the ecological relevance of neuropsychological assessment with HIV (Woods 
et al., 2009) and considers a functional rather than impairment perspective 
as suggested by the WHO-ICF. The inclusion of mediating variables should 
identify and assist in developing which of these factors may affect 
performance and thereby aims to understand the nature and place the 
experience of executive function problems in people with HIV within a 
context (Barker, Pistrang & Elliott, 2002). 
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Extended Methodology 
This chapter expands on, and justifies the methodology used in this study. 
In particular, it discusses the epistemological framework guiding the study, 
expanded elements of the study procedure, details on the reliability and 
validity of the assessment measures used and ethical considerations. 
 
Epistemological Position 
Most quantitative research is conducted under the framework of positivism. 
Positivism states that there is an objective reality from which laws, rules 
and knowledge about human behaviour can be derived through observation 
and measurement (Guba, 1990). The philosophical position of positivism is 
closely related to reductionism and materialism, whereby all mental 
processes are ultimately reducible to their component parts, in a direct 
cause-and-effect mechanism relating to underlying biology and physical 
mechanisms. One of the fundamental tenets of positivism is that by 
understanding the world well enough, it might be possible to predict, control 
and manipulate it. By virtue of this, knowledge is considered as static and 
external to individuals.  
 
However, there has been a strong critique against positivism within applied 
sciences and psychology, as not representing the true complexity in human 
action and behaviour. The positivist epistemological view seems to be 
apolitical and does not consider human behaviour within its context, history 
or meaning. Positivism also premises the potential of true objectivity in 
measurement and assessment, and the active role of the observer in 
deriving knowledge is not considered.  
 
In response to the wide-spread malaise with positivism as a guiding 
framework for social sciences research, a social constructionist framework 
developed, closely aligned to post-modernism (Barker, Pistrang & Elliott, 
2002). This puts forward a position which refutes the assumption that there 
is any objective reality at all; instead each individual idiographically 
constructs their reality through interactions with the social world leading to 
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increased focus on language constructions (Willig, 2001). However, many 
social science researchers have preferred a mid-ground perspective in 
critical realism. Within critical realism there is an independent reality, and 
thereby truth-conditional statements have a meaning, however, it is not 
possible to ever truly objectively measure and access this reality (Cook & 
Campbell, 1979). There are multiple interpretations and each individual 
interprets and constructs an individualised world view. Critical realism also 
acknowledges the active role of the observer as biased and imperfect. 
Therefore, all measurement is inherently fallible and importance is placed 
on multiple measurement, observations and triangulation which will all 
contain inherent errors, although even this approach will not obtain the laws 
and ‗truth‘ as in positivism. Similarly, cognitive measures can only choose a 
small set of items that are good examples or salient features of the larger 
construct, but no measure can possibly capture all the iterations of the 
construct (Westerman, 2006). This thereby requires researchers to have a 
detailed knowledge of the limitations and assumptions of the measurement 
approaches used (Mingers, 2004).  
 
Many researchers directly link epistemology with research methods and 
approaches. Subsequently, quantitative research is linked to positivism and 
qualitative research is linked to post-positivism, social constructionism and 
critical realism (Gergen, 2001). This tends to suggest that quantitative and 
qualitative research contrast with one another (Westerman, 2006). 
However, epistemological frameworks are not committed to single forms of 
research and several commentators have theoretically articulated how 
quantitative research can be considered from multiple epistemological 
frameworks (e.g. Mingers, 2004). Numbers and statistical analyses can 
contribute to critical realist understandings and exploring patterns of 
behaviour (Stiles, 2006). Statistical analyses can be regarded as quasi-
experimental, imposing closure on an open system for the purposes of 
exploring the patterns. Statistical findings are not conclusive but point 
towards developments for further research (Mingers, 2004). 
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It is also important to acknowledge the role of hermeneutics and 
interpretivism in quantitative research. Hermeneutics (Merleau-Ponty, 
1962; Wittgenstein, 1958; Heidegger, 1962) purports that knowledge 
emerges from interpretation, and these meanings assigned to concepts play 
a significant, yet often unacknowledged role, in quantitative research. For 
example, measures and language assessing concepts such as ‗irritability‘ 
are heavily value-laden and based on a deep understanding of human 
behaviour (Westerman, 2006). These terms are meaningless unless they 
are employed with understanding and background knowledge. Likewise, 
meaning attributed to certain measurement strategies plays a central role in 
the development of research, for example, deciding research topics, 
approaches and/or measurement tools used; these are all interpretive 
processes embedded in the researchers‘ understanding and attribution of 
meaning (Westerman, 2006). There are even interpretations in deciding 
which statistical tests to perform, and determining the inferences of the 
results. From this perspective, quantitative research is clearly interpretive 
(Westerman, 2006).  
 
Hermeneutics also acknowledges an observer can never be objective 
because they are always involved in meaningful activities in the world which 
influence their interpretations (Fischer & Bidell, 1998). Moreover, this focus 
on meaning suggests that research should always refer to context, what 
people are doing and meaningful activities they engage in on an everyday 
basis (Westerman, 2006). This is how it is possible to appreciate the 
significance of a subset of examples, because of the meaning that is 
attributed to them (Nagel, 1974).  
 
Having discussed the advantages and disadvantages of various 
epistemological frameworks, a critical realist approach is the most relevant 
for the current research question. This approach acknowledges that, despite 
measurement, it is not possible to access the executive function construct 
exhaustively. This research study also placed emphasis on the context of 
the individual and how changes in the brain may influence behaviour in 
everyday life through ecological validity of measurement. In combining a 
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critical realist epistemology with quantitative research, this study aimed to 
develop the research body whilst recognising the limitations of all methods, 
including measures and statistics. This study also used triangulation, on this 
premise. In line with this framework, it is important to acknowledge the 
researcher‘s own interpretations will have influenced the interpretation of 
this research, from initial development through to write-up. For excerpts 
from personal reflective notes on the potential way the researcher‘s pre-
reflective understanding influenced the design and interpretation of this 
study see Appendix K. 
 
Methodology  
Design: 
This study did not include variables manipulated by the researcher but 
observes differences between existing groups. However, the literature has 
used various terminologies to describe this type of study design. These 
include ‗passive-observational‘, ‗group difference comparison‘ ‗post-facto‘ 
‗experimenter-selected independent variable‘ and ‗retrospective 
experimentation‘ (Cook & Campbell, 1979; Sprinthall, 2003; Solso & 
Johnson, 1998; Robson, 2002). Group difference comparison design was 
selected to describe the current study as this was deemed to provide the 
clearest brief explanation of the study.  
 
Participants: 
Sample Size 
Traditionally, sample size calculations are conducted to determine the 
sample size for a research study based on the power, critical probability 
level and minimum effect size. Effect size is preferably calculated by past 
research; however, this pilot study is exploratory because no previous 
research has used an executive function battery approach with good 
ecological validity in this population. For example, although Sahakian et al. 
(1995) used a battery approach, the battery was not specific to executive 
functions and was conducted in the pre-HAART era so effect sizes are not 
easily transferable to inform the current study. Other studies which have 
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considered executive function using the Butters et al. (1990) battery have 
only included one/two measures assessing executive functions. Hardy et al. 
(2006), although they used a measure with good ecological validity,  only 
assessed one aspect of the executive functions so is not applicable to a 
battery approach. The empirical research into people with HIV and their 
executive functions does not therefore specifically identify effect sizes which 
could have been appropriately used in a statistical power analysis. As this 
study was an explorative pilot study and without an appropriate effect size 
from previous research, a formal power calculation was not conducted.  
 
Therefore, sample size was decided by considering previous pilot studies 
which had employed similar methodologies, but researching different 
questions (Jovanovski et al., 2007; Moriyama et al., 2002). These research 
studies have used samples sizes of between 20 and 30 participants. This 
was further discussed with professionals working with people with HIV and 
considered within the context of the practical constraints of DClinPsy 
research. From an inferential statistics point of view the larger sample size 
the better, however, recruitment of large samples is cost and time-
intensive. Researchers need to prevent inappropriate spending of resources, 
and as such a pilot study into this area at this stage of theory development 
is an appropriate methodology (Falagas & Bliziotis, 2007). 
 
Inclusion criteria: 
o Diagnosis of HIV-1 infection 
This was confirmed through contact with healthcare 
professionals who work with the participant (either through 
referral or contact to confirm diagnosis directly). The 
healthcare professional confirmed this through evidence of 
ELISA antibody tests.  
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o Age range 18-60 years old 
This included participants who were not experiencing major 
cognitive changes associated with developmental stages and 
were able to give full consent to participate in the research. 
This also ensured that normative data on the tests being used 
was available for all the participants. 
Exclusion criteria: 
Each criterion was developed to balance the inevitable trade-off between 
internal and external validity as well as pragmatic demands, through 
discussion and operationalisation with experts working in the field. These 
criteria try to preserve scientific rigour, so performance on the BADS can be 
more confidently attributed to the executive function of HIV participants, 
rather than confounding factors such as substance misuse, whilst ensuring 
the generalisability of results to the wider population of people living with 
HIV. 
 
o Time since diagnosis less than three months, defined as: 
The first few months after a positive HIV diagnosis are likely to 
be distressing (Melrose et al., 2008). The individuals may be 
subject to a variety of medical tests and trialling medication 
regimes introducing variability in neuropsychological 
performance (Lovejoy & Suhr, 2009). Therefore, to protect the 
individual's emotional state and to ensure validity, individuals 
who were diagnosed less than three months prior to 
recruitment were excluded (based on discussion with 
clinicians). 
 
o Medically unstable, through discussion with clinicians defined as: 
 Hospitalisation (>one night stay) for illness or infection 
over the last two weeks 
 Changes in HIV medication regime in last two weeks  
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Fluctuating medical status, suggested by recent illness, can 
influence performance on neuropsychological tests by 
increasing levels of fatigue and decreasing concentration 
(Henderson, Safa, Easterbrook & Hotopf, 2005). It also takes a 
number of weeks for psychological adjustment to complex 
medication regimes such as Highly Active Anti-Retroviral 
Therapy (HAART) (Lovejoy & Suhr, 2009). These factors may 
lead to neuropsychological performance which does not provide 
a true reflection of abilities or a discrepancy between self-
report and test performance (Lovejoy & Suhr, 2009). 
 
o Major psychiatric disorder, defined as: 
 Current episode of psychosis, mania or severe 
depression 
Psychosis, mania and severe depression can result in moderate 
executive dysfunction (Chandra et al., 2005; Ottowitz et al., 
2002). However, most evidence points to this recovering once 
the episode has remitted (Westheide et al., 2007). Other 
psychiatric disorders have limited or no evidence pointing to 
executive dysfunction so were not included in the criterion.  
 
o Significant substance misuse, defined as: 
 Self-reported intravenous drug use in the last week 
Research has shown that substance misuse, in particular 
intravenous drug use is associated with executive dysfunction 
(Chandra et al., 2005). However, these effects are not thought 
to be long lasting so this criteria controls for the effects of 
current severe substance dependence but pragmatically tries to 
ensure representation of the population.  
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o Severe neurological deficits, defined as: 
 Self-report of any of the following: 
 Head injury/cerebral incident requiring hospital 
admission  greater than 24 hours 
 Degenerative neurological diseases, for example, 
Multiple Sclerosis 
 Brain tumours  
Neurological deficits are known to have ongoing influences on 
executive functions (Marder et al., 1992) so excluding 
participants with neurological co-morbidities should improve 
internal validity.  
 
o People who cannot complete the assessment 
 Visual impairment – unable to read a sentence on a card 
written in font size 28 with corrected vision 
 Hearing impairment – unable to hear the researcher in a 
quiet room with a hearing aid 
 Unable to understand and consent to the research 
process – based on the principles set out in the Mental 
Capacity Act (2005) 
As assessment of participants‘ executive function is the main 
aim of the study it is not possible to include people who cannot 
physically complete the assessment.  
 
o Language ability 
 Score of less than 15 on the Sheffield Screening Test for 
Acquired Language (SST) (Syder, Body, Parker & Boddy, 
1993) 
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The BADS involves understanding complex instructions. 
Therefore it is not possible to include people who cannot 
understand or communicate in English. The study screened for 
this using the SST to control for language impairment 
associated neuropsychological problems and language 
comprehension for those for who English is not their first 
language. Individuals were excluded if they scored below the 
cut-off of 15 as suggested by Blake, McKinney, Treece, Lee and 
Lincoln (2002). 
 
Information 
Table 7 summarises what information was collected and the purpose of 
collecting the information for this study. For a justification of variable 
information that was collected see extended background. Table 7 also 
includes data coding (if appropriate), level of measurement and data 
source. The sources listed are: 
o Referral – initial information given to the researcher 
o Medical Notes – information collected from the medical notes  
o Clinical Interview – information collected during the assessment 
session through discussion between the researcher and participant 
and selection of multiple choice options 
Measures which have employed standard scores were treated as interval 
level data (Coolican, 2004). For further explanation of level of measurement 
see extended results section. 
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Table 7. 
Details of information collected through the research study 
Information Purpose Coding Level of 
data 
Source 
HIV Medical Factors 
HIV Diagnosis  
Inclusion 
criteria 
- - Referral 
Medical History 
Exclusion 
Criteria 
o Current major psychiatric disorder 
o Significant substance misuse 
o Severe neurological deficits 
o Hospitalisation in the last two 
weeks 
- 
Clinical Interview 
 
Time since diagnosis 
Exclusion 
Criteria o Months Ratio Medical Notes  
Analysis 
Medication Regime 
Exclusion 
Criteria 
o Length  
 Months  
o Type 
 Mono-therapy 
 Duo-therapy 
 Triple-therapy (HAART) 
 Quad-therapy  
 None 
Ratio 
 
 
 
 
 
Ratio  
Medical Notes 
CD4 count Analysis 
o Most recent test result  (cells per 
cubic millimetre mm3) 
Ratio 
 
Medical Notes 
Plasma Viral Load Analysis 
o Most recent test results (copies 
per millilitre cc/mL) 
Ratio Medical Notes 
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Current CDC Stage Analysis 
o Asymptomatic 
o Symptomatic 
o AIDS 
Ordinal Medical Notes 
Demographic Factors 
Sexual Orientation 
Description of 
Sample 
o Homosexual 
o Heterosexual 
o Bisexual 
o Not sexually active 
- Clinical Interview  
Employment 
Description of 
Sample 
o Employed  
 Part/Full time 
 Paid/Voluntary 
 Occupation 
o Unemployed  
 Disability related to HIV  
 Disability other than HIV  
- Clinical Interview  
Living Arrangements 
Description of 
Sample 
o Alone 
o With spouse/partner 
o With others 
- Clinical Interview  
Ethnicity Analysis  
o Ethnic groups as specified on the 
census 
Nominal Clinical Interview 
Cognitive, Emotional & Behavioural Factors 
Language Ability 
Exclusion 
Criteria 
o Cut off <15 (Blake et al., 2002) - 
Sheffield 
Screening Test for 
Acquired 
Language 
Disorders (SST) 
Drug and Alcohol 
Intake  
Analysis 
o None 
o Weekly frequency of use of: 
 Alcohol (units) 
Ratio Clinical Interview 
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 Cannabis (joints) 
 Amphetamine (grams) 
 Opiate (grams) 
 Other 
Education Analysis 
o Years of education 
 <5 years 
 5-11 years 
 12-13 years 
 14-16 years 
 17+ years 
Ratio Clinical Interview 
Pre-morbid IQ Analysis o Standard score  Interval  
Wechsler Test of 
Adult Reading 
(WTAR) 
Mood Analysis 
o Anxiety score 
o Depression score 
Ordinal 
Hospital Anxiety 
and Depression 
Score (HADS) 
Measures of Executive Function 
Self-report of 
executive function 
Analysis o Self-report score Ordinal 
Dysexecutive 
Questionnaire 
(DEX) 
Proxy-report of 
executive function 
Analysis o Proxy-report score Ordinal 
Dysexecutive 
Questionnaire 
(DEX) 
Executive Function Analysis o Age-related standard score Interval  
Behavioural 
Assessment of the 
Dysexecutive 
Syndrome (BADS) 
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Measures 
 
This section expands on the descriptions, reliability and validity of the 
measured used in the current study. Examples of alternative measures are 
briefly discussed before a justification for why the measure used was 
chosen. 
 
Sheffield Screening Test for Acquired Language Disorders (SST)  
(Syder, Body, Parker & Boddy, 1993) 
 
The SST consists of 20 verbal items (nine comprehension items and, eleven 
expression items). The comprehension items ask participants to point to 
objects in the room, follow simple and complex commands, identify the odd 
one out of a group of words and answer questions about a short paragraph. 
The expression items ask participants to generate a list of words, describe a 
sequence, express synonyms, describe the meaning of some common 
words and explain the purpose of some common activities. 
 
Reliability and Validity 
There is no reliability or validity data for this measure in people who are 
HIV-positive. However, it has been shown to be accurate, with 89% 
sensitivity and 100% specificity in one study comparing the SST to speech 
and language therapists‘ assessments in people with brain injury (Al-
Khawaja, Wade & Collin, 1998). This study also found a strong association 
(r = .91)  between the SST and the Short Orientation, Memory and 
Concentration test (SOMC) (Katzman et al., 1983) which the authors 
suggest that if comprehension and/or expression is impaired, it is unlikely 
that the patient will be able to complete the more complex 
neuropsychological tests. The SST is recommended as a screening measure 
for language difficulties in stroke (Blake et al., 2002) and multiple sclerosis 
(das Nair, 2007). The SST is also thought to be useful as it is independent 
of visual or verbal memory problems (Blake et al., 2002).  
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Alternative Measures Examples 
There are several alternatives to using the SST: other screening measures 
or more comprehensive language batteries (a group of subtests measuring 
the same construct). For example: 
 Frenchay Aphasia Screening Test (FAST) (Enderby, Wood, Wade & 
Langton Hewer, 1987) 
This is also a brief screening measure of acquired language disorders with 
good reliability and validity (Salter, Jutai, Foley, Hellings & Teasell, 2006). 
However, this requires the use of stimulus cards and results may reflect 
visual rather than communication problems (Al-Khawaja et al., 1998). 
Furthermore, the FAST also assesses writing and reading ability, which are 
not required for participation in this study. The FAST may inadvertently 
assess executive functions, for example, verbal fluency – number of animals 
named in a minute making it less appropriate for this study. Al-Khawaja et 
al. (1998) examined the relationship between the FAST with the SST in 
adults with brain injury and found equivalent sensitivity but that the SST 
had higher specificity.  
 Western Aphasia Battery (Kertesz, 1982) 
This provides more comprehensive communication assessment. However, 
this takes up to one hour to administer and also relies on visual skills 
(McCabe, Sheard & Code, 2008). However, this depth of information is not 
required for participation in the present study. 
 
Justification for the use of the SST 
Although the SST has not been used with people with HIV, it does require 
comprehension of complex instructions required for completing the BADS, 
and has been used in previous neurological populations with good reliability 
and validity.  
 
 
 
 
 
 Page 90 of 255 
 
Hospital Anxiety and Depression Scale (HADS)  
(Snaith & Zigmond, 1994) 
 
The HADS is a quick and easy self-report measure which provides separate 
scales for depression and anxiety (seven items on anxiety; seven items on 
depression). The anxiety items encompass feelings of tension, anticipation, 
cognitions, ease, restlessness and panic. The depression items cover 
enjoyment, ability to laugh, cheerfulness, lethargy and interest in 
appearance and the environment (Dunbar, Ford, Hunt, & Der, 2000). The 
HADS does not include items related to physical functioning (Lewis & 
Wessely, 1990) and is more normally distributed than alternative self-report 
measures (Herrmann, 1997). 
 
Reliability and Validity  
A specific measure for understanding affective disorders in people with 
physical illnesses is needed as physical illnesses often represent a 
significant life event and particularly where cognitive processes are 
involved, impairments in these may mimic or mask affective difficulties 
(Dawkins, Cloherty, Gracey & Evans, 2006).  
Internal consistency co-efficients range from .80 to .93 (e.g. Moorey et al., 
1991) and test-retest reliability was above the acceptable level of .80 over a 
two week period (Herrmann, 1997). High levels of sensitivity and specificity 
are reported (Bjelland, Dahl, Haug & Neckelmann, 2002), for example, 
Whelan-Goodison, Ponsford and Schonberger (2009), showed the 
depression subscale had sensitivity of 62% and specificity of 92%, and the 
anxiety subscale had sensitivity of 75% and specificity of 69%. However, 
the HADS represents a dimensional rather than categorical measure. 
Therefore positive predictive power would be expected to be relatively small 
(Herrmann, 1997) and using clinical cut-off might not be useful (Golden, 
Conroy & O‘Dwyer, 2007). There are some questions as to whether scores 
on the HADS are affected by cultural differences in emotional expression 
(Al-Adawi et al., 2007), although the HADS is widely used internationally 
and cross-culturally (Herrman, 1997). 
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In terms of construct validity, although some research has queried this two 
factor structure (Johnston, Pollard & Hennessey, 2000), the anxiety and 
depression subscales do seem to measure meaningfully different constructs, 
not just general distress (Herrmann, 1997). The HADS has reasonable 
correlation with other measures, such as the Beck Inventories with 
correlation coefficients ranging from .49 to .83 (Bjelland et al., 2002).  
Examples of Alternative Measures  
There are several alternative ways of assessing anxiety and depression, 
including: other self-report inventories or standardised clinical interviews. 
 Beck Depression/Anxiety Inventory (BDI/BAI) (Beck, Steer & Brown, 
1996) 
These are commonly used self-report measures with good reliability and 
validity (Beck et al., 1996). However, they include physical health items, for 
example, appetite, making it inappropriate for this study. Moreover, the BDI 
has been reported to have significant floor effect (Zigmond & Snaith, 1983). 
 General Health Questionnaire (GHQ) (Goldberg & Williams, 1988) 
This is a similar measure to the HADS. However, it does not differentiate 
between anxiety and depression (Lewis & Wessely, 1990). 
 Structured Clinical Interview for DSM Disorders (SCID) (First, Spitzer, 
Gibbon & Williams, 2002) 
Despite structured interviews gathering detailed information, they are 
lengthy and this volume of information is not required for this study.  
 
Justification for the use of HADS 
The HADS has good reliability and validity for screening for mood (Barczak 
et al., 1988). Moreover, it has been developed for people with physical 
health problems and in previous research has been used with people with 
HIV (Barczak et al., 1988), people with Hepatitis C (Golden, Conroy & 
O‘Dwyer, 2007) and neurological populations (Dawkins et al., 2006). 
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Wechsler Test of Adult Reading (WTAR)                                     
(Wechsler, 2001) 
 
Word reading estimates of pre-morbid IQ are commonly used because, for 
most people, an IQ test score is not available before they experienced 
changes in cognition (Graves, Carswell & Snow, 1999). The WTAR involves 
reading aloud a series of 50 unusual words with scoring is based on whether 
the words are pronounced correctly. Word reading estimates of IQ assume 
that IQ is correlated to reading ability, constant over time and not affected 
by current cognitive functioning (Willshire, Kinsella & Prior, 1991). This is 
supported by empirical research showing reading ability accounts for 38% 
of variance in IQ scores (Johnstone et al., 1997). There are standard scores 
and UK normative data for the WTAR for adults aged 16-89 which provide a 
good basis for comparison to the BADS. However, reading tests assume 
exposure to English language (Graves et al., 1999) and the WTAR UK 
standardisation sample was not ethnically diverse so it is important to use 
years of education to assist interpretation (Crawford, 1992).  
 
Reliability and Validity 
In the normative sample the WTAR displayed high internal consistency and 
high test-retest reliability (Wechsler, 2001). The WTAR has been found to 
be more accurate predictor of pre-morbid IQ and cognitive reserve than 
demographic-based assessment alone (Basso & Bornstein, 2000). However, 
the normative sample was only assessed over two to twelve weeks and is 
predominantly based on US data.  
 
In terms of validity, the WTAR has been shown to be associated with 
performance on full scale IQ batteries (Wechsler Adult Intelligence Scale-III 
[WAIS-III]; Wechsler, 1999), with correlation coefficients ranging from .63 
to .80. The WTAR also has good convergent validity with other word reading 
pre-morbid IQ measures such as the National Adult Reading Test (NART) 
(Nelson & Willison, 1991) with correlations coefficients ranging from .73 to 
.90. Pre-morbid IQ as estimated by word reading is thought to be 
influenced by age, so the authors developed age-appropriate normative 
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data. Although accuracy in IQ prediction appears to reduce as severity of 
dementia increases (Schmand, Geerlings, Jonker & Lindeboom, 1998), 
word-reading measures may still be a useful predictor of IQ (Paque & 
Warrington, 1995). In clinical samples there was clear dissociation of 
performance on the WTAR and performance on other measures of cognitive 
function (Wechsler, 2001) which provides evidence the WTAR is not 
inadvertently measuring other cognitive domains such as memory. 
However, it is important to remember accuracy of pre-morbid IQ is inferred, 
not based on actual data (Wechsler, 2001). 
 
Examples of Alternative Measures 
There are several other approaches and measures to assessing pre-morbid 
IQ including: other measures of reading ability, word recognition measures 
and demographic measures. For example: 
 National Adult Reading Test (NART) (Nelson & Willison, 1991) 
This measure also involves reading a series of words. However, it is older 
and considered more dated (Mathias, Bowden, Bigler & Rosenfeld, 2007). 
 Spot-the-Word test (Baddeley, Emslie & Nimmo-Smith, 1993)  
This is a lexical-decision task where the participant is presented with a real 
word and a non-word and has to decide which word is the real one. 
However, standard scores are not available for this assessment. 
 Years of Education  
This is not affected by the disease process but taken alone does not seem 
to be an accurate predictor of IQ (Graves et al., 1999). Moreover, this is 
based on the idea that all individuals with the same level of education will 
have the same IQ (Johnstone et al., 1997). However, there are obvious 
discrepancies in the delivery of education in different institutions, nations 
and cultures (Ryan, Byrd, Rivera Mindt, Rausch & Margello, 2008)  
 
Justification for WTAR 
As previous research as pointed to the importance of pre-morbid IQ in 
determining performance in other cognitive domains it is important to 
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collect this information. The WTAR is a quick and easy test to administer 
and has good normative data, with many studies reporting good reliability 
and validity data. The provision of standard scores provides a useful 
comparison, as this is on the same scale as the BADS standard scores, 
which is not possible using the Spot-the-Word test. Years of education were 
also collected to triangulate the evidence (Ryan et al., 2008), and move 
away from educational achievement measurement which might not be 
ethnically inclusive.  
 
Dysexecutive Questionnaire Self-rater (DEX-S) Other-rater (DEX-O)  
(Wilson et al., 1996) 
 
The DEX gives a picture of executive functions in everyday life whilst still 
being quick to complete and easily understandable (Chan, 2001). It has 
been developed specifically with the BADS so is likely to represent the same 
constructs and includes both self- and proxy-scales to provide different 
perspectives. Items cover emotional, personality, behavioural and cognitive 
changes (Wilson et al., 1998). There is no normative data available to 
classify participants into clinical/non-clinical range. However, this 
encourages movement away from categorisation and dichotomisation which 
masks individual differences towards dimensional measurement of everyday 
functioning. 
  
Reliability and Validity 
The DEX has been shown to have high internal consistency (Cronbach α = 
.93, above .70 suggested by Nunnally, 1978) (Shinagawa et al., 2007). 
Shinagawa and colleagues (2007) also found moderate construct validity of 
the DEX compared to the Frontal Assessment Battery (FAB) (Dubois, 
Slachevsky, Litvan & Pillon, 2000). Most validation studies have taken place 
in Japan, with a translated version of the DEX, so coefficients may be 
different for the English version. However, most authors have reported good 
validity across cultures (e.g. Chan, 2001). Care should be taken over the 
use of total scores as potentially obscuring difficulties on particular aspects 
of executive functions (Chaytor & Schmitter-Edgecombe, 2007) and falsely 
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suggest that the data is continuous (Chan & Bode, 2008). In spite of this, 
research is not conclusive on systems for clustering the DEX scores, with 
different authors suggesting different clustering of scores and different 
labels for these clusters. Therefore, DEX total score is still predominantly 
used (Shinagawa et al., 2007). There is also evidence of convergent validity 
between the DEX and other functional measures of executive functions but 
differences may suggest that these measures are accessing different 
components of the executive function construct (Chaytor & Schmitter-
Edgecombe, 2003).  
 
There has been contradictory evidence on the ability of self- and other-rater 
comparison to provide a measure of insight. In a non-clinical sample 
participants reported more problems on self-report than other-report, which 
might be expected as this was the non-clinical sample (Chan, 2001). 
Although there is some evidence that self- and other-ratings may be 
weighted on different factors (Chan & Bode, 2008) there is considerable 
evidence to suggest the usefulness of both the DEX-S and DEX-O (Evans et 
al., 1997). 
 
Examples of Alternative Measures  
There are several alternative approaches to gather information on the 
functional impact of executive function difficulties. For example: 
 Frontal Systems Behaviour Scale (Grace & Malloy, 2001) 
This is a behaviour-rating scale with good normative data, which, similar to 
the DEX, has self- and proxy-report. However, it was not developed with 
the BADS, and research as suggested that it is weighted strongly on 
personality factors of executive function, which are not measured by the 
BADS (Stout, Ready, Grace, Malloy & Paulsen, 2003). Therefore, this 
measure might not provide the most useful comparison with the BADS. 
 Frontal Behaviour Inventory (Kertesz, Davidson & Fox, 1997) 
This is an informant-based interview with caregivers which has good 
reliability and validity (Kertesz et al., 1997). However, this measure is 
lengthy and includes items on physical functioning (e.g. incontinence, 
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hyperorality) (Malloy & Grace, 2005) which may be affected by the HIV-
infection or side effects of the medications. Furthermore, this only considers 
the caregiver perspective and not individual experience. 
 Barthel Activities of Daily Living Index (Mahoney & Barthel, 1965) 
This assesses self-care abilities such as washing and dressing. However, as 
executive functions are higher-order cognitive abilities, basic activities of 
daily living are less likely to be affected (Alderman, Dawson, Rutterford & 
Reynolds, 2001). 
 
Justification for use of the DEX 
It is important to explore the functional outcomes specifically related to 
executive functions. The DEX has been designed for use with neurological 
populations, and maps well on to the constructs of the BADS compared to 
other measures (Grace & Malloy, 2001). Although the DEX has not been 
used in people with HIV before, it is widely used measure which avoids 
traditional categorisation and dichotomisation, and combines both self- and 
other-report to triangulate information sources. 
 
Behavioural Assessment of the Dysexecutive Syndrome (BADS)  
(Wilson et al., 1996) 
 
For a further description, information on reliability and validity and 
consideration of examples of alternative measures to the BADS see the 
extended background section. 
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Procedure  
This section outlines additional information on how participants were 
recruited and what happened to them through the research process. Figure 
5 outlines the process of the research for participants. 
 
Recruitment: Identification and Approach 
The researcher maintained relationships with clinical staff at local NHS and 
the chair of a local charitable service by attending meetings and discussing 
the project, purpose of the research and recruitment and determining 
practical details of how recruitment would work in that service, including 
arrangements for collecting medical information. The researcher maintained 
regular contact with these individuals throughout the course of the research 
to answer any questions and maintain the profile of the study. 
 
Pre-assessment 
Contact details of the lead researcher (name, mobile number and e-mail 
address) and supervisors (name) were on all advertising and documentation 
to facilitate the two streams of referral: professional and self-referral. On 
initial referral name, date of birth, time since diagnosis, contact details 
(telephone number and/or address), name and position of referrer (if 
appropriate) were required. If a staff member felt unsure about whether a 
potential participant could be included or that a potential participant may be 
a risk to themselves (self-harm or suicide) or others (violence or 
aggression) they were advised to contact the researcher. However, no 
participants were excluded in this way. As detailed in Figure 5, once the 
referral was received, the potential participant was contacted by the lead 
researcher, to arrange the assessment. At this point the participant was 
assigned an ID code, used instead of names, on all further information. If 
the potential participant self-referred to the study a key member of staff 
was contacted (with participant consent), to confirm positive HIV diagnosis 
and ensure there were no risks to the participant from taking part. 
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Assessment  
The location of the assessment was not standardised but all locations were 
quiet, distraction-free and confidential. Participants were offered a short 
break during the assessment session, as can be seen in Figure 5, to control 
for fatigue. 
 
Post-assessment   
The DEX-O was sent to the designated proxy for each participant with a 
covering letter stating the purpose of the DEX-O, that the participant had 
consented and included a stamped addressed envelope, to return to the 
researcher. In a similar way the medical note proforma was sent to relevant 
healthcare professionals who knew the participant to collect clinical 
information, again including a stamped addressed envelope. 
 
Participants were offered feedback on their test performance if they desired. 
Results were only described in terms of above average/below 
average/average range. The report contained a disclaimer about its purpose 
and how it could be used. If participants desired, this report was forwarded 
to pre-identified healthcare professionals for their information. 
 
Contact details of the researcher were made available if participants or 
healthcare professionals who wanted more information or had further 
questions. Referral pathways for psychological support were pre-identified 
at the outset of the research to manage the psychological impact of these 
results if required. However, no participants required or requested this 
referral. 
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‗Caseworker‘ contacted (where appropriate and with participant 
consent) to consider risks to/from the participant and confirm HIV 
diagnosis 
 
Medical note proforma completed by a staff member working in the 
service and returned to the researcher. 
 
Assessment with lead researcher and participant (1 ½ hours) 
– Sight, hearing and communication test (SST)  
– Check against exclusion information 
 
Exclusion point – if did not meet criteria 
 
– Information sheet discussed and written consent taken    
– Dysexecutive Questionnaire (DEX-S)  
– Wechsler Test of Adult Reading (WTAR) 
– Hospital Anxiety and Depression Scale (HADS)                    
 
Short Break 
 
– Behavioural Assessment of the Dysexecutive Syndrome (BADS) 
 
(Optional) Written/face-to-face feedback of results to participant. 
(Optional) Written report forwarded to caseworker/referrer as required 
with consent from the participant 
 
Staff-Referral – name, age, 
diagnosis, contact details 
 
Participant was contacted by the lead researcher by phone/letter  
Recruitment and Identification of potential participants  
 
Self-Referral – name, age, 
diagnosis, contact details 
 
Time 
(weeks) 
6 
5 
1 
3 
Designated ‗other‘ contacted to explain purpose of DEX-O. This was 
posted to them with a stamped addressed envelope to return to the 
researcher. 
 
Figure 1 – Procedure Timeline 
Figure 5. Flowchart and timeline of the research 
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Ethical Issues  
As ‗the dignity, rights, safety and well-being of participants must be the 
primary consideration of any research‘ (Department of Health, 2005, p.6), 
this section considers the main ethical issues of this research. 
 
1. Potential Distress  
a. Participants excluded from the study 
In the information sheet individuals were informed that there may be 
situations where they were not able to be included in the study. When this 
arose the researcher dealt with this sensitively and collaboratively by giving 
the potential participant the reasons for exclusion, any further information 
and discussing onward referral where appropriate. However, this was not 
requested or required by any of the participants. 
b. Poor performance on tests 
This was addressed by the researcher by discussing that everyone has their 
own strengths and weaknesses and exploring onward referral where 
appropriate. However, although discussed this was not requested or 
required by any of the participants. As part of the debrief after the 
assessment and any feedback sessions, participants were asked if they had 
found anything distressing or had any concerns in relation to the study 
(Barker et al., 2002). 
c. Differing opinions on the DEX 
The completion of the questionnaires was prefaced with a discussion about 
how the forms must be completed independently and it was not possible to 
share answers. It was emphasised that there are no right or wrong answers 
and everyone sees things differently. If problems arose from this the 
researcher had planned to deal with this sensitively and referred to further 
services in exceptional circumstances. However, this was not requested or 
required by any of the participants. 
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2. Confidentiality 
Participants were informed that all data was kept confidential by assigning 
participants a unique research code, used instead of name on all 
information. Information was marked confidential, dated and will be stored 
in a locked filing cabinet at the university for seven years (for reference 
purposes). It will subsequently be destroyed securely in accordance with the 
University Research Code of Conduct. Electronic information was stored on 
password-protected databases. Participants were made aware of who had 
access to their information and if they chose to withdraw from the study 
this information would be retained, but not used.  
Although their case−worker was contacted by the researcher, it was made 
clear that no information was shared with the case−worker without 
permission of the participant unless there was significant risk to the 
participants or others (for example, self-harm or violence).  
All this information was within the information sheet which the participant 
had the opportunity to question and agreed to by signing the consent form. 
 
3. Informed Consent 
The participant was informed of the potential risks and benefits of 
participating through the information sheet. The information sheet provided 
information on what was expected of participation and information that they 
needed to know in order to make a rational decision about whether to take 
part (Barker et al., 2002). Participants were also informed of the wholly 
voluntary nature of their participation and that they were free to withdraw 
at any time. The principles of the Mental Capacity Act (2005) were used to 
assess informed consent: ability to understand and retain information and 
ability to consider the possible consequences. The participant had 
opportunities to ask questions. They were also given the details of the Trust 
complaints procedure should they have a complaint about the research. 
 
As well as approval from a Research Ethics Committee approval was also 
sought from relevant Research and Development departments and honorary 
contracts obtained (Appendices L-O). 
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Supplementary Analysis Plan  
This is a quasi-experiment, as the independent variables are not being truly 
manipulated, for example, people arrive with gender assigned already. In 
addition to the primary analyses, the association between BADS subtests 
was calculated through Spearman‘s rank correlation coefficients (two-tailed) 
to determine the potential fractionated executive function skills affected in 
people with HIV.  
 
Parametric or non-parametric tests were used based on whether 
appropriate assumptions were met. Parametric tests were preferred 
because they are more robust and power efficient (Coolican, 2004).  
 
Challenges in Conducting the Research 
Some of the challenges that were encountered when conducting the 
research study are discussed with the strategies that were developed to 
manage these. 
 
1. Some potential participants were not contactable.  
Strategies were built into the protocol, so if no answer was obtained by 
phone, a letter was sent asking participant to get in touch with the 
researcher. If the participant did not respond the referrer was contacted to 
inform them that it had not been possible to contact the participant and to 
determine whether the potential participant was still interested in the 
research. Seven participants were non-contactable. 
2. Despite participants having the information sheet prior to the 
assessment they often had not read it.  
The researcher ensured that participants had the information sheet in 
advance of the appointment. At the start of the assessment the information 
sheet was discussed in detail, encouraging questions. The researcher asked 
strategic questions which required an answer which would convey 
understanding of the research. 
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3. It was hard to structure constructive feedback when participants 
performed within the ‗impaired‘ range. 
The terms below average, average and above average were used to denote 
performance instead of the labels from the manuals. This helped 
understanding and avoided emotionally-laden labels such as ‗impaired‘. The 
researcher also discussed with the participant their expectations and 
feelings about the results.  
4. There was no standardised assessment location and the researcher was 
often lone-working outside of office hours. 
The researcher negotiated the use of clinic rooms and did home visits, 
where appropriate. The researcher ‗buddied‘ up with another trainee for out 
of office hours appointments in accordance with the Trust Lone Worker 
Policy. 
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Extended Results 
This section describes the additional statistical analyses conducted within 
the study. This explains how results are presented, tests of assumptions 
(including normality), comparison tests to determine if the sample is 
representative of the wider population and comparison of participants who 
were included and excluded. Additional correlational analyses and multiple 
regressions of predictor variables for the BADS are reported. Finally a 
missing data analysis is conducted.  
 
Background 
As well as significance, actual p-values were reported to move away from 
the dichotomous reject/non-reject of hypotheses to provide meaningful 
interpretation of the data (Wright, 2003). Wherever a result is reported as 
significant, this should be interpreted as statistically significant, where 
chance is unlikely to be the explanation of the result (Kirk, 1999).  
 
Standardised effect sizes were reported where possible to supplement null 
hypothesis testing, to describe the magnitude of the effect and to provide a 
way of communicating the results to allow for comparison with future 
research (Baguley, 2009). Of the several different types of effect sizes (for 
example, Cohen‘s d, Pearson‘s r, Hedges g), Pearson‘s r were used in the 
present study (converted from t-test data using Rosnow and Rosenthal 
(2005) statistic). r is a more flexible statistic and has a more direct 
relationship with power as it is sensitive to base-rate differences, which is a 
feature of other inferential statistics, making r more ecologically valid 
(McGrath & Meyer, 2006). r is a widely used effect size and easily 
understood as it is constrained to lie between -1.00 and 1.00 (Field, 2009). 
Benchmark classifications have been proposed to interpret size of effects 
(.10 small, .30 moderate, .50 large, Cohen, 1988; 1992). However, 
McGrath and Meyer (2006) have suggested that these classifications are too 
conservative and a different system should be used (.10 small, .24 
moderate, .37 large). However, it is important to remember r is not 
measured on a linear scale so an effect size of .6 is not double .3 (Field, 
2009). For a full discussion on effect sizes see Baguley (2009) and McGrath 
and Meyer (2006). 
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Assumptions 
Statistical analyses are traditionally divided into parametric and non-
parametric tests. Parametric tests are more powerful and are relatively 
robust to violations however, certain assumptions are made about the data: 
the data is normally distributed, interval or ratio level of measurement, 
independence and homogeneity of variance (Field, 2009). If these 
assumptions are seriously violated non-parametric tests are used which, 
although not as powerful, make fewer assumptions about the nature of 
data. Therefore, the general strategy adopted for the analyses of this study 
was to use parametric tests on those cases that meet the assumptions 
because they are more powerful, and to use non-parametric where the 
assumptions of parametric tests had been seriously violated.   
 
Normally distributed data 
A normal distribution describes data that is symmetrically distributed with 
the majority of scores clustered around a central mean. As scores start to 
deviate from the centre, their frequency and probability of obtaining them 
decreases. Deviations from the normal distribution are described as skew 
(lack of symmetry: scores are clustered at one end of the distribution) or 
kurtosis (too much or too little frequency in the ends of the distribution). If 
it is possible to assume the data to be a normal distribution it is possible to 
make certain justified inferences from samples to populations. In the 
current study this means inferring characteristics about the HIV population 
in general from the sample of participants. The central limit theorem 
purports that with a sample size of approximately 30 it is likely to have 
important distributional properties that approach a normal distribution. The 
current study sample has less than 30 participants so the data has been 
checked to determine whether it meets the assumptions for parametric 
tests.   
 
Although normality can be judged visually from scatterplots/histograms, 
this is very subjective. z-skew and z-kurtosis scores can be calculated by 
converting scores to a z-distribution (mean 0 and sd 1), where values above 
1.96 represent a significant deviation from the normal distribution, p<.05. 
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Shapiro-Wilk tests, used in preference to Kolmogorov-Smirnov tests when 
n<50, to compare the scores to a normally distributed sample. If the test 
statistic is non-significant then the sample is not significantly different from 
a normal distribution. Results of Shapiro-Wilk, z-skew and z-kurtosis 
calculations for interval or ratio level data are presented in Table 8. 
 
Table 8 shows monthly alcohol use is statistically significantly different to 
the normal distribution (W(20) = .56, p=.001) and is significantly positively 
skewed and positively kurtotic (leptokurtotic). This suggests the distribution 
is weighted towards minimal alcohol use and the distribution is significantly 
peaked around the mean. The WTAR score is also significantly non-normally 
distributed (W(20) = .88, p=.01) and negatively skewed, which means that 
there was an unsymmetrical leaning towards higher scores on the WTAR. 
Although the HADS-A was not statistically significantly on Shapiro-Wilk‘s 
(W(20) = .91, p=.06), it was positively skewed and kurtotic, which means 
there was a weighting towards minimal anxiety and an excessively peaked 
mean. The BADS subtests were also statistically significant on the Shapiro-
Wilk‘s but only the Action Program was significantly negatively skewed, with 
weighting towards higher scores. However, the BADS Total Score, DEX-S, 
DEX-O, HADS-D, length of current medication regime, CD4 count, time since 
diagnosis and age were all normally distributed.  
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Table 8. 
Tests of normality in the continuous data 
Characteristic Shapiro-Wilk 
statistic 
Significance 
p-value 
z-skew z-kurtosis 
Age (Years) .95   .43  0.13     0.22 
Alcohol (Units) .56 <.01**  4.93*     5.56* 
Length of 
Diagnosis (Years) 
.91   .10  1.68     0.39 
CD4 count (cells 
per mm3) 
.94   .26 -0.22    -1.18 
Length of current 
medication regime 
(Months) 
.91   .13  1.09    -0.70 
WTAR .88   .02* -1.96*    -0.01 
HADS 
   Anxiety 
   Depression 
 
.91 
.95 
 
  .06 
  .30 
 
 2.18* 
 0.18 
 
    2.82** 
    0.41 
DEX 
   Self 
   Other 
 
.98 
.97 
 
  .96 
  .88 
 
 0.62 
 0.86 
 
    0.16 
    0.25 
BADS 
   Total Score 
   Card Sort 
   Action Program 
   Key Search 
   Temporal 
Judgement 
   Zoo Map 
 Modified Six 
Elements Test 
 
.91 
.82 
.63 
.81 
.87 
 
        .85 
.85 
 
  .06 
  .002** 
  .001** 
  .001** 
  .01** 
 
  .005** 
  .005** 
 
 -1.65 
 -1.56 
 -3.02** 
 -0.79 
  0.07 
   
  0.20 
 -0.83 
 
    0.03 
   -0.36 
    1.04 
   -1.54 
   -0.59 
   
   -0.58 
   -1.23 
Note. * p<0.05, ** p<0.01 denotes measures/characteristics that are significantly different 
from the normal distribution. WTAR: Wechsler Test of Adult Reading; HADS: Hospital Anxiety 
and Depression Scale; DEX: Dysexecutive Questionnaire; BADS: Behavioural Assessment of 
the Dysexecutive Syndrome 
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Level of measurement of data 
In order to use parametric tests data should be at interval level. The 
researchers theoretical background and prior beliefs can influence how the 
researcher categorises the variable as well as the more objective properties 
of the variable (e.g. that height or weight has a true zero) (Field, 2009). 
Where nominal data is arbitrarily categorical, ordinal data is ranked and 
interval data is when the distance between each point on the scale is the 
same. Ratio data is when the distance between each of the points on the 
scale is the same and the scale has a true zero.  
The BADS Total standard score data is clearly not arbitrarily categorical but 
also does not have a ‗true zero‘. The standardised scores of the BADS Total 
score are not ‗ranked‘ but can be considered to have an equal difference 
between scale points (e.g. Coolican, 2004) and so the BADS Total standard 
score can represent interval level data, and is considered as such 
throughout the analysis.  
Independence 
This means independence of participants, the performance of one 
participant did not influence the performance of others (Field, 2009). In the 
current study participants were unable to confer about responses within the 
testing session and participants were asked not to share details of the test 
with others. Therefore independence of scores has been assumed for the 
analysis.   
Homogeneity of variance 
This final assumption claims that variance, or spread of the scores, should 
be the same throughout the data‘ (Field, 2009, p.133). When comparing 
two groups, this means both groups should have equivalent variance in 
scores, assessed using Levene‘s test for equality of variances (Levene, 
1960). In correlational design this means that variance at different levels of 
variables should be roughly equivalent (Field, 2009), assessed using 
graphs. Where appropriate these tests/graphs have been presented.  
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Summary and Implications 
On this basis, for Aim One, considering the BADS Total score, parametric 
statistics were used. However, for Aim Two and Three, to be consistent 
throughout, non-parametric statistics were used because the majority of 
data is not interval level (e.g. DEX, HADS) or not normally distributed (e.g. 
WTAR, alcohol use). Although non-parametric statistics have less statistical 
power, this is preferable to transforming the data to a normal distribution, 
as transforming the data changes the construct measured from geometric 
to arithmetic (Field, 2009). As a result, analyses of transformed data have 
implications for interpretation (Grayson, 2004; Games, 1984) making it less 
meaningful with questionable validity for the untransformed data 
(Tabachnick & Fidell, 2001). For a full discussion about transformation see 
Tabachnick and Fidell (2001). 
 
Research sample characteristics compared to other populations 
To inform interpretation and clinical implications of the study it is important 
to: 
1. Determine if the study sample are representative of the wider 
population of people with HIV the sample was drawn from. To explore 
this, the characteristics of study sample were compared to regional 
demographic details of people accessing HIV services as published by 
the HPA (2008). The data available was the proportion of individuals 
living with HIV in the region by age category, gender and ethnicity.  
2. Determine if the demographic characteristics of the study sample are 
broadly equivalent to the demographic characteristics of the BADS 
normative sample (as described in Wilson et al., 1996; Wilson et al., 
1998). If these groups are comparable this supports the comparison 
between the average sample and normative data on the BADS. Only 
limited data is available to describe the BADS normative sample: 
approximate gender proportion, mean age and mean IQ. 
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Percentages of the participants with certain characteristics are presented in 
Table 9. Table 9 also presents the percentage of people with those 
characteristics in the regional population who were eligible for inclusion into 
the study (HPA, 2009) and BADS normative sample (Wilson et al., 1996).  
Table 9. 
Demographic details of the study sample compared to regional data and 
BADS normative sample data 
Characteristic Study Sample Regional Data 
(HPA, 2009) 
BADS Normative 
Sample Data 
(Wilson et al., 1996) 
Sample Size 20 2466 216 
Gender 
    Male (%) 
    Female (%) 
 
65 
35 
 
53.9 
46.1 
 
 
Age (years) 
    Mean (SD) 
    Range 
 
43.5 (8.3) 
28-59  
 
 
 
 
 
46.6 (19.8) 
16-87  
Age group 
(years) 
    18-30 (%) 
    30-40 (%) 
    40-50 (%) 
    50-60 (%) 
 
 
  5.0 
21.1 
52.6 
21.1 
 
 
13.2 
41.1 
33.4 
12.3 
 
 
Ethnicity 
    White (%) 
    Black 
African/ 
Caribbean (%) 
 
 
75.0 
25.0 
 
 
 
39.4 
51.6 
 
 
 
IQ 
    Mean (SD) 
    Range 
 
96.5 (21.0) 
50-120 
 
 
 
102.7 (16.3) 
69-129 
Note. BADS=Behavioural Assessment of the Dysexecutive Syndrome 
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1. Compared to regional data for people living with HIV   
Comparison to regional data for people who were eligible for the study was 
conducted to determine if the sample was representative or whether the 
sample is biased towards certain groups. Chi-squared tests were used to 
determine the degree of association between two categorical variables 
based on comparing observed frequencies to what would be expected by 
chance (Field, 2009).  
Age 
As sample size was small, age was collapsed into two categories: 20-40 
years and 40-60 years. Although this does not allow for any detailed 
analysis, this gave a broad idea of whether the sample characteristics are 
what would be expected compared to the regional population data. The 
results showed a significant difference in the age proportions of the sample 
and the regional population age proportions χ2 (1) = 15.01, p=.01. This 
means the proportional representations of ages in participants in the study 
sample was different to that seen in the regional population data. The study 
sample had significantly higher proportions of people in the older age 
groups than the regional population.  
Ethnicity 
Ethnicity was collapsed to ensure that there was sufficient data in each cell; 
this was collapsed to White British and Black African/Black Caribbean. The 
results showed a significant difference between the proportions of people 
from different ethnic backgrounds in the sample and the regional population 
χ2 (1) = 35.22, p=.01. This means the ethnic proportions of participants in 
the study sample was different to that reported in the regional population 
data for people living with HIV, with significantly fewer sample participants 
in the non-White British ethnic groups compared to the regional population. 
Gender 
There was no significant difference between  the sample and the population 
in terms of gender proportions χ2 (1) = 0.49, p>.05. This means that the 
gender ratios in the sample were equivalent to the regional population. 
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Overall, the sample were different from the eligible regional population on 
proportion of participants within age and ethnicity categories but were 
broadly equivalent on gender ratios. Therefore, findings related to age and 
ethnicity should be interpreted with care. 
 
2. Compared to BADS normative data 
The comparison between BADS average score of the sample and the BADS 
normative data average assumed these samples are comparable on 
demographic factors. As assumptions of normality, independence and 
interval data have been met an independent samples t-test was conducted 
to test this. It was not possible to conduct Levene‘s test for homogeneity of 
variance as the raw data was not available for the BADS normative sample.  
Age 
On average, participants in the BADS normative sample (M = 46.40 years, 
SD = 19.80) were older than the sample of participants in this research 
study (M = 43.47, SD = 8.26). However, this difference was not statistically 
significant t(234) = 0.70, p=.48, with an effect size of r = .05. 
IQ 
On average, IQ of participants in the BADS normative sample (M = 102.70, 
SD = 16.30, as measured by the NART) was higher than the sample of 
participants in the research study (M = 96.50, SD = 20.98, as measured by 
the WTAR). However, this difference was not statistically significant t(234) 
= 1.59, p=.11, r = .10. 
 
Overall these results show the sample recruited in this research study was 
not significantly different on age or IQ to the sample that provided the 
BADS normative data. This should mean that comparing average BADS 
scores from this sample to the average normative scores is valid, as the 
groups are matched in these variables. However, several characteristics, 
such as ethnicity of the BADS normative sample, were not recorded and 
therefore, could not be checked. Although homogeneity of variance between 
groups could not be statistically checked, an independent t-test was still the 
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most appropriate statistic, and as a robust test the t-test results are more 
likely to be valid even if an assumption is violated (Field, 2009). 
 
Comparison between included and non-responders/excluded participants 
It is also important to determine whether the sample included in the study 
were different to the potential participants who were excluded or could not 
be contacted. There is very limited information available on the 
excluded/non-responders in line with confidentiality. The demographic 
characteristics and reasons for exclusion are outlined in Table 10. Those 
who were included in the study were compared to those who were not 
included on: the proportion of males/females, using a Fisher‘s exact test, 
and mean age using an independent samples t-test. For the sake of 
simplicity participants who were not included for whatever reason are 
termed ‗excluded participants‘. 
Table 10. 
Demographic characteristics of participants not-included compared to 
included participants 
Characteristic Number of 
Participants 
Excluded 
Number of 
Participants 
Included 
Gender 
    Male 
    Female 
 
6 
4 
 
13 
7 
Age (years) 
    Mean (SD) 
    Range 
 
40.44 (7.80) 
27-51 
 
43.58 (8.18) 
28-59 
Referral Source 
    Self 
    Healthcare Professional 
 
14 
6 
 
8 
2 
 
Reasons for non-inclusion 
     Not contactable 
     Insufficient language ability 
     Severe depression   
 
7 
2 
1 
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Age 
On average, included participants were older (M = 43.47 years, SE = 1.88) 
than excluded participants (M = 41.30 years, SE = 2.48). The samples were 
normally distributed and Levene‘s test for homogeneity of variance was not 
significant, showing the variance between those included and excluded can 
be considered equivalent F(27) = 0.004, p=.95. An independent samples t-
test found the difference in ages between the groups was not statistically 
significant t(27) = 0.72, p=.48, r=.13. 
Gender 
For a 2x2 frequency table when expected frequencies are low (cell 
frequencies less than 5) the sampling distribution is too deviant from the chi 
square statistic. A Fisher‘s exact test, based on exact probabilities, is used 
instead. A Fisher‘s exact test showed no significant association between 
gender and whether participants had been excluded or not (one-sided) 
p=.55. 
Referral Source 
A Fisher‘s exact test showed no significant association between referral 
source and whether participants had been excluded or not (one-sided) 
p=.44. 
 
Overall these results point to no significant difference between included and 
excluded participants on the variables measured. As both included and 
excluded groups were roughly equivalent on age, gender and referral 
source, it is unlikely that these variables systematically influenced the 
pattern of results as a consequence of exclusion.  However, there were 
several variables which were not collected on the referral forms and so 
could not be analysed. Further there was no information collected on 
participants who did not complete a referral form because they did not meet 
the inclusion criteria. 
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Aim One 
Average sample scores on the BADS Total score and BADS subtests are 
presented in Table 11. 
Table 11. 
Means and SDs of the BADS and the BADS subtests 
BADS Score Mean SD Range 
Total Profile Score 85.30 23.67 33-113 
Card Sort   2.95 1.05 1-4 
Action Program   3.40 1.05 1-4 
Key Search   2.60 1.43 0-4 
Temporal 
Judgement 
  2.25 0.85 1-4 
Zoo Map   1.80 1.32 0-4 
Modified Six 
Elements Test 
2.65 1.35 0-4 
Note. BADS=Behavioural Assessment of the Dysexecutive Syndrome 
 
As the assumptions for parametric tests were met an independent samples 
t-test was used to compare the average BADS Total standard score in the 
sample to the average BADS Total standard score from the normative data. 
The independent t-test is used to test whether average performance in 
participants from different groups are statistically significantly different from 
one another, based on the null hypothesis that performance in different 
populations is roughly equal. As with previous analyses it was not possible 
to test the assumption of homogeneity of variance because there is 
insufficient data from the manual.  
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Internal Consistency of the BADS 
It is worth noting the internal consistency of the BADS in this sample and 
determining whether scores on individual subtests are consistent with the 
BADS total score. Reliability of the BADS was analysed using Cronbach‘s α 
which assesses whether a measure can consistently reflects the construct it 
claims to be measuring (Coolican, 2004). Cronbach‘s α approximately 
represents splitting the measure in half in every possible combination, 
correlating each split with each other and taking the average correlation as 
Cronbach‘s α statistic (Field, 2009). Values of .80 to 1.00 traditionally 
represent an acceptable level of Cronbach‘s α to confer reliability and means 
that participants‘ performance on subtests was similar (Coolican, 2004). 
Kline (1999) suggests that .70 is a more suitable cut-off point for ability 
tests and high internal consistency suggests a test is measuring a very 
narrow aspect of a construct. However, this interpretation of using 
Cronbach‘s alpha to measure unidimensionality is discouraged (Cortina, 
1993).  
The BADS had satisfactory internal consistency within this sample 
(standardised Cronbach‘s α = .72). Standardised alpha was used because 
items are standardised before being summed to provide the BADS total 
score. 
 
BADS subtest analysis 
It is useful to look for associations between subtests to determine whether 
subtests are measuring similar executive functions skills. Two-tailed non-
parametric Spearman‘s rank correlation coefficients (ρ) were calculated 
between the BADS subtests to determine the degree of association between 
them. Spearman‘s correlation coefficients were used in preference to 
Kendall‘s τ because there were only few tied ranks.  
 
Table 12 presents these results. The Card Sort test was statistically 
significantly positively correlated with the Zoo Map test (rs = .45, p=.05, 
two-tailed). The Key Search test was correlated with the Zoo Map (rs = .65, 
p=.002, two-tailed) and also the Temporal Judgement test (rs = .52, p=.02, 
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two-tailed). However, there were no other statistically significant 
correlations between subtests. This suggests the following pattern of 
subtest results may relate to the underlying aspects of the fractionated 
executive function these tests represent. This is represented visually in 
Figure 6. This might point towards weighting on different executive 
functions skills, although at this point it is not possible to conclusively 
identify which skills as all subtests are multi-faceted in nature in line with 
ecological validity.  
Table 12. 
Subtest correlations with each other (two-tailed) 
Correlation coefficient: rs (p-value) 
 Card Sort Action 
Program 
Key 
Search 
Temporal 
Judgement 
Zoo Map 
Action 
Program 
.35 (.13)  
Key Search .41 (.08)  .32 (.16)  
Temporal 
Judgement 
.31 (.18)  .36 (.13) .52 (.02)*  
Zoo Map .45 (.05)* -.02 (.95) .65 (.01)** .33 (.16)  
Six 
Elements 
Test 
.25 (.29)  .40 (.08) .14 (.55) .13 (.60) -.07 (.77) 
Note. * p<.05, ** p<.01 
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Aim Two 
Non-parametric Spearman‘s ρ correlation coefficients were conducted to 
explore the association between the BADS, DEX-O and DEX-S. Non-
parametric tests were used because although the DEX and BADS can be 
assumed to be normally distributed, the DEX is ordinal, rather than interval 
level data. One-tailed tests were carried out as previous research can 
hypothesise the predicted direction of the relationship between these 
variables. It is predicted that the BADS would be negatively correlated with 
the DEX-O and positively correlated with the DEX-S, based on suggestions 
about insight. 
 
 
Zoo Map 
 
Card Sort 
 
Modified 
Six 
Elements 
 
Action 
Program 
 
Temporal 
Judgement 
 
Key Search 
rs = .41, p=.08 
rs = .45 
p=.05 
rs = .51 
p=.02 
rs = .65 
p=.01 
rs = .40 
p=.08 
Figure 6. Visual depiction of the correlations between the BADS subtests 
Key 
 BADS Subtest 
 
 Statistically significant 
correlation 
  
 Correlation approaching 
statistical significance 
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Internal consistencies of the DEX-S and DEX-O for both of these measures 
were high (Cronbach‘s α .91 and .83 respectively). This suggests that these 
measures have good reliability. A Mann-Whitney U, the non-parametric 
version of the independent t-test, showed that DEX-O scores from 
family/friends (Median 22.00) were statistically significantly lower than 
professionals (Median 33.00), U=12.50, z=-2.06, p=.04, r=-.50. 
 
Comparison between BADS subtests, DEX-O and DEX-S 
The DEX-S was not significantly correlated with any of the subtests: Card 
Sort (rs = .16, p=.25, one-tailed), Key Search (rs = .24, p=.16, one-tailed), 
Temporal Judgement (rs = .08, p=.37, one-tailed), Zoo Map (rs = -.05, 
p=.41, one-tailed) and SET (rs = -.05, p=.41, one-tailed). Although the 
DEX-S approached significance with the Action Program (rs = .36, p=.06, 
one tailed). 
 
The DEX-O also not correlated with any of the subtests: Key Search (rs=-
.14, p=.30, one-tailed), Temporal Judgement (rs = .01, p=.48, one-tailed), 
Zoo Map (rs = -.08, p=.39, one-tailed) and SET (rs = -.16, p=.27, one-
tailed). Although this approached significance with the Card Sort (rs = -.38, 
p=.07, one-tailed) and Action Program (rs = -.38, p=.07, one-tailed).  
 
DEX-O compared to DEX-S 
A Wilcoxon signed-rank test showed participants rated themselves as 
having fewer problems with executive function in everyday life on the DEX-
S (Median=22.50) than informants on the DEX-O (M=29.00), but this 
difference was not statistically significant, z = -1.80, p=.07, r=-.31, 
although this difference closely approaches significance. Previous research 
in non-clinical samples on the DEX-S and DEX-O (Chan, 2001) is 
descriptively compared to the study sample scores in Table 13. This 
demonstrates very little difference between participants in the sample and 
non-clinical sample on the DEX-S. Other-raters in the present study sample 
seem to report on average more problems than the raters in the non-clinical 
sample. However, as there is no formal normative data available for the 
DEX, it is not possible to statistically compare these scores. 
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Table 13. 
Mean and SD of the DEX-O and DEX-S as compared to an example of a 
non-clinical sample 
 
Study sample 
Non-clinical sample 
(Chan, 2001) 
DEX-S 
Mean (SD) 
Range  
 
22.80 (10. 07) 
4-46 
 
22.13 (8.86) 
4-49 
DEX-O 
Mean (SD) 
Range 
 
29.76 (13.31) 
9-60 
 
20.61 (10.52)  
0-48 
Note. DEX-S=Dysexecutive Questionnaire-Self Report; DEX-O=Dysexecutive Questionnaire-
Other Report 
 
Aim Three 
This associative hypothesis examined demographic and clinical factors that 
contribute to executive function impairment as measured by the BADS, 
DEX-S and DEX-O. Continuous variables were compared to the executive 
function measures using non-parametric Spearman‘s ρ correlations due to a 
number of the variables being non-normally distributed or ordinal level. 
One-tailed correlation coefficients were calculated because the direction of 
association can be predicted from previous research as outlined in Table 14. 
The dichotomous categorical variables were compared with the continuous 
variables of the executive function measures using point-biserial 
correlations. Point-biserial correlations (rpb) consider dichotomous variables 
with two discrete categories (for example, gender, ethnicity, referral 
source), as opposed to biserial correlation coefficient where variables are on 
a continuous dichotomy (for example, passing or failing an exam).  
Bonferroni Correction 
It is worth a note on Bonferroni corrections which were not used in this 
study. The Bonferroni correction uses a more stringent criteria to judge 
whether a coefficient is statistically significant (critical p-value) by dividing 
the α level by the number of correlations conducted. In this analysis 12 
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variables were compared to the 9 executive function measures (BADS Total 
and subtest scores, DEX-S and DEX-O) amounting to 21 variables. 
Therefore, if a Bonferroni correction was to be used the significance level 
would be .05/21=.002. However, due to the development method of the 
Bonferroni correction, a significant result after applying the correction does 
not confirm that that specific variable is statistically significant, but that 
there is a statistically significant finding somewhere within the dataset 
(Perneger, 1998). Furthermore, Bonferroni corrections seem counter-
intuitive as results are interpreted based on the number of other 
comparisons performed with little consistency on which comparisons 
warrant inclusion under the adjusted Bonferroni correction, for example, 
just those published or including those performed but not published, or how 
this relates to future research in similar areas (Perneger, 1998). Moreover, 
a Type II error is as much an error as a Type I, however, within positivistic 
frameworks a Type II is seen as more acceptable, stemming from the 
emphasis on statistical rather than practical significance (Nakagawa, 2004). 
However, the epistemological position and pilot nature of this study aimed 
to identify possible patterns and relationships to point to further research 
directions.  
This section considers how the subtests of the BADS are related to the 
medical, demographic and cognitive, emotional and behavioural variables. It 
is worth noting that plasma viral load could not be included in the analysis 
as all but three participants had undetectable viral loads. Drug use, apart 
from alcohol use, could also not be included in the analysis as no drug use 
was recorded by the study. It is also important to acknowledge that a 
correlation does not imply causality. As one-tailed tests were conducted the 
predicted direction of associations are outlined based on previous research, 
outlined in the literature review in Table 14. 
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Table 14.  
Expected direction of association between variables 
Variable Expected Direction of Association with EF 
Medical factors  
Time since diagnosis Longer time since diagnosis: poorer EF  
HIV stage Later HIV stage: poorer EF 
CD4 count Lower CD4 count: poorer EF 
Medication regime More medication: better EF 
Months on medication regime More months on medication: better EF 
Demographic factors  
Gender Female gender: poorer EF 
Ethnicity Non-white: poorer EF (or poorer 
performance) 
Age Older age: poorer EF 
Referral source Professional referral: poorer EF 
Cognitive, emotional and behavioural factors 
Average monthly alcohol use Higher monthly alcohol use: poorer EF 
Years of education More years education: better EF 
WTAR Higher IQ: better EF 
HADS-A More anxiety: poorer EF 
HADS-D More depression: poorer EF 
Note. EF = executive function; WTAR = Wechsler Test of Adult Reading; HADS-A = Hospital Anxiety and 
Depression Scale-Anxiety; HADS-D = Hospital Anxiety and Depression Scale-Depression 
 
Medical Factors 
The subtest correlation coefficients associated with medical factors are 
presented in Table 15. The Action Program subtest of the BADS was 
positively correlated with length of diagnosis (rs = .44, p=.04, one-tailed) 
so participants diagnosed for longer performed better on this subtest. Key 
Search was positively correlated with CDC stage (rs = .55, p=.007, one-
tailed) and negatively correlated with months on medication (rs = -.50, 
p=.03, one-tailed). Therefore, participants in this sample who were in later 
stages of HIV-infection and who had been on medication regimes for longer 
performed worse on this specific subtest. 
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CD4 count was positively correlated with months on medication (rs = .72, 
p=.001, one-tailed) which suggests the medication was working through 
the mechanism indicated. Gender was associated with medication regime 
(rpb = -.40, p=.04, one-tailed) such that female gender was associated with 
being on fewer medications.  
Table 15. 
Correlation coefficients of Medical Factors compared to BADS Subtests 
Correlation coefficients rs / rpb (p-value) one-tailed 
 Card Sort Action 
Program 
Key Search Temporal 
Judgement 
Zoo Map Modified Six 
Elements 
CD4 count .26 (.14)  .30 (.10) -.18 (.24) .14 (.29) .15 (.26) -.05 (.42) 
Time since 
Diagnosis 
-.21 (.20) .44 (.04)* .09 (.36) .16 (.27) -.02 (.47) .14 (.30) 
CDC stage .35 (.07)  .22 (.18) .45 (.03)* .08 (.38) .16 (.25) -.10 (.35) 
Medication 
regime 
-.01 (.48)  .18 (.23) .13 (.30) -.10 (.34) .01 (.50) .30 (.10) 
Length of 
Current 
Medication 
Regime 
.35 (.10)  .12 (.34) 
 
-.50 (.03)* 
 
-.20 (.24) -.02 .47) -.13 (.32) 
Note. *p<.05, CDC=Center for Disease Classification; BADS=Behavioural Assessment of the 
Dysexecutive Syndrome 
Demographic Factors 
On further consideration (Table 16) of the BADS subtests, gender was 
statistically significantly associated with the Key Search (rpb = -.57, p=.004, 
one-tailed) where women perform less well than men on this subtest. 
Ethnicity was correlated with the Action Program task (rpb = -.57, p=.004, 
one-tailed), Key Search (rpb = -.63, p=.001, one-tailed) and Zoo Map (rpb =-
.443, p=.03, one-tailed) where White British participants tended to perform 
better on these tasks of the BADS than Black African/Caribbean 
participants. The Key Search test was positively correlated with age (rs = 
.49, p=.02 one-tailed) so older participants performed better on this 
subtest. The Action Program subtest was positively correlated with referral 
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source (rpb=.39, p=.05) so those who self-referred performed better on this 
subtest. 
Table 16.  
Correlation coefficients of Demographic Factors compared to BADS Subtests 
 Correlation coefficients rs / rpb (p-value) one-tailed  
 Card Sort Action 
Program 
Key Search Temporal 
Judgement 
Zoo Map Modified 
Six 
Elements 
Age -.06 (.40)   .26 (.13) .49 (.02)* .36 (.06)   .23 (.16) .16 (.25) 
Gender -.37 (.05)
* -.19 (.22) -.62 (.001)** -.22 (.17) -.37 (.05)* -.25 (.14) 
Ethnicity  -.31 (.09) -.45 (.02)* -.67 (.001)** -.17 (.23) -.45 (.02)* .07 (.39) 
Referral 
Source 
 .35 (.06) .39 (.05)*   .11 (.32) .20 (.20)  -.15 (.26) .01 (.49) 
Note. * p<.05, ** p<.01 BADS=Behavioural Assessment of the Dysexecutive Syndrome 
 
Cognitive and Emotional Factors (Table 17) 
The Card Sort was statistically significantly correlated with WTAR (rs = .44, 
p=.03, one-tailed), suggesting that participants with higher pre-morbid IQ 
performed better on this subtest than those with lower pre-morbid IQ. 
However, the Action Program was statistically significantly negatively 
correlated with years of education (rs = -.46, p=.02, one-tailed) which 
suggests the contrary relationship, participants with more education 
performed less well than participants with fewer years of education. The 
modified Six Elements Test was statistically significantly correlated with 
HADS Anxiety score (rs = -.38, p=.05, one-tailed) so participants who were 
more anxious performed worse on this subtest. 
A Wilcoxon signed-rank test, the non-parametric equivalent of the 
dependent t-test, was used to determine whether participants from the 
study performed equivocally on the BADS (standard score) and the WTAR 
(standard score) by ranking the data. The non-parametric option was 
chosen as the WTAR is non-normally distributed. Participants standard 
scores on IQ were found significantly higher (Median = 103.50) than their 
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standard scores on the BADS (Median = 88.00), z = -2.02, p=.04, with a 
moderate effect size, r = -.31. 
 
WTAR was positively correlated with years of education (rs = .50, p=.01, 
one-tailed), as would be expected those with longer in education had higher 
WTAR scores. CDC classification positively correlated with HADS Anxiety 
(rs=.57, p=.005, one-tailed) so those who were at more advanced stages of 
HIV experienced more anxiety or those more anxious had increased disease 
progression. 
Table 17. 
Correlation coefficients of Cognitive, Emotional and Behavioural Factors 
compared to BADS Subtests 
Correlation coefficients rs (p-value) one-tailed 
 Card 
Sort 
Action 
Program 
Key Search Temporal 
Judgement 
Zoo Map Modified 
Six 
Elements 
Monthly 
alcohol 
use 
.05 (.42) -.11 (.32) .37 (.06) -.23 (.16) .28 (.12) .24 (.15) 
Years of 
Education 
.17 (.23) -0.46 
(.02)* 
.06 (.40) -.16 (.24) .31 (.10) -.24 (.16) 
WTAR .44 
(.03)* 
-.20 (.20) .13 (.29) .08 (.38) .29 (.11) .26 (.13) 
HADS-A  .12 (.31) .08 (.38) .15 (.27) -.11 (.33) -.14 (.28) -.38 (.05)* 
HADS-D  .01 (.48) .02 (.47) -.03 (.45) -.17 (.23) -.31 (.09) 0.22 (.18) 
Note. * p<.05, BADS=Behavioural Assessment of the Dysexecutive Syndrome; HADS-
A=Hospital Anxiety and Depression Scale-Anxiety Subscale; HADS-D=Hospital Anxiety and 
Depression Scale-Depression Subscale. 
 
Further analysis of variables  
Gender  
Figure 7 displays the differences in gender on the individual BADS subtests. 
Women did not perform as well as men on any of the subtests. However, an 
independent t-test showed that there was no significant difference between 
males and females on pre-morbid IQ as measured by the WTAR, although 
homogeneity of variance cannot be assumed t(7.48) = 1.09, p=.31, r=.37. 
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Gender was also not significantly associated with years of education (rpb = 
.15, p=.26, one-tailed) or alcohol use (rpb = -.30, p=.10, one-tailed). The 
difference between men and women could also not be accounted for by 
differences in CD4 counts (rpb = .15, p=.27, one-tailed). However, gender 
was statistically significantly correlated with medication regime (rpb = -.46, 
p=.03, one-tailed), with women less likely to be on more complex regimes.  
0
1
2
3
4
Subtest Profile 
Score
CS AP KS TJ ZM mSET
BADS Subtest
Mean subtest score by Gender
Male
Female
 
 
Ethnicity 
On the WTAR there were no differences between the White British sample 
(M=96.67, SE=5.23) and the Black African/Caribbean sample (M=96.60, 
SE=11.44), t(18)=0.60, p=.95, r=.14, with the assumption of equal 
variance met (Levene‘s F(18)=0.78, p=.39). Ethnicity was also not 
significantly associated with years of education (rpb = .03, p=.45, one-
tailed), alcohol use (rpb = -.23, p=.16, one-tailed), although association 
between ethnicity and medication regime approached significance (rpb = -
.35, p=.07, one-tailed), with Black African/Caribbean participants less likely 
to be on more complex regimes. In summary, this means Black 
African/Caribbean participants were not significantly different to White 
British participants on pre-morbid IQ, years of education and alcohol use. 
Therefore, these are unlikely to be the cause of the significant difference 
between these groups on the BADS. Although Black African/Caribbean 
Figure 7. Mean subtest score by gender 
Note. CS=Card Sort; AP=Action Program; KS=Key Search; TJ=Temporal 
Judgement; ZM=Zoo Map; mSET=Modified Six Elements Test 
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participants were less likely to be on complex medication regimes compared 
to White British participants. 
 
Multiple Regression – BADS Total standard score 
The data was further explored by a multiple linear regression to further 
explore these relationships. To maintain richness and depth of the data, the 
BADS was kept as a continuous rather than categorical variable, which 
necessitates the use of a multiple regression rather than a logistic 
regression. Previous research has suggested that one predictor variable can 
be entered into the regression for every 10 participants (Field, 2009). 
Therefore, as this study recruited 20 participants, entering two variables 
into the regression analysis is appropriate. Therefore gender and ethnicity 
were entered hierarchically into the regression to predict the BADS Total 
score. 
 
The assumptions required to conduct a multiple regression are outlined in 
Table 18. Although the majority of the assumptions were met, including 
independence of errors and no perfect multi-collinearity. An analysis of the 
assumptions suggests that errors are not normally distributed and data 
from two participants may have undue influence on model. This is shown as 
the score for these participants was more than three times the average 
centred leverage value (0.35 compared to average of 0.10). However, this 
does not justify removing the case/s but it might mean regression models 
are less able to generalise to the wider population (Field, 2009). 
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Table 18. 
Test of Multiple Regression Assumptions for Gender and Ethnicity as 
predictors of the BADS 
Assumption Test Results 
1. All predictor variables are quantitative or 
dichotomous with no zero variance 
Both ethnicity and gender 
are dichotomous 
2. Normally 
distributed 
errors 
i. Shapiro-Wilks test of 
Standardised Residuals 
W=.85, p=.005  
So distribution cannot  be 
assumed to be normal 
3. Homogeneity 
of variance  
 ii. Visual analysis of 
scatterplot of residuals  
No funnel shape 
No obvious curve shape 
Figure 8 4. Linearity 
5. Independence 
of errors 
iii. Durbin-Watson Statistic  
Significant if below 1 or 
above 3 (Field, 2009) 
1.62, ns 
6. No multi-
collinearity 
iv. Correlation between 
gender and ethnicity 
Significant if r above 
.80 or .90 (Field, 2009) 
v. Variance Inflation 
Factor (VIF)  
Significant if above 10 
or below 1 (Bowerman 
& O‘Connell, 1990) 
vi. Tolerance  
Significant if  below 
0.20 (Menard, 1995) 
r = .55 p=.007, ns 
 
 
Average VIF = 1.42, ns  
 
 
Tolerance 0.70, ns 
7. No outliers vii. Cook‘s Distance  
Significant is greater 
than 1 (Cook & 
Weisberg, 1982) 
viii. Mahalanobis distance 
for small samples with 
two predictors  
Significant if above 11 
(Barnett & Lewis, 1978) 
ix. DFBeta should be 
within ±1 (Field, 2009) 
One data point 1.59 
(range  0.03 – 0.73) 
 
No Mahalanobis distance  
>11 (range 0.55 – 6.65) 
 
 
 
 
Two data points have 
DFBeta outside of ±1 
Note. DFBeta=difference between a parameter estimated using all cases and estimated when 
one case is excluded 
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Results of the multiple regression are reported in Table 19. The regression 
model was statistically significant (F2,17 = 3.950, p=.039) and R2 was 
0.27, so the model accounted for 27% of the variance in BADS Total 
standard scores. Despite this model being significant neither predictor was 
individually statistically significant. This may be because the variables are 
associated with each other, although there was not perfect multicollinearity. 
Figure 8. Scatterplot of Residuals 
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Table 19. 
Results of Multiple Regression 
 B SE B Beta t 
Step 1 
   Ethnicity 
 
-27.60 
 
10.74 
 
-0.52 
 
-2.57* (p=.02) 
Step 2 
   Ethnicity 
 
   Gender 
 
-19.35 
 
-13.75 
 
12.66 
 
11.50 
 
-0.36 
 
-0.28 
 
-1.53   (p=.15) 
 
-1.20   (p=.25) 
Note. R2 = 0.27 for Step 1, R2 change = 0.06 * p<.05  
 
Missing Data Analysis 
There were several data points that were missing for a variety of reasons: 
 Unreturned or incomplete medical note proforma (7 data-points) 
 Unreturned DEX-O (3 data-points) 
 
This amounted to 10 data points, or 1% of the entire data set. The missing 
data is described in Table 20. 
 
Table 20. 
Characteristics of missing data 
Characteristic Number of missing 
values (%) 
n included in 
analysis 
Time since diagnosis 2 (10) 18 
CDC Classification 1 (5) 19 
Medication Regime 1 (5) 19 
Length of Medication Regime  1 (5)  19 
DEX-O 3 (15) 17 
Note. CDC=Center for Disease Classification; DEX-O=Dysexecutive Questionnaire-Other 
Report 
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An independent t-test was conducted to determine if there was a significant 
difference between performance on the BADS for those who had some 
missing data (n=5) and those who did not (n=15). On average, participants 
with no missing data scored more highly on the BADS (M = 88.21, SE = 
5.93) than those who did have missing data (M = 73.80, SD = 12.63). 
Equal variances can be assumed as Levene‘s test was not significant 
(p=.96). This difference between groups was not found to be statistically 
significant t(17) = 1.17, p=.26, r=.28. This shows that on the main 
measure there was no difference between those who had missing data and 
those who did not. 
 
 
 
 Page 132 of 255 
 
Extended Discussion 
This section provides a supplementary interpretation of the study findings 
within the context of previous empirical research and theoretical 
background. A critical consideration of the strengths and limitations of this 
study and how this might inform future research is presented before 
discussing the clinical and everyday implications of these findings. Finally, 
reflections on the scientific, theoretical and ethical issues raised by this 
research are briefly discussed. 
Aim One  
 Explore executive function in people with HIV-infection using the BADS 
relative to published norms (Wilson et al., 1996).  
 
The results show a proportion of people with HIV may have difficulties with 
executive functions, in that they are less able to create models of self-
directed action (Jurado & Rosselli, 2007). This finding converges with the 
limited previous research which specifically assessed executive functions in 
people with HIV using the CANTAB (Sahakian et al., 1996), Stroop (Hinkin 
et al., 1999) and IGT (Hardy et al., 2006). This also corresponds to 
previous findings where impaired executive functions are a central feature 
in the prototypical cognitive profile in people with HIV, even from early in 
the course of infection (Dawes et al., 2008). The current study adds a 
unique contribution to the research literature in the post-HAART era by 
considering a neuropsychological battery with good ecological validity to 
measure executive functions. Furthermore, this is the first study since the 
introduction of HAART to provisionally break down an executive function 
battery into dissociable skills particularly affected in people with HIV, 
moving the research forward as suggested by recent reviews (Woods et al., 
2009). This finding is also compatible with reports showing problems with 
executive functioning using the BADS in other populations including 
individuals with psychosis (Jovanovski et al., 2007) as well as other 
neurodegenerative diseases such as Parkinson‘s Disease (Kamei et al., 
2008). 
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These findings support the clinical utility of the BADS as a measure of 
executive function above the global cognitive assessment advocated by 
Butters et al. (1990) or traditional tests such as the TMT or Stroop. This 
research thereby overcomes a significant limitation of previous research by 
assessing executive functions on a continuum rather than dichotomously 
determining whether individuals have/do not have global cognitive 
impairment.  
 
Dissociable Executive Function Skills 
The significant impairments shown by participants in the sample on the Zoo 
Map subtest may point to its utility and sensitivity for people with HIV and 
be useful in determining where to target interventions. This finding parallels 
research with men with chronic problem alcohol use (Moriyama et al., 2002) 
who also found the Zoo Map to be the most useful. On the other hand, the 
current finding diverges from research with adults with brain injury, where 
the Action Program and Modified Six Elements Test were reported as the 
most useful BADS subtests (Bennett et al., 2005). However, it is possible 
the Zoo Map is overly inclusive and results in false positive results (Type I 
errors) although this is unlikely as the BADS subtest is normally found to 
make Type II errors (Manchester et al., 2004). 
 
It is useful to embed performance on measures of executive function within 
the theoretical models of executive functions. The pattern of performance 
on the BADS subtests in this sample does not support a unitary model of 
executive functions. In unitary models, such as the SAS (Norman & Shallice, 
1980), executive functions are seen as underpinning and regulating 
response to novel and complex tasks. However, these results show that the 
least affected subtest was the novel task – the Action Program. Instead this 
study‘s findings support a fractionated model of executive function with 
different dissociable skills (e.g. Stuss & Alexander, 2007). This would 
further support the use of a battery approach to assess executive functions, 
rather than using traditional tests which only provide information on one 
single aspect of the executive function concept (Boone et al. 1998).  
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Considering the Stuss and Alexander (2007) proposed executive function 
sub-systems: energisation (initiating and sustaining responses), task setting 
(planning, choosing an appropriate plan and suppressing salient responses) 
and monitoring (checking the task over time) the results in this study 
suggest self-monitoring and task-setting were disproportionately affected in 
people with HIV in this sample, with relatively preserved energisation as 
evidence by their preserved performance on the Action Program. The 
pattern of subtest performance suggests involvement of orbito-frontal and 
dorso-lateral region brain areas (associated with monitoring and task-
setting respectively) (Malloy et al., 1993; Bamdad et al., 2003); with the 
ventro-medial region (associated with energisation) (Stuss & Levine, 2002), 
largely spared. However, there are differing theoretical configurations of the 
executive functions systems (e.g. Fisk & Sharp, 2004) and there are 
significant overlaps between these executive function systems which can be 
seen both theoretically and in associated brain areas. 
 
However, it may the BADS is actually not be sensitive the energisation 
subsystem, for example, initiation and apathy (Burgess et al., 1998). This 
may be, in part, due to the office-based testing environment required for 
administration of the BADS where the examiner taking the role of the 
initiator, providing rules, goals and prompts (Stuss & Alexander, 2000).  
 
Aim Two 
 To triangulate quantitative measurement of executive deficits on the 
BADS to self- and proxy-report questionnaires on day-to-day experience 
of executive functioning (DEX)  
 
There was no statistically significant relationship between the BADS and the 
DEX-S which suggests limited insight as participants were no better than 
chance at predicting their executive function performance. This might be 
supplemented by the only subtest correlation which even approached 
significance with the DEX-S (Action Program) was in the positive direction – 
so people who had more executive function problems as suggested by the 
BADS reported fewer problems indicative of limited insight (Hart et al., 
 Page 135 of 255 
 
2005). Although it is important to remember that this correlation only 
approached significance.  
 
However, this lack of association between cognitive performance and self-
report may be attributed to fluctuating medical status, leading to discrepant 
self-report and cognitive performance (Lovejoy & Suhr, 2009). However, 
the exclusion criteria for the study controlled for this variable, so limitations 
in participants‘ insight are a more probable explanation for this finding.  
 
The close approach of significance in the inverse relationship between the 
BADS and DEX-O, where high scores on the DEX and low scores on the 
BADS represent more executive function difficulties, reflect similar 
appraisals of the participants‘ executive functions. Professionals‘ scores on 
the DEX-O were significantly higher than ratings from friends or family. This 
finding is in keeping with Fordyce and Roueche (1986) who found family 
and friends provided an under-estimate of participants‘ abilities compared 
to professionals. There may also be effects of differing interpretations by 
different raters on the DEX items as suggested by Chan and Bode (2008). 
Chan and Bode (2008) used a Rasch analysis in 92 patients to identify that 
patients and proxies disagreed on interpretation of items on the DEX, such 
as unconcern for social rules, distractibility, decision making, emotional 
regulation problems such as aggression and euphoria. It is not possible to 
make conclusions based on this as participants had only either professionals 
or family/friend to act as a proxy on the DEX. Participants who had more 
executive function problems may have either had fewer friends/family to 
complete the measure or felt uncomfortable asking friends/family.  
 
The DEX-O was not significantly associated with any of the BADS subtests 
with correlations ranging from .01 to -.38. This is considerably lower than 
the correlations (-.31 to -.46) reported by Wilson et al. (1998). However, 
the negative correlations that approach significance between the DEX-O and  
Action Program and Card Sort in the current study suggests proxies more 
accurately report participants‘ responses to novel complex tasks, set-
shifting and flexibility. Interestingly, these two subtests were the subtests 
on which participants performed best. These particular executive skills may 
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be more externally observable than others. This is supported by the finding 
that participants who had difficulties in the Action Program were more likely 
to have been referred by a professional rather than self-referral. This is 
despite participants themselves being less able to accurately report 
performance on this subtest. Perceptions of skills on novel tasks seem to be 
the point where self- and other- report conflict, where proxies report more 
accurately map onto BADS performance. Alternatively, the finding in 
relation to insight may represent proxies did not know the participants 
sufficiently well to accurately determine the impact of executive function 
ability in everyday life. However, this is unlikely as participants chose the 
proxy themselves.  
 
The convergence of the DEX-O and BADS scores, compared to the DEX-S 
represents triangulation which suggests the DEX-O and BADS measures 
more closely represent how participants use their skills in social situations. 
Even if the individual is not experiencing the difficulties, the DEX-O 
demonstrates how their behaviour is being interpreted in social situations, 
which may well influence their social interactions. As assessment of 
executive functions presents a particular challenge for neuropsychologists, 
this finding supports the use of the BADS to assess executive functions, 
supplemented particularly by proxy report to triangulate the relative impact 
for individuals.   
 
This study‘s findings significantly add to the evidence base by focusing on 
the functional outcomes of executive function for people with HIV, reflecting 
the predominance of day-to-day management issues (Melrose et al., 2008). 
This study begins to consider the behavioural consequences and activities of 
daily living associated with executive functions which are a defining feature 
of cognitive impairment in people with HIV. The findings of this study 
suggest the importance of assessing not just basic activities of daily living 
but behaviour associated with executive functions and abilities in social 
interactions, similar to Katz et al. (2007). By exploring these functional 
outcomes this study adds to the evidence base by using the WHO-ICF 
conceptualisation of an individual within their environment. This model, as 
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presented in Table 21, can be used to represent some of the difficulties an 
individual with HIV and executive function difficulties may have. 
Table 21.  
HIV understood within the WHO-ICF framework 
Health 
condition  
Impairment 
 
Activity Limitation  
 
Participation 
Restriction  
 Problem with  
body function, 
structure, deviation 
or loss 
 
Difficulties an 
individual has 
executing an 
activity 
Problems 
experienced in 
involvement in life 
situations 
HIV Compromised 
immune system, 
reduced cognitive 
and executive 
function 
Less capable of 
socially appropriate 
behaviour 
 
People‘s reactions 
leading to fewer 
social relationships 
 
Note. WHO-ICF=World Health Organisation-International Classification of Functioning 
 
Aim Three 
 To explore risk factors that might contribute to expression of executive 
deficits in people with HIV.  
 
Medical factors: 
CD4 Count 
The findings of this study that CD4 count did not have an effect on BADS 
performance are in line with Reger et al. (2005) who found CD4 count could 
not predict neuropsychological impairment. However, this does not reflect 
previous longitudinal studies, such as Childs et al. (1999), who found that a 
CD4 count of less than 200 cells per mm
3 was a moderate risk for HAD. 
However, Childs et al. (1999) reported on research with participants prior to 
the introduction of HAART and was primarily concerned with the 
development of HAD rather than mild-moderate cognitive difficulties. The 
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current study adds to the evidence base as it offers specific information on 
the executive function cognitive domain. It seems that in the changing 
context of HIV treatment, the immuno-variables traditionally used to predict 
cognitive decline are less useful. This has implications for the use of 
traditional classification systems as well, which are strongly based on CD4 
level, as they may no longer be appropriate. 
 
Plasma Viral Load 
It was not possible to determine the relative impact of viral load to 
executive function in this sample as 85% of the sample had undetectable 
viral load levels. On the other hand, this strongly suggests that executive 
function difficulties can occur even in the context of maximum viral 
suppression; thus supporting other research which has found that cognitive 
impairment had no relationship with viral load (Ellis et al., 1997; Hammer 
et al., 1997; Reger et al., 2005;). For example, Cysique et al. (2006) found 
individuals with HIV continued to show cognitive decline despite 
undetectable viral load. However, the current sample had an even higher 
proportion of participants in the below average range (35-50%) compared 
to only 8-34% in Cysique et al. (2006). 
 
Time since HIV-diagnosis 
Time since HIV diagnosis was not related to BADS overall performance in 
this study. This does not correspond to previous research that participants 
living with the HIV infection for longer would have compounded neurological 
problems (Bhaskaran et al., 2008; Brew et al., 2009). However, there was a 
statistically significant positive association between the Action Program and 
duration of diagnosis. The direction of this relationship suggests participants 
who lived with the infection for longer performed better, possibly indicative 
of the development of specific compensation strategies to approach novel 
tasks. The Action Program subtest also approaches significance with the 
DEX-S, where participants who performed well on the Action Program, 
reported more problems on the DEX-S, and compensation may help explain 
this provisional relationship. Participants may consciously employ 
compensation strategies when they approach a novel task, however, the 
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subtest score does not measure this increased effort. On the other hand, 
compensation may not be a conscious process. Melrose et al. (2008) found 
people who had stable frontal lesions had increased activation in the 
parietal lobes on traditional executive function tests. However, it is 
important to bear in mind that time since diagnosis is not a conclusive 
measure as someone may have been living with the infection for an 
unspecified period of time before diagnosis. 
 
Stage of Infection 
The finding that the stage of HIV-infection was not associated with BADS 
performance does not sustain the vast majority of research findings (e.g. 
Grant et al., 1999), which found that cognitive impairment increased with 
disease progression. CDC stage was, however, statistically significantly 
positively associated with the Key Search task, which suggests, as above 
that there may be the development of some compensation strategies in the 
symptomatic/AIDS stages of infection. However, this may be related to the 
changing context of HIV treatment and utility of immuno-variables to 
predict cognitive decline as described above. It may be that CDC is no 
longer a useful or sensitive tool to describe the fluctuating and variable 
course of HIV with the modern treatment.  
 
HAART  
Medication regime was not associated with BADS overall performance. 
HAART may not improve the subtler cognitive functions in the same way it 
reduces the likelihood of HAD (Gibbie et al., 2006). There is some evidence 
to suggest there was a specific neurological detrimental effect as 
participants on HAART regimes for longer, performed statistically 
significantly worse on the Key Search subtest. This finding agrees with 
Starace et al. (2002), who also found individuals on HAART regimens to be 
more likely to have cognitive impairments than those not taking HAART. 
However, this finding may be due to prescribing procedures of HAART, with 
more medications prescribed pre-emptively because they were experiencing 
cognitive difficulties. There were also some potential benefits of medication 
on the Card Sort subtest, particularly mental flexibility, although 
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importantly this association only approached significance. This might 
suggest that similar to cognitive functions in general, HAART has non-
uniform affect across the executive functions (Cysique, Maruff & Brew, 
2004a). Subsequently, this research adds to the evidence base by 
confirming the necessity of using a battery approach with ecological validity, 
rather than individual traditional tests, to assess executive functions in HIV.  
 
Demographic Factors: 
Age 
The lack of association between BADS performance and age does not 
replicate previous research which suggested older age had a negative effect 
on neuropsychological performance, especially on novel tasks that require 
faster speed of processing (Grant, 2008). Valcour et al. (2004) found 
individuals with HIV aged over 50 had a higher prevalence of cognitive 
problems than those with HIV younger than 50. However, the finding of the 
present study is in keeping with Sevigny et al. (2004) who also found no 
effect of age of neuropsychological performance. However, the lack of 
association with age in the current study might be expected as the majority 
of the sample included were under 50 years old (SD=8.26). 
 
In fact, the Key Search subtest was significantly positively associated with 
age so older participants tended to perform better. As with medical 
characteristics, this suggests older participants developed compensation 
strategies and tasks such as the Key Search are amenable to compensation 
strategies. However, it may be generational differences affect approaches to 
planning tasks resulting in improved performance in older participants, not 
necessarily an improvement in participant executive function ability over 
time.  
 
Gender 
This study found a strong effect of gender on the BADS, where male 
participants achieved higher scores on each of the BADS subtests compared 
to female participants. Unlike Failde-Garrido et al. (2008), this gender 
difference in executive functions could not be accounted for by differences 
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in pre-morbid IQ, alcohol use or years of education. However, women were 
less likely to be taking HAART medication than men, which may have 
negatively influenced performance. It may have been medication was not 
indicated for the women in the sample, or that they chose not to take 
medication. However, there were no significant differences between men 
and women on CD4 status as an immune variable, the mechanism of 
HAART, so the differences between men and women are not directly 
attributable to difference in medication.   
 
Moreover, although gender was strongly correlated with the BADS total 
score, gender was only significantly associated with the Key Search subtest, 
although statistical significance was approached with the Action Program 
and Zoo Map tests. These subtests, particularly the Key Search and Action 
Program are the subtests which have potentially been associated with 
development of compensation strategies as age and disease progress. This 
could suggest that women are less able to develop these compensation 
strategies, leading to the discrepancy between male and female 
performance in this sample. However, this may instead be due to pre-
existing structural or functional differences between male and female brains 
(Melrose et al., 2008).  
 
However, neither self- nor other-report on the DEX was associated with 
gender. Women may be more likely to experience executive function 
difficulties and so are more likely to have limited insight into their difficulties 
and report them at levels similar to the men in the study or the non-clinical 
population (Hart et al., 2005). This is supported by the specific findings in 
the DEX, in relation to Aim Two. On the other hand, everyday problems 
may not be reported because executive function impairment do not cause 
significant problems in everyday life for the participants in this sample as 
their environments are low demand.  
 
In a multiple regression analysis, gender only accounted for 6% of the 
variance in BADS score and was not a significant individual predictor. This 
might suggest that the differences in ethnicity were more significant, and 
differences in gender may in part be attributable to the 71% of the female 
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participants who were Black African/Caribbean. This study points to the 
value of considering cognitive domains individually to consider gender 
differences. 
 
Ethnicity 
The finding of cultural difference on the BADS supports the work of Proctor 
and Zhang (2007) who also found participants from non-White backgrounds 
performed worse on the BADS. In particular, Black African/Caribbean 
participants in the current study performed statistically significantly less 
well on the Action Program, Key Search and Zoo Map subtests. This is in 
line with Proctor and Zhang (2007) research, which reported that Latin and 
African American participants performed worse on the Zoo Map subtest. 
However, ethnicity only accounted for 27% of the variance in the BADS 
total score and when gender was included in the regression model, although 
the model was statistically significant, neither gender, nor ethnicity were 
significant individual predictors. This suggests that there is some combined 
effect, although these results cannot be generalised to the wider population 
due to a number of influential ‗cases‘ violating the outlier assumption.  
 
These differences in BADS performance based on ethnicity may be due to 
genetically different subtypes of HIV-1. The different genetic subtypes of 
HIV-1 have a subtle influence on medication resistance so it is conceivable 
that they influence development and patterns of cognitive difficulties. 
However, Proctor and Zhang (2007) found cultural differences on measures 
of executive function in the non-clinical sample, which indicates that genetic 
variations in the strains of HIV-1 is not sufficient to explain these 
differences.  
 
There may still be different risk factors in people from BME backgrounds, 
similar to those between men and women (Rivera Mindt et al., 2008). For 
example, there may be differences in access to education (Kaufman, Cooper 
& McGee, 1997), acculturation (Lucas, 1998) or literacy (Manly, Touradji, 
Tang & Stern, 2003). Socio-economic status may also restrict access to 
services such as healthcare, and influence brain development (Brickman 
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Cabo & Manly, 2006). However, the current study did not find differences in 
executive function between ethnic groups could be accounted for by 
premorbid IQ, years of education or differences in language ability. 
However, there may have been other risk factors not accounted for by the 
current study, which mediate performance on the effects of ethnicity on the 
BADS. Alternatively this finding may be accounted for through inherent 
limitations of the BADS. 
 
Cognitive, Behavioural and Emotional Factors: 
Drug & Problem Alcohol Use 
The lack of effect of alcohol use with the BADS performance does not agree 
with previous research finding the negative impact of problem alcohol use 
on cognitive and executive function (Schulte et al, 2005). However, the lack 
of any report of problems or hazardous drinking in the study sample is 
clearly lower than the 29-60% rates of problem drinking in people with HIV 
predicted from previous research (Meyerhoff, 2001). The average alcohol 
use of the sample was only two units/month; which does not equate to 
problem drinking. Therefore, alcohol use within the normal range in people 
with HIV does not seem to affect neuropsychological functioning. However, 
it is important to remember that this was based on self-report so alcohol 
use may have been under-reported due to social desirability. It was also not 
possible to consider the impact of co-morbid drug use on executive 
functions in HIV as only extremely low levels of drug use were recorded by 
participants, which might reflect social desirability or fears over legal 
consequences, despite reassurances over confidentiality. 
 
Depression 
The lack of association between depression and the BADS in this sample, 
bearing in mind that by virtue of the exclusion criteria, none of the 
participants were experiencing current severe depression, supports previous 
research which suggests that those in the non-clinical range for depression 
(i.e. diagnosable with a current major depression disorder) do not have 
increased executive function impairment (Gibbie et al., 2006). This was also 
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reflected in the lack of association between self- and other-report and levels 
of depression. This adds to the evidence base exploring non-clinical levels of 
low mood in people with HIV in a dimensional rather than categorical way. 
However, there is scope for further research to examine the relationship 
between more clinical levels of depression and HIV when considering 
executive function replicating the work of Westheide et al. (2007).  
  
Anxiety 
The lack of general association between anxiety and the BADS in this 
sample supports Hoffman and Al‘Absi (2004) who suggested that anxiety 
does not have an effect on neuropsychological performance. However, other 
authors have suggested that the effects of anxiety are cumulative 
(Kizilbash, Vanderploeg & Curtiss, 2002). Moreover, like depression, on 
average participants did not score within the clinical range for anxiety and 
were not diagnosable with anxiety disorder. Anxiety at this level may not be 
expected to influence performance on the BADS. 
 
Those participants with high levels of anxiety did perform statistically 
significantly less well on the modified Six Elements subtest as compared to 
those with lower levels of anxiety. As participants scores on average did not 
fall within the clinical range, this suggests that even low levels of anxiety 
may affect ability to multi-task, sequence and plan which supports previous 
research on the detrimental effects of anxiety (Kizilbash et al., 2002) but 
only to specific executive function processes. On the other hand, it is 
commonly acknowledged that the modified Six Elements Test is the least 
structured on the BADS (Manchester et al., 2004), allowing for the greatest 
comparison to everyday behaviour, so this association may be more 
generalisable to other executive function skills in the everyday world. 
However, as correlation cannot suggest causality, it may be that problems 
with multi-tasking in everyday life cause more anxiety. Although this is less 
likely to be the case as executive function difficulties are associated with 
impaired insight as described above. 
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Anxiety might also be a product of disease progression as high levels of 
anxiety were significantly associated with later CDC stages. However, it is 
not possible to determine whether disease progression contributes to 
increased anxiety, with increasing levels of uncertainty and hypervigilance, 
or whether high levels of stress hormones are implicated in additive effects 
of insult to the brain (Kopinsky et al., 2007).  
 
Level of Education & Pre-morbid IQ 
The finding that the BADS score was not associated with years of education 
or pre-morbid IQ does not agree with the findings of DeRonchi et al. (2002) 
or Basso and Bornstein (2000). These authors suggested cognitive 
impairment is mediated by pre-morbid ability and cognitive reserve in 
people with HIV. However, the current study directly and specifically 
considers executive functions rather than global cognitive functioning. Pre-
morbid functioning may have less of a protective/buffering role in the 
development of executive function difficulties. Indeed, the significant 
difference between the standard score on the WTAR and BADS lends further 
support to the concept of executive function as distinct from generalised 
intelligence (Burgess et al., 1998).  
 
There might be some differential effects of education and ‗cognitive reserve‘ 
ability on more specific executive function skills: those with higher pre-
morbid IQ performed statistically significantly better on the Card Sort 
subtask, however, those with fewer years of education performed better on 
the Action Program task, although this latter finding only approached 
significance. This might suggest that cognitive reserve has different benefits 
for different subtests. Anecdotally, the participants with more education 
seemed to ‗over-think‘ their approach to novel tasks, perceiving the task as 
more complex than it was, anticipating some ‗trick‘, whereas participants 
with fewer years of education approached the task in a more direct way. 
This ties in with the findings on compensation, and participants may be 
more consciously trying to apply a strategy to solve the task. Although it 
only closely approached significance the finding in relation to the Card Sort 
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was in the expected direction, suggesting that for tasks requiring mental 
flexibility, cognitive reserve did benefit for participants‘ performance.  
 
Summary 
As well as factors related to BADS overall performance, there are 
dissociable experiences of executive function skills by considering the BADS 
subtest analysis. This suggests that there is a dissociable fractionated 
executive function system, such as that suggested by Stuss and Alexander 
(2000) underlying the BADS, although at present this is hard to define. In 
people with HIV it might be the task-shifting and monitoring systems which 
are most affected as measured by the Zoo Map. In particular the Action 
Program subtest seems to provide valuable information on compensation 
and insight. Approaches and strategies to solve novel tasks are likely to be 
the most observable executive function characteristic. However, these 
compensation strategies seem to be limited to specific executive function 
skills and some participants may be less able to develop this compensation.  
Overall, using the BADS as a battery measure has been shown to be useful. 
On the two dimensions of ecological validity: verisimilitude and veridicality, 
the BADS clearly shows greater verisimilitude than traditional measures in 
that it relates well to everyday activities on face validity. In terms of 
veridicality, this study has shown that the BADS approaches significant 
associations with the DEX-O. Although this association is not the extent 
found in previous research and does not quite reach statistical significance, 
this may confer a degree of veridicality to the BADS in this sample.  
 
Strengths and Limitations 
As the study sample is small these findings point to trends and patterns in 
the sample, rather than conclusions. The study sample also differed 
significantly from the regional population of people, in terms of proportional 
representation of age and ethnic groups. Therefore, generalisations of the 
findings to the wider population of people with HIV need to be considered 
with caution. However, the approximate representative proportion of gender 
is a strength of the study, as only 31% of studies with people with HIV 
include this approximate parity (Maki & Martin-Thornmeyer, 2009). 
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Furthermore, the broad inclusion and exclusion criteria attempt to recruit a 
sample more representative and less elitist of people living with HIV. 
However, the size of the sample limited the ability to analyse some of the 
variables. Several variables with discrete categories had to be collapsed 
together to allow for large enough sample sizes to be included in the 
analysis. This is not ideal and does not necessarily allow for fine-grained 
analysis of the results. Moreover, although effort was made to club items 
together logically and according to prior research and theory, there might 
have been alternative ways of combining this data which could have lead to 
different outcomes.  
 
The recruitment methods attempted to be inclusive. However, there may be 
people with HIV who do not regularly access NHS or charitable services, and 
hence were not able to participate in the study. These may be participants 
who are able to work and effectively use their executive functions, which 
might bias the sample. However, it might equally be that the unsampled 
population experienced more problems with executive functions, and were 
unable to plan or organise sufficiently to attend appointments. Additionally, 
although the inclusivity of the sample can be seen as a strength, it also 
introduces heterogeneity into the sample, which means the internal validity 
of the study may be compromised. 
 
As a small and hard-to-access population, people with HIV often participate 
in many research studies, possibly including neuropsychological research. 
This might influence expectations of the assessment procedure and 
outcomes. This was not controlled for through the exclusion criteria 
however, because no research has been conducted looking directly at 
executive functions in people with HIV using a measure with good ecological 
validity. No participants had previously completed the measures involved in 
this study so practice effects should not have influenced the results.  
 
In referrals from professionals participants who reported more problems 
were more likely to be referred to the study, which might suggest that 
people participating in the study had pre-existing concerns about their 
cognitive status. However, this finding was not replicated by participants 
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who self-referred to the study, who made up the bulk of the participants. 
Further self-report of problems was actually negatively associated with 
BADS performance, although not statistically significant this points towards 
potential lack of insight in people with executive function difficulties. This 
would suggest the bias resulting from participants who took part due to 
pre-existing concerns may have only minimally affected the results.  
 
A matched control group is often recommended in this methodology. 
Matching is a highly controversial issue as outlined by the contrast between 
the positive praise supporting its use by some authors (Pike, Hill & Smith, 
1980) and strong refute by others (Howe & Choi, 1983). Matching does 
seem intuitively helpful to reduce the impact of confounding variables 
(Gefeller et al., 1998). However, there is significant controversy on matched 
control group selection, particularly the number of factors to match for 
(Wacholder et al., 1992) as over-matching (matching participants on many 
variables) can actually increase bias (Fletcher, 1997). All of the variables 
included in the correlational analysis could be considered as variables to 
match for, although this would be nearly impossible. The defining feature of 
a case-control is the recruitment of a sample with a particular characteristic 
compared to a sample without that characteristic. Previous research in 
people with HIV has used a variety of control groups, including people with 
HIV with no neuropsychological impairment, people who have been tested 
for HIV but had a negative result and people from other neurological 
populations, people from the non-clinical population. However, there is no 
obvious control group. 
 
The inclusion of a traditional measure of executive function, such as the 
WCST, has often been used in previous studies to provide a supplementary 
analysis on which measure suggests more difficulties. This could have 
provided a more in-depth analysis and allowed more explorations of the 
utility of the BADS as a useful measure in people with HIV. However, a 
traditional measure was not included as there is already a significant 
evidence base to suggest the movement of neuropsychological assessment 
towards ecological validity (e.g. Jovanovski et al., 2007; Norris & Tate; 
2000, Evans et al., 1997). Moreover, determining the ecological validity of 
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the BADS was not the aim of the present study, but the BADS was used 
for its validity in this area. This methodology is also consistent with 
maintaining the reflection of neuropsychologists working in the field, who 
often do not have time to complete several different measures of the same 
cognitive construct but opt for the most appropriate, based on the 
research evidence. 
 
However, it is important to acknowledge and be aware of the limitations of 
the BADS and other measures used. As already mentioned above there are 
questions over the cultural validity and cultural equivalence of measures 
such as the BADS in non-White populations (Brickman et al., 2006). 
However, despite the growing research and commentary on this, there is 
currently no consensus as to how this should be approached, other than to 
consider the clients‘ ethnicity when interpreting their results and interpret 
with caution the results of people from different cultural backgrounds 
when measured on standardised measures like the BADS. This is further 
complicated by the significant lack of information provided about the 
normative sample provided in the BADS manual.  
 
However, there may be inherent limitations of the BADS as ‗eurocentric‘ as 
it was developed and normed in the UK, with European values and 
standards and with White participants who have been socialised with these 
values and standards (Helms, 1992). These standards and values may not 
apply to other cultural experiences. The BADS manual or related published 
articles do not comment on or provide any descriptive statistics for the 
ethnic diversity of their normative sample. Therefore, it is not possible to 
determine the cultural validity of the BADS and whether comparison with 
the normative data is appropriate for these participants. Normative data 
allows neuropsychologists to compare individual performance to a wider 
non-clinical sample to identify whether scores are comparable or not 
(Brickman et al., 2006). The BADS norms are useful as they were relatively 
recently created, included a large sample and stratified for age, education 
and sex (Brickman et al., 2006). The demographic similarities of the 
normative sample and the individual are crucial to increase validity of this 
inference. On this basis several authors have argued for race-specific norms 
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to increase the accuracy for individuals from non-White backgrounds (Lucas 
et al., 2005). However, race-specific normative data does not consider the 
cultural validity of these tests. Moreover, race-specific norms suggest that 
everyone from the same racial background has the same cultural 
experience which is not always the case (Brickman et al., 2006). Finally, 
given the number of different ethnic groups it is not possible to create 
specific normative data for each group and creates a conflict where there is 
dual heritage. Knowing someone‘s ethnic background does not measure 
level of acculturation or the level of socialisation they have had with the 
concepts behind the BADS (Helms, 1992). 
 
This study only breaks ethnicity down into White British or Black 
African/Caribbean. There are other ethnic groups which were not accounted 
for in this research. Moreover, although not possible for the purposes of 
statistical analysis, the Black African/Caribbean group could be further sub-
divided into regional and national differences.  
 
Although the BADS has been shown to have good ecological validity, it is 
still an office-based test. Office-based tests have been criticised for 
creating an artificial environment. It is not often people have a quite 
distraction-free space with a non-judgemental examiner to explain the 
task and rules, to try and solve novel, complex and challenging problems 
with no long term consequences attached to them (Manchester et al., 
2004). However, more observational measures such as the Multiple 
Errands Test are time-consuming and require high levels of physical ability 
and confidence from participants. Taking this into consideration the BADS 
seems like a viable alternative to the MET, being shorter and less 
physically demanding than the MET. Furthermore, the BADS does include a 
modified version of the Six Elements Test which is based on the same 
principles, so similar information should be gathered. Indeed the findings 
point towards some of the anxiety that administering the MET might 
cause.  
 
The BADS, although allowing for some subtest analysis, requires further 
clarification of what each subtest is measuring and it is important to 
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acknowledge that the Total profile standard score might mask more 
specific difficulties as can be seen by the analyses in this study. The BADS 
also does not provide information on error analysis or strategies used to 
solve problems and their relative success. This information is invaluable as 
this could lead to the development of rehabilitation programs and 
strategies.  
 
One of the strengths of this study is the maintenance of executive functions 
on a continuous rather than dichotomised (impaired/not impaired) scale. 
Furthermore, the present study includes a functional assessment of the 
everyday impact of executive function in the lives of people with HIV. This is 
in line with the WHO-ICF suggesting the importance of the person in a 
social and political context. This should be a regular feature of research in 
people with HIV and cognitive difficulties as the everyday impact is a major 
diagnostic feature. However, this study did not include a measure of 
individual environmental demands. This represents more than functional 
assessment, including an assessment of the demands an environment 
places on individuals. For example, for people on HAART, the complexity of 
the regime may place significant burden on individuals, and necessitate 
executive functions to plan and manage. In this context executive function 
difficulties are of large importance. 
 
As there is no normative data available for the DEX it is difficult to 
determine whether participants‘ scores were what would be expected in the 
non-clinical population. On the other hand, this approach preserved the 
dimensional nature of the DEX, moving away from arbitrary categorisation 
of impaired/not impaired. In spite of this Likert scales, as used in the DEX 
still describe behaviour in narrow and absolute terms (Alderman, 2001).  
 
There is also a question over the development of the circular validity of the 
BADS and DEX. Both measures have been used to validate each other: 
correlation with the BADS has validated the DEX as a functional measure 
of executive functions and correlation with the DEX has validated the 
BADS as a cognitive assessment tool with good ecological validity. 
Therefore, comparison between different subjective measure and the 
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BADS and different cognitive measures with the DEX is needed to confer 
greater validity and utility of thee measures. 
 
Measures such as the WTAR, which focus solely on pronunciation, may not 
have given an accurate assessment of pre-morbid IQ, especially as with 
relatively high numbers of people for whom English was not a first 
language, it may have been appropriate to use an alternative measure 
such as the Spot-the-Word test. Although this is a factor to consider in 
future research statistically there was no difference between participants 
of different ethnic background on the WTAR in this study. Many 
researchers have suggested that when participants are being assessed in a 
language outside their first language, even if they are fluent, there will be 
a time lag in performance. As several of the BADS subtests include a 
measure of speed to determine the raw score, this may have had an effect 
on performance. However, it is unlikely that this is the sole factor 
associated with performance on the BADS as ethnicity was associated with 
performance on subtests that did not include timing in the raw score, for 
example, the Action Program subtest. 
 
Other cognitive abilities, such as memory, may have had an effect on 
cognitive test performance. This might lead to the results being attributed 
to difficulties with executive function when in fact the difficulties were with 
memory.  However, the BADS has been specifically designed to reduce 
load on memory and all written instructions for each subtest are placed in 
front of the participant throughout the subtest. Results may also be 
attributed to lack of sufficient effort, and secondary gains a participant 
may get through a poor neurocognitive performance, which could have 
been controlled for through the use of a brief test of ‗effort‘ such as the 
Rey Fifteen Item Test (Rey-FIT). However, there were no obvious 
incentives for participants for a poor performance, as results did not 
inform medication prescription, legal cases or other variables often 
associated with insufficient effort in neuropsychological performance.  
 
Other demographic variable information could have been collected such as 
family history of psychopathology, and socio-economic status which some 
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recent research has suggested may have an influence on 
neuropsychological ability (Brickman et al., 2006). More medical 
information could also have been collected such as specific antiretroviral 
medications used in each HAART combination. This could explore the 
neuroactivity of these medications in relation specifically to executive 
functions. However, in such a small sample this would unlikely have 
yielded enough similarities to conduct an analysis. Information on 
medication adherence was also not collected in this study. Poor medication 
adherence may account for the lack of effect of HAART on BADS 
performance. However, the vast majority of the sample had undetectable 
viral load levels, maximal viral suppression and length of the medication 
regime was associated with an improved CD4 count which suggests that 
HAART improved CD4 count over time, which is the mechanism through 
which HAART claims to work. So even if medication adherence was low the 
medical status is what would be expected for someone with good 
adherence to medication.  
 
However, there would always be more information which could be 
collected and the researcher has to decide for themselves which appear to 
be the most important and valuable factors from previous research. In-line 
with the epistemological stance taken in this study, the variables chosen to 
be measured will inevitably be influenced by the researcher‘s 
interpretation.  
 
Future Research Directions 
As a pilot study there are several patterns that have been identified which 
would warrant further research. Future research should concentrate on 
trying to resolve these limitations of the current study and previous 
research. Recruitment should take place from a variety of sectors, possibly 
including culturally and gender sensitive charitable organisations. This 
should aim to recruit samples that are representatively diverse in terms of 
ethnicity and sexual orientation in an attempt to avoid selection bias and 
broaden the scope and applicability of the findings. A larger sample would 
allow for more analysis between diagnostic and severity groups as well as 
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testing the similarity of underlying constructs being measured. A 
longitudinal study would be useful ideally recruiting participants from a 
wider regional area, with a variety of severity presentations screening for 
executive function difficulties soon after initial positive HIV diagnosis and 
repeating this assessment over time. This might help to make sense of 
within-person fluctuations and individual variability over neuropsychological 
performance (Salthouse, 2007) and determine the long-term effects and 
implications of executive functions difficulties in people with HIV. 
 
It might be useful to recruit a HIV-negative control sample. However, care 
needs to be taken over how a control group is recruited and the factors that 
participants are matched on. For example, previous research has suggested 
little statistical benefit in matching for more than four variables (Woodward, 
1999; Ury, 1975). It would also be important to carry out a measure of 
exposure in both people with HIV and controls to improve validity of using a 
matched control group (Fletcher, 1997).  
 
Future research should aim to move away from global cognitive 
assessments as suggested by Butters et al. (1990) and away from 
traditional measures capturing only one aspect of the executive functions. 
In place of this, measures with better ecological validity (verisimilitude and 
veridicality) could relate neuropsychological performance more directly to 
everyday experience of individuals. Using a measure with ecological validity 
has been shown to be superior to traditional laboratory measures as it 
allows for closer comparison to everyday experiences. However, future 
research should focus on the subtest analysis and the underlying executive 
function skills that these represent. This is especially important in the 
knowledge and findings of this research that overall scores may mask 
specific patterns of difficulties or strengths for individuals. Furthermore, 
moving away from overall scores may uncover the mask of increased effort 
(Bennett et al., 2005).  
 
Increased focus on ecological validity would entail future research 
considering activities of daily living associated with executive function, 
moving away from categorical generic dichotomous functional outcomes, 
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such as employment status. The suggestion of compensation strategies in 
this study further points to the validity of using a measure with good 
ecological validity which aims to assess the participants within their context, 
what they do day-to-day rather than what they do in an ideal environment, 
as measured by traditional tests. Examining these behavioural 
consequences in future research should also include development of 
methods of assessment of environmental demands for individuals (Chaytor 
et al., 2006). Especially, as some participants may hold cognitive 
demanding occupations or have to adhere to cognitive demanding 
medication regimes, more subtle executive function deficits in early HIV-
infection may have a large impact (Knippels et al., 2002).  
 
The relationship between the BADS and DEX and the complex issue of 
insight when considering the everyday impact of people with HIV also 
merits further research attention. This might compare these quantitative 
measures to more qualitative interview approaches with both the individual 
and ‗others‘. Furthermore, exploration of the factor structure underlying the 
BADS would be useful, especially if this could be related to the fractionated 
aspects of executive functions, for example energisation, task setting and 
monitoring (e.g. Stuss & Alexander, 2000) and specific executive function 
skills such as impulsivity. Research in this direction may also clarify whether 
executive function measures truly tap into the entire executive function 
construct, especially as there have been pointers towards the lack of 
inclusion of apathy and inhibition (Bechara et al., 1999). Specifically in 
relation to the BADS there needs to be better description of the normative 
sample to determine the relevance of comparing individual performances 
against this baseline.  
 
In a similar vein, it would be useful for future research to consider the 
strategies used by people to solve executive function tasks and consider 
adding to the BADS or indeed other executive function measures. It would 
be useful to design some appropriate way of recording these strategies and 
working out how they work for individuals. If research could find a way of 
meaningfully recording strategies that are used to successfully undertake 
activities that require executive functions then it might be possible to 
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identify rehabilitation strategies for people with HIV. This may lead to 
further research considering the benefit of these strategies compared to 
people who have not used them. This might also allow for consideration of 
the factors related to the employment of compensation strategies, for 
example, whether women are able to employ these strategies in the same 
way as men. 
 
The neuroactive and differential effects of HAART need to be considered as 
a factor of newer research (Bhaskaran et al., 2008). It might also be useful 
for further research to include assessment of further variables. For example, 
more information on history of drug and alcohol use with more sophisticated 
recording procedures to avoid the social desirability factor. It would also be 
useful to include variables such as socio-economic status. Importantly, 
future research with people with HIV needs to consider tests of effort, 
possibly using the Rey FIT as a quick measure to determine how invested 
participants are in the assessment procedure. It might also be valuable to 
further consider the role of anxiety, cognitive reserve and insight in further 
research to determine the relative impact of this to self-reported problems, 
and the hypervigilance/lack of insight continuum, and executive functions.  
 
It would also be useful to supplement quantitative research considering 
further the patterns of difficulties with qualitative research into the 
experiences of executive function difficulties in people with HIV and the 
people who live with/work with them. This might also offer some insight 
into how these factors impact on stigma of HIV and social isolation. 
 
Clinical Implications 
The implications of these results are wide ranging. Although there are 
some limitations which may restrict validity of the results, these results 
allow for the preliminary discussion of the clinical implications. The findings 
of this study confirm the need for neuropsychological provision for people 
with HIV. This also suggests a move away from reliance on tests which do 
not represent the skills required in everyday life and do not consider the 
individual within a wider community, social and political context. Table 22 
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shows examples of the potential of the ICF-WHO to be used to consider 
the levels of clinical implications.  
Table 22. 
HIV and potential intervention level considering the WHO-ICF 
Health 
condition  
Impairment 
 
Activity 
Limitation  
Participation 
Restriction  
 Problem with 
body function, 
structure, 
deviation or loss 
Difficulties an 
individual has 
executing an 
activity 
Problems 
experienced in 
involvement in life 
situations 
HIV Compromised 
immune system, 
reduced cognitive 
and executive 
function 
Less capable of 
‗socially 
appropriate‘ 
behaviour 
 
People‘s reactions 
leading to fewer 
social relationships 
 
 
Intervention 
Level 
HAART Rehabilitation/ 
Compensation 
strategies 
Wider awareness of 
this issue 
Note. WHO-ICF=World Health Organisation-International Classification of Functioning; 
HAART=Highly Active AntiRetroviral Therapy 
 
Impairment Level 
The mixture of positive and negative effects of HAART medication warrants 
further research. Prescribers should consider cognitive functioning when 
prescribing (Antony & Bell, 2008). It might be valuable for prescribing staff 
to develop clear information for people with HIV. This might inform people 
with HIV on the potential effects of HAART, more than just medical side-
effects, but realistic and evidence-based consideration of the potential 
negative side-effects in relation to executive function. This might indicate 
that patients starting on a HAART regime should be offered the option of 
regular monitoring of executive functioning.  
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Activity Limitation 
The potential evidence of some compensation strategies suggests that 
there might be some benefit of rehabilitation strategies. This might 
contribute towards the development of rehabilitation programs or 
information on rehabilitation which could be provided to patients after 
diagnosis. It might also point towards ways that others, including 
healthcare professionals, might provide help and useful approaches for the 
patient. 
 
Participation Restriction 
The implications of this study also highlight the limitations of the previous 
research often excluding women and people from non-White backgrounds. 
In fact the predominance of research samples containing solely white 
homosexual men severely limits the ability to use this evidence in day-to-
day practice. New research needs to develop the applicability of the 
evidence base through more representational samples. This research goes 
some way to enabling executive functions in people with HIV to be 
understood in a more diverse group of people. 
 
Executive functions in HIV also have clinical implications for participants‘ 
abilities to undertake substantial employment (Heaton et al., 1994), 
maintain social support structures (Honn & Bornstein, 2002) and 
medication adherence (Hinkin et al., 2002). 
 
Further exploration of executive functions difficulties and the challenges 
impairment can cause to social relationships might be beneficial for both 
staff and families of people with HIV. As difficulties with executive function 
can make people seem eccentric, it is important that the findings of this 
study potentially provide a starting point for developing better information 
for families and patients themselves about executive functions. This may 
also assist staff in providing effective support strategies for people with 
HIV. This should on a wider level help to reduce the isolation of people 
with HIV and executive function difficulties and increase understanding. 
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This understanding of executive function difficulties might also work on a 
wider level to help social understanding and may help to reduce stigma. 
 
Critical Reflection 
This section briefly discusses the issues this piece of research has raised. 
This should be considered in addition to the epistemological position stated 
in the extended methodology section.  
 
This reflection is a guided critical exploration of the central scientific, ethical 
and theoretical positions raised by this research and developing strategies 
for future action (Boud, Keogh & Walter, 1985). Reflection consists of three 
main stages: description of the events, reflective phase against relevant 
theories and finally the development of a learning component (Kim, 1999) 
to help make more sense of complex practice (Driscoll & Teh, 2001). As 
previous authors have suggested guiding structures improve learning 
outcomes from reflection (Platzer, Snelling & Blake, 1997) the Johns model 
(2000) for structured reflection has been flexibly used here. This model 
focuses on discrete events or generalised reflection, such as an individual 
research study rather than process reflection. Although this model was 
developed within nursing practice and has been criticised in its use in 
ongoing situations (Rolfe, Freshwater & Jasper, 2001), it is widely used and 
has strengths in its acknowledgement of the epistemological base of 
reflection (Platzer et al., 1997). However, there is no acknowledged 
validated mechanism for reflection (Platzer et al., 1997) and the evidence 
underlying the value of reflection is limited (Lockyear, Gondocz & Thivierge, 
2004) with no empirically derived models (Lowe, Rappolt, Jaglal & 
Macdonald, 2007).  
 
Reflection does not occur in isolation but within systems and therefore this 
reflection is based on discussion in formal and informal supervision (Ixer 
1999). In addition, because this is reflection-on-action rather than 
reflection–in-action, this is based on my, probably biased, recollections of 
events (Jones et al., 1995). Furthermore, the critical reflective component is 
often seen as being opposed to evidence-based practice due to its basis in 
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the everyday world of the practitioner (Rolfe et al., 2001). In particular, 
critical reflection in research can ‗make visible the vision and stance of the 
researcher, which might otherwise be hidden‘ (Jasper, 2005, p.249), 
particularly important given the epistemological framework of the study. 
Although this reflection does not focus on the narrative of the research 
journal it is written in the first person to allow for more creative and critical 
reflection to emerge. 
 
Johns (2000) Model for Structured Reflection (Appendix P) 
I have not focused on the descriptive elements of the reflection as these are 
covered elsewhere, including an example of the background factors to the 
experience (Appendix K – Example of reflective notes), or are not 
appropriate to be covered here, a description of the experience itself as a 
research narrative. Instead this reflection will focus on the issues that seem 
significant. Particularly this focuses on psychological research within a 
medical domain, commenting on expectations, epistemological frameworks 
and ecological validity. 
 
Aesthetics (Knowledge from Subjective Sources) 
The main aim of the research as I saw it was to attempt to bring meaningful 
neuropsychology into the everyday world of people living and working with 
HIV. Ecological validity is an approach which I tried to apply to the study as 
a whole not just the specific measures used, for example, by using 
pragmatic and real-world approaches to interpretation and scoring. From 
reading the neuropsychological research it seems the people behind HIV 
have sometimes been lost. It seems questionable how meaningful it is to 
dichotomise people into impairment/not impaired based on arbitrary cut-off 
points, with no back-up in the form of functional outcomes or self-report as 
to how cognitive difficulties might affect people in their day-to-day life. This 
may be because of the medical nature of HIV, and the focus until recently 
on preserving life as a very real and valid priority. However, although 
medication has progressed, it seems that research into the neuropsychology 
of people with HIV has become stuck in this phase. This is understandable 
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within the historical context, where cognitive impairment was seen as a sign 
of impending mortality.  
 
I hope that the consequences of this research have started to facilitate a 
shift away from a solely medical model, and also positivistic research, 
perspective with people with HIV and executive function difficulties. If so 
the consequences may contribute an increasing acknowledgement of 
multiple narratives and available perspectives. Ideally this research 
attempts to empirically bridge a gap between quantitative research and 
alternative epistemological frameworks, which might have consequences for 
future research in this area.  
 
Personal 
I may have responded this way to the prior research, because although a 
scientist, as a psychologist my focus is on people, making sense of 
behaviour and the narrative that people tell about their lives, rather than 
HIV-infection per se. This focuses on the meaning people make of cognitive 
difficulties and how that meaning impacts, and is impacted by the social 
world within which we live. 
 
Ethics 
I attempted to minimise the limitations of recruitment strategies in previous 
research by being inclusive, in particular including women, people who 
describe their sexual orientation as heterosexual and people from non-
White ethnic backgrounds. This has wider implications for the research body 
and the requirement to make samples more representative of the changing 
demographic of people with HIV.  
 
I can also reflect on the complexity of giving neuropsychological feedback 
out of context for the individual. The value of considering the meaning of 
executive function impairment based on level of environmental demand and 
the potential effects of anxiety has been demonstrated in the study. This 
should look to influence the wider research and move towards considering 
the individual interpretation and importance of high level cognitive 
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functioning. Bearing in mind that individuals who have HIV will also be 
aware of the history of cognitive difficulties in HIV and the fear this may 
therefore inspire. 
 
Empirics 
This research approach was informed by awareness of different 
epistemological stances and a desire to empirically put into practice 
theoretical issues discussed by authors such as Westerman (2006). This 
provided a basis for understanding neuropsychology in HIV using ecological 
validity as a guiding concept. Despite its common use in neuropsychology 
there are significant controversies over using normative data and whether a 
‗normal curve‘ even exists (Johnson, 1999). Further the research has 
highlighted a personal need to explore alternatives to hypothesis-testing 
research in Bayesian theory (Johnson, 1999). 
 
Reflexivity 
These reflections therefore relate to future research studies both for myself 
and the wider scientific discourse: 
 
 I would use a critical realist perspective again in quantitative research as 
I feel it has enabled a more reflective and honest approach, moving 
away from the assumption that quantitative research can be objective. 
This is a personal development and increased change in my approach to 
research from my previous experiences. 
 A wider development and increasing personal awareness of the 
limitations of using the ‗normal curve‘ assumption within psychology and 
neuropsychology. 
 A greater use of ecological validity as a guiding principle in 
neuropsychology and HIV, focusing on the meaning attributed to 
cognitive functions by individuals and the functional outcomes for them. 
 Although it is not possible to escape the history of cognitive impairment 
in HIV infection, it might be possible to see a new and different way 
forward that moves away from a purely medical model to incorporate the 
socially created aspects of disability taking the lead from the WHO-ICF. 
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Appendices 
Assessment of executive functions in HIV infection using the Behavioural 
Assessment of the Dysexecutive Syndrome: A pilot study 
Name of Researcher: Amanda Campbell Supervisors: Dr. Roshan Das Nair, Jill Balmont 
 
REFERRAL FORM 
We are recruiting people with HIV aged 18 to 60 who meet the following criteria: 
 Diagnosed at least 3 months ago 
 No current intravenous drug use 
 No history of psychosis or current severe depression 
 English speaking 
 Not blind or deaf 
 No previous diagnosis of brain damage, dementia or other neurological disease 
 
 
Please complete the following sections for anyone who you think might be 
suitable and return the form for: 
 
MISS A CAMPBELL, C/O MS SHEILA TEMPLER, 
INSTITUTE OF WORK, HEALTH AND ORGANISATIONS, UNIVERSITY OF NOTTINGHAM,  
INTERNATIONAL HOUSE, B FLOOR, JUBILEE CAMPUS,  
WOLLATON ROAD, 
 NOTTINGHAM, NG8 1BB  
 
Name of Potential Participant:                                                         MALE /
 FEMALE 
Date of Birth: DD/MM/YYYY    
Diagnosis more than 3 months ago: YES/NO                                                       
Telephone Number:                                           as 
Address:                                                                                                                 sd 
                                                                                                                      s                                                                                                                         
 
Preferred contact time: Daytime/Evening/Weekend 
Name of Referrer:                                                                Date: DD/MM/YYYY  
Position of Referrer:                                                          Tel: 
 
If you think there is any risk in completing the research for the potential participant or have any other issues you think 
the psychologist should know about please contact the researcher on the above details before referral 
 
 
 
CONSENT TO PASS ON THIS INFORMATION TO RESEARCHER NAMED ABOVE: 
I consent to have the above mentioned details sent to Amanda Campbell, in order that they 
can determine my eligibility for the study and provide me with further information about the 
research  
 
___________________________  ___________________________    ____________ 
    (Potential Participant’s Name)                  (Signature)           (Date) 
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Study Title:  
Assessment of executive functions in HIV infection using the Behavioural 
Assessment of the Dysexecutive Syndrome: A pilot study 
We would like to invite you to take part in a research study. Before you decide 
to participate you need to understand why the research is being done and what 
it would involve for you. Please take time to read the following information 
carefully. You should: 
 Talk to others about the study if you wish. 
 Ask us if there is anything that is not clear or if you would like more 
information.  
 Take time to decide whether or not you wish to take part. 
Part one of this information sheet will outline the purpose and process of the 
study. Part two will detail the research procedures. 
PART ONE 
What is the purpose of the study? 
HIV infection can sometimes influence how the brain works. This can affect 
skills such as problem solving, planning and decision making. This group of 
skills are called “executive functions” and are important in day to day life, to 
enable us to adapt to everyday situations and inhibit inappropriate social 
behaviour. Problems with these skills are often referred to as the „dysexecutive 
syndrome‟ and can be measured on tests such as the Behavioural Assessment 
of the Dysexecutive Syndrome (BADS). The results of this study should give us 
an idea of the specific effects of HIV infection on executive functions (problems 
solving etc.) on everyday life. This will hopefully allow us to identify any 
problems early in the course of the HIV infection and provide recommendations 
and rehabilitation. The write up of this study will also contribute to completion of 
Doctorate in Clinical Psychology and may lead into further and larger research.  
Why have I been invited?  
You have been chosen because you are living with the day to day impact of HIV 
and are aged between 18 and 60 years. You may have seen some advertising 
and referred yourself or you may have been referred by one of the healthcare 
professionals working with you. We hope to recruit 20 participants to be 
assessed in the same way from NHS services for people with HIV in 
Nottingham. 
Do I have to take part? 
It is up to you to decide. We will describe the study and go through this 
information sheet, which we will then give to you. We will then ask you to sign a 
consent form to show you have agreed to take part. You are free to withdraw at 
any time, without giving a reason. This would not affect the standard of care you 
receive in any way. 
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What will happen to me if I take part? 
Once your details have been forwarded to us we will contact you within one 
week to confirm your details, answer any questions and arrange the 
assessment. With your consent, we will contact a healthcare professional who 
you have contact with (for example, your social worker, nurse, consultant, 
health advisor) – we will not pass on any information about you, this is just to 
inform them of your participation in this study and check you are ready to 
participate in this research.  
The assessment will be one to two weeks after we contact you. Depending on 
what is best for you, you will meet with the researcher at the clinic/centre where 
you are normally seen, or your home. The appointment will be with you and the 
lead researcher and will last approximately an hour and a half. First we will 
collect some demographic information (this is general information which might 
describe you, such age, gender and ethnicity). We will then confirm that you 
understand what will be required of you. You will then be asked to fill in some 
brief questionnaires. These will look at how things are for you day to day 
(Dysexecutive Questionnaire – 20 multiple choice questions), a baseline 
measure of general ability (Wechsler Test of Adult Reading – reading some 
common and uncommon words) and a questionnaire on mood (Hospital Anxiety 
and Depression Scale – 14 multiple choice questions). At this point we will have 
a short break. The following part will involve a series of 6 short pencil and paper 
tasks. This will involve some drawing, answering questions and practical tasks 
that require „executive‟ skills like planning and decision making. We will ask you 
for the name of a member of staff who works with you (for example, nurse, 
medical consultant, social worker, health advisor) or alternatively someone who 
knows you well. We will send them a questionnaire to complete about how they 
see any difficulties you might have. With your permission we will also find out 
your HIV stage, CD4 count, plasma viral load and what, if any, type of 
medications you are taking. This will help us understand your results. 
After two weeks you will be sent written feedback. You can choose to meet with 
the researcher to discuss the results if you would like. Dependent on your 
consent, the people who work with you may also have a copy of your written 
report.  
This is a cross-sectional descriptive study, which means that we are 
measuring what is happening already rather than trying to change anything. 
Therefore, this assessment should not interfere with your current treatment in 
any negative way. There is no arrangement for long-term follow-up. However, 
referrals to appropriate services can be made if we feel it might be useful for 
you.  
There is the possibility that you may not be able to complete the research or 
that this is not the right time for you to complete this research. If this is the case, 
the researcher will discuss the reasons for this with you and we can refer you 
on to other services if you think this would be useful. 
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‗Caseworker‘ contacted (with your consent) to consider risks for you 
from participation in the study 
 
Some clinical information from your notes will be collected by a 
member of staff working in the service or the lead researcher. 
 
Assessment with lead researcher and you (about 1 ½ hours) 
– Sight, hearing and communication test  
– Demographic information 
 
May stop here if you could not complete the assessment  
 
– Information sheet and question discussed and take consent    
– Dysexecutive Questionnaire (DEX)  
– Wechsler Test of Adult Reading (WTAR) 
– Hospital Anxiety and Depression Scale (HADS)                    
 
Break  
 
– BADS 
 
Written feedback of your test results – with option for face-to-face 
feedback if you would prefer 
 
(Optional) Written report forwarded to caseworker/referrer as required 
with your consent. 
 
Staff-Referral  
 
You will be contacted by the lead researcher by phone/letter  
Recruitment  
 
Self-Referral  
 
Information sheet sent out to you 
 
Designated ‗other‘ will be contacted by phone to explain purpose of 
DEX. This will then be posted out to them with a stamped addressed 
envelope to return to the researchers. 
 
Time 
(weeks) 
6 
5 
1 
3 
Flowchart 
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Appendix C 
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Expenses and Payment? 
We offer a £10 voucher for Boots for participation in the study. 
What will I have to do? 
If you agree to participate you will be asked to take part in one session 
(described above). As well as participation in the study you will be asked to give 
consent for: 
 A member of healthcare staff to be informed of your participation 
 Your medical notes to be reviewed by the lead researcher 
 A person who knows you well to complete a questionnaire  
You will not have to change any medication or treatment that you are currently 
receiving or any day-to-day activities. 
What are the possible disadvantages and risks of taking part? 
There are no particular risks for you in taking part. However, some people may 
find the results of the testing upsetting. However, we can help to refer you to 
support services in these circumstances if needed. 
What are the possible benefits of taking part? 
The results of the study might help you and others around you understand why 
you might find some things more difficult than other people. If the results do not 
show any problems this may help to put your mind at rest or provide a baseline 
for possible future assessments in other services. However, although we cannot 
promise the study will help you directly, the information we get from this study 
might help improve the treatment of other people with HIV. 
What happens when the research study stops? 
Your care and treatment continue as usual. 
What if there is a problem? 
Any complaints about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. Detailed information on this is 
given in Part 2. 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will 
be handled in confidence. The details are included in Part 2.  
If the information in Part 1 has interested you and you are considering 
participation, please read the additional information in Part 2 before 
making any decision. 
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PART TWO 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw at any time in the study process without ongoing care 
being affected in any way. Although you do not have to give a reason for 
withdrawing, there will be the opportunity to express your reasons if you wish. If 
you withdraw from the study your information will be removed from the study 
and all information will be kept confidential (see ‘Will my taking part in this 
study be kept confidential?’ below for details). However, information cannot 
be destroyed and has to be stored confidentially in accordance with the 
university policy 
What if there is a problem? 
It is unlikely that any harm will come to you by taking part in this study. 
However, if you have a concern about any aspect of this study, you should ask 
to speak to the researchers who will do their best to answer your question. If 
you remain unhappy and wish to complain formally, you can do this through the 
NHS Complaints Procedure. Contact details for the Nottinghamshire Healthcare 
NHS Trust Complaints are: 
Patient Advice and Liaison Service Telephone Number – 0800 015 3367 
Or: Elaine Read  
Service Liaison Manager 
Nottinghamshire Healthcare NHS Trust, Duncan Macmillan House, 
Porchester Road, Nottingham, NG3 6AA  
Tel: 0115 993 4542  
In the event that something does go wrong and you are harmed during the 
research and this is due to someone‟s negligence then you may have grounds 
for a legal action for compensation against Nottinghamshire Healthcare NHS 
Trust, but you may have to pay your legal costs.  
Will my taking part in this study be kept confidential? 
All data collected through your participation in the study will be kept completely 
confidential. If you join the study, some parts of your medical records might be 
looked at by the researcher to find out your CD4 count, plasma viral load and 
HIV medication details. Any information about you which leaves the 
hospital/surgery will have your name and address removed so that you cannot 
be recognised. You will be assigned a unique research code which will be used 
instead of your name on all information so you will not be identifiable. Data will 
be stored securely under responsibility of the custodian at the University of 
Nottingham (the researcher‟s supervisor, Dr. Roshan das Nair). Paper 
information will be marked confidential and stored in a locked filing cabinet and 
electronic information will be stored on a password-protected database. People 
who have access to your information are: the lead researcher, research 
supervisor. They may also be looked at by authorised people (sponsors, 
regulatory authorities and R&D audit) to check that the study is being carried  
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out correctly. All who have access to your information have a duty of 
confidentiality to you as a research participant and we will do our best to meet 
this duty. Your information will not be retained for future studies although due to 
the University of Nottingham policy, it has to be kept for reference purposes. 
The information will be dated and stored securely for 7 years and subsequently 
destroyed securely. You have the right to check the accuracy of data held about 
you and correct any errors. 
The only time we would break your confidentiality is if we felt that you or 
someone else were at risk, and if this was the case we are obligated by law to 
disclose this to people in authority, on a need to know basis, but we would try 
and discuss this with you first. 
Involvement of Other Healthcare Professionals? 
If you have referred yourself to this study, with your consent, we would like to 
contact a member of healthcare staff who you have contact with (for example, 
your social worker, nurse, consultant, health advisor) to inform them of your 
involvement. This is to ensure that there are no risks to you in taking part at this 
time and that you can receive the best care if the study finds any problems. At 
the end of your time on the research study, dependent on your consent, the 
written report can be forwarded to relevant healthcare professionals. This report 
will include results of your participation in the study and any recommendations 
we think might help. We are happy to share or discuss any of this information 
beforehand. 
What will happen to the results of the research study? 
The overall results of the study are intended to be published in a scientific 
journal and possibly presented at conferences. At the end of the study you will 
be asked if you would like a summary of results to be sent out to you when 
these are available. You will not be identified in any report/publication.  
Who is organising and funding the research? 
This research is forming part of a Doctorate in Clinical Psychology qualification 
at the University of Nottingham. 
Who has reviewed this study? 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee to protect your safety, rights, wellbeing and dignity. 
This study has been reviewed and given favourable opinion by Leicestershire, 
Northamptonshire & Rutland Research Ethics Committee. 
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Further information and contact details 
You might want further information for example about:  
 General or specific information about the process 
 Advice on whether to participate 
 Who you should go to if you are unhappy with the study 
 
In the first instance the researcher should be able to answer your questions. 
Further information sources are available on request from the researcher. 
If you have any concerns during the study please contact: 
Amanda Campbell, Trainee Clinical Psychologist  (mobile 07990938967) 
Or Dr. Roshan Das Nair, Consultant Psychologist 
I-WHO, University of Nottingham, International House, B Floor, Jubilee 
Campus, Wollaton Road, Nottingham, NG8 1BB Telephone: 0115 846 6646  e-
mail: lwxajc@nottingham.ac.uk  
 
Or Jill Balmont, Clinical Psychologist 
Clinical Psychology Department, Nottinghamshire Healthcare NHS Trust, The 
Forest, Southwell Rd., Mansfield, Nottingham, NG18 4HH Telephone: 01623 
784910 
 
Alternatively messages can be left with: 
 
Sheila Templer, Course Administrator – DClinPsy 
I-WHO, University of Nottingham, International House, B Floor, Jubilee 
Campus, Wollaton Road, Nottingham, NG8 1BB Telephone: 0115 846 6646  
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For a study looking at problem-solving skills 
in people who are living with HIV. 
We are looking for adults, aged between 18 to 60 years 
old, who have been living with the effects of HIV for more 
than 3 months, to participate in an assessment to explore 
problem-solving and decision making skills. 
The results of this will help us learn how to identify 
people with HIV who have difficulties with problem 
solving. This will mean that we can design treatment 
programmes and services to offer appropriate support 
for these people. Feedback will also be available on your 
own performance on the tests.  
You will receive a £10 Boots voucher for your 
participation. 
If you would like more information or you want to 
express an interest in taking part then please discuss this 
with staff and/or contact: 
Amanda Campbell, Trainee Clinical Psychologist 
I-WHO, University of Nottingham, International House, B 
Floor, Jubilee Campus, Wollaton Road, Nottingham, NG8 1BB 
Supervised Dr. Roshan Das Nair and Jill Balmont 
 
Telephone: 0115 846 6646     e-mail: lwxajc@nottingham.ac.uk 
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CONSENT FORM  
 
Title of Project: Assessment of executive functions in HIV-1infection 
using the Behavioural Assessment of the Dysexecutive Syndrome: A 
pilot study 
 
Name of Researcher: Amanda Campbell 
Supervisors: Dr. Roshan Das Nair, Jill Balmont 
 
Please initial box  
 
1. I confirm that I have read and understand the information 
sheet (version 2 19/11/08) for the above study. I have had the 
opportunity to consider the information, ask questions and 
have had these answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, 
without my medical care or legal rights being affected.  
 
3. I confirm that I have seen the medical note proforma and 
give permission for relevant sections of my medical notes to 
be accessed and recorded by the researcher.  
 
4. I give permission for                                                  to fill 
in a questionnaire to provide additional information in the 
assessment. 
 
5. I understand that a healthcare professional who I have contact 
with will be informed of my participation. 
 
6. I agree that my case-worker or the person who referred me 
may be informed of the results. 
 
7. I agree to take part in the above study.  
 
 
_______________    ________________ _________________  
Name of Patient   Date     Signature  
 
 
_________________ ________________ _________________   
Name of Person   Date     Signature  
taking consent  
 
 
When completed: 1 for patient;  
 1 for researcher site file;  
 1 (original) kept in medical notes. 
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ID: 
Date: 
 
Sight test:       YES/NO 
Hearing:       YES/NO 
Sheffield Screening Test administered:  YES/NO  
Hospitalisation (>1 night stay) for illness/infection in last 2 weeks:     
YES/NO 
Medication change in the last 2 weeks:  YES/NO 
Any of the following: 
 Head Injury/Stroke     YES/NO 
Further Information: 
 
 
 Degenerative neurological condition YES/NO 
Further Information: 
 
 Brain Tumour     YES/NO 
 
 Schizophrenia     YES/NO 
 
 Current Severe Depression   YES/NO 
 
 Current injecting Drug Use   YES/NO 
 
Consent Taken:      YES/NO 
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Ethnicity:  White 
A British 
B Irish 
C Any other White background 
 
Mixed 
D White and Black Caribbean 
E White and Black African 
F White and Asian 
G Any other mixed background 
 
Asian or Asian British 
H Indian 
J Pakistani 
K Bangladeshi 
L Any other Asian background 
 
Black or Black British 
M Caribbean 
N African 
P Any other Black background 
 
Other Ethnic Groups 
R Chinese 
S Any other ethnic group 
 
Z Not stated 
 
Sexual Practice: Homosexual 
   Heterosexual 
   Bisexual 
   Abstinent   
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Education:  5-11 years 
   12-13 years 
   14-16 years 
   17+ years 
 
Employment: Employed  
Part/Full time 
Paid/Voluntary 
Occupation: 
   Unemployed: 
Disability related to HIV 
 
Disability other than HIV (specified) 
 
Living Arrangements: Alone 
With Spouse/Partner 
With other/s – specified 
  
Drug and Alcohol Intake per Week:   
Type of Substance Frequency (daily) Frequency (monthly) 
Alcohol   
Cannabis   
Amphetamine   
Opioid   
Other   
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DEX Self Rated:  YES/NO 
 
DEX Other Rated:  YES/NO 
 
WTAR Administered:  YES/NO 
 
HADS Administered: YES/NO 
 
BADS Administered: YES/NO 
 
Designated Significant Other: 
       Relationship: 
      Contact Details (if known): 
 
 
 
Feedback:    Face-to-face/Written/None 
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Medical Note Review  
 
Title of Project: Assessment of executive functions in HIV-1infection 
using the Behavioural Assessment of the Dysexecutive Syndrome: A 
pilot study 
 
Name of Researcher: Amanda Campbell 
Supervisors: Dr. Roshan Das Nair, Jill Balmont 
 
ID Code: 
Approximate Date of Diagnosis:   DD/MM/YYYY 
Current CDC Classification:  Asymptomatic/Symptomatic/AIDS 
 
CD4 Count:   Most Recent:                       ss 
 
Plasma Viral Load:  Most Recent:                       s 
 
Medication Regime:  Mono-therapy 
Duo-therapy 
Triple-therapy (HAART) 
Quad-therapy + 
None 
 
Date of last medication change: DD/MM/YYYY 
 
Name of staff completing form: 
Position: 
(Circle one) 
(Circle one) 
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Measure 
(Abbreviation) 
Author Brief Description Executive Function 
Skills Assessed 
Traditional Tests 
Controlled Oral 
Word Association 
(COWAT/Verbal 
fluency/FAS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
Benton & 
Hamsher 
(1976) 
People are asked to 
name as many words as 
they can within one 
minute. This is repeated 
for three letter: F, A, S 
and sometime for 
categories  
 Generation of 
ideas 
 Set-shifting 
 
Cognitive 
Estimates Test 
(CET) 
Shallice & 
Evans 
(1978) 
People are asked to 
estimate answers in 
response  to questions 
relating to: quantity, 
size, weight, height, 
time 
 Devising an 
appropriate 
cognitive plan 
Tower of London Shallice 
(1982) 
People are asked to 
move four different sized 
disks stacked over three 
pegs to create a certain 
arrangement. However, 
only one disk can be 
moved at once and a 
larger disk can never be 
placed on top of a 
smaller one  
 Problem-solving 
 Inhibition 
Trail Making Test 
(TMT) 
Reitan 
(1958) 
People have to make a 
‗trail‘ first between a 
series of numbers and 
secondly alternating 
between numbers and 
letters 
 Visuo-motor 
tracking 
 Set-shifting 
Stroop Test Stroop 
(1935) 
People are presented 
with colour-words, for 
example ‗blue‘, although 
typed in a consistent or 
different colour 
described by the word. 
People are instructed to 
say either the word or 
the colour the word is 
printed in 
 Inhibition 
 Speed of 
processing 
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Wisconsin Card 
Sort (WCST) 
Heaton, 
Chelune, 
Talley, Kay 
& Curtiss 
(1993) 
People are presented 
with a series of cards 
and have to identify the 
rule governing them. 
This rule changes from 
time to time without 
informing the person; 
they have to identify 
that rule changes  
 Abstract 
reasoning 
 Set-shifting 
 
Neuropsychological batteries based on traditional tests 
Cambridge 
Neuropsychological 
Test Automated 
Battery (CANTAB) 
Sahakian & 
Owen 
(1992) 
Computerised battery of 
22 tests includes go/no-
go, Cambridge Gambling 
task, Intra-extra 
dimensional set shift 
 Decision-
making 
 Complex 
attention 
 Planning 
 Verbal and 
visual memory 
Delis-Kaplan 
executive Function 
System (D-KEFS) 
Delis, 
Kaplan & 
Kramer 
(2001) 
This battery has adapted 
and included versions of 
all of the above 
individual tests as well 
as new versions 
 All as above 
Measure with good ecological validity 
Hayling & Brixton 
Tests 
 
Burgess & 
Shallice 
(1997) 
Used to assess people 
who might find the 
BADS easy. Assess 
sentence completion and 
spatial anticipation 
 Logical 
reasoning 
 Inhibition 
 Speed of 
processing  
 Set-shifting 
Iowa Gambling 
Task (IGT) 
Bechara et 
al. (2001) 
People are asked to 
select cards from four 
decks. Each card 
selection either results in 
winning or losing money 
and people have to 
amass as much money 
as possible  
 
 Decision-
making 
Multiple Errands 
Test (MET) 
Shallice & 
Burgess 
(1991) 
People are observed 
carrying out a set of 
tasks within the 
naturalistic environment 
of a shopping centre 
 Strategy 
application 
 All executive 
function skills 
Virtual Planning 
Test (VIP) 
O‘Niel-
Pirozzi, & 
Goldstein 
(2005) 
People have to plan and 
sequence activities 
through a board game 
 Planning 
 Sequencing 
     
 
 
 
 
 
Appendix K Excerpts from Reflective Notes 
Previous clinical experience with 
the BADS (25/01/08) 
 
―I have had previous positive 
experiences, particularly in 
terms of client engagement, 
using isolated subtests of the 
BADS prior to conducting the 
research. This may make me 
more likely to point towards the 
benefits of the BADS. However, 
I have no used the battery as a 
whole before so this new 
experience may be an 
opportunity for me to revise my 
beliefs about it as a measure.‖ 
My understanding and values of 
relating to everyday functioning 
(23/03/09) 
 
―As I have started the assessment it 
has brought to mind my own views 
on what ‗good‘ everyday functioning 
might be. Although I am open to 
idiographic preferences and values 
for everyday I am also becoming 
aware that I place a value on 
employment which I am now 
beginning to question. This 
importance on employment may be 
due to the underlying cultural 
assumption that people are 
happiest when they are occupied 
and unless there is a physical 
reason preventing them people 
should work. This might make me 
place additional importance on 
functional outcomes such as 
employment, rather than other, 
equally valid functional outcomes. It 
might be more valuable to place 
importance the demands an 
environment place on each 
individual.‖  
     
 
 
Appendix L Trust A R&D Approval (2 pages) 
Page 1 of 2 
     
 
Appendix L 
Page 2 of 2 
     
 
 
 
 
Appendix M Trust A Honorary Contract (2 Pages) 
Page 1 of 2 
     
 
 
Appendix M  
Page 2 of 2 
     
 
 
Page 1 of 2 
Appendix N Trust B R&D Approval (2 Pages) 
     
 
 
Appendix N 
Page 2 of 2 
     
 
 
Appendix O Trust B Honorary Contract (4 pages) 
Page 1 of 4 
     
 
 
Appendix O 
Page 2 of 4 
     
 
 
Appendix O 
Page 3 of 4 
     
 
 
Appendix O 
Page 4 of 4 
     
 
 
 
 
1. Looking in 
Find a space to focus on self 
Pay attention to your thoughts & emotions 
Write down those thoughts & emotions that seem significant in realising 
desirable work 
 
2. Looking out 
Write a description of the situation surrounding your thoughts & feelings 
Describe the ‗here and now‘ experience 
What essential factors contributed to this experience? 
What are the significant background factors to this experience? 
 
3. What issues seem significant? 
 
Aesthetics 
What was I trying to achieve? 
Why did I respond the way I did? 
What were the consequences of my action for myself/the patient/family/the 
people I work with? 
How did the others feel about it? 
How did I know how others felt that way? 
 
Personal 
Why did I feel the way I did within this situation? 
 
Ethics 
Did I act for the best? 
What factors (either embodied within me/within the environment) were 
influencing me? 
 
Empirics 
What knowledge did or could have informed me? 
 
 
4. Reflexivity 
Does this situation relate to other experiences? 
How could I have handled this situation differently? 
What would be the consequences of alternative actions for the 
patient/others/myself? 
How do I feel about this experience now? 
Has this experience changed my way of knowing? (empirics, aesthetics, 
ethics or personal)  
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